BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17. [PMID: 15168363 DOI: 10.1053/j.gastro.2004.01.063] [Cited by in Crossref: 2061] [Cited by in F6Publishing: 2226] [Article Influence: 108.5] [Reference Citation Analysis]
Number Citing Articles
1 Nawghare P, Jain S, Chandnani S, Rathi P. A Case of Acute Severe Ulcerative Colitis Triggered by COVID-19 Infection. Cureus 2023. [DOI: 10.7759/cureus.34369] [Reference Citation Analysis]
2 Torres J, Chaparro M, Julsgaard M, Katsanos K, Zelinkova Z, Agrawal M, Ardizzone S, Campmans-Kuijpers M, Dragoni G, Ferrante M, Fiorino G, Flanagan E, Gomes CF, Hart A, Hedin CR, Juillerat P, Mulders A, Myrelid P, O'Toole A, Rivière P, Scharl M, Selinger CP, Sonnenberg E, Toruner M, Wieringa J, Van der Woude CJ. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. J Crohns Colitis 2023;17:1-27. [PMID: 36005814 DOI: 10.1093/ecco-jcc/jjac115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Chen Q, Fan Y, Zhang B, Yan C, Chen Z, Wang L, Hu Y, Huang Q, Su J, Ren J, Xu H. Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis. Front Cell Infect Microbiol 2022;12:1086885. [PMID: 36683707 DOI: 10.3389/fcimb.2022.1086885] [Reference Citation Analysis]
4 Harjunen A, Puolakkainen E, Laine HK, Rautava J. Men with Crohn's disease may have an increased risk for head and neck squamous cell carcinoma - a nationwide register study. Clin Oral Investig 2023;27:625-30. [PMID: 36308560 DOI: 10.1007/s00784-022-04762-w] [Reference Citation Analysis]
5 Sil M, Mitra S, Goswami A. Probiotics and immunity: An overview. Viral, Parasitic, Bacterial, and Fungal Infections 2023. [DOI: 10.1016/b978-0-323-85730-7.00007-2] [Reference Citation Analysis]
6 Rintala RJ, Pakarinen MP. Inflammatory Bowel Disease. Pediatric Surgery 2023. [DOI: 10.1007/978-3-030-81488-5_76] [Reference Citation Analysis]
7 Yang L, Chen H, Yang Y, Deng Y, Chen Q, Luo B, Chen K. Single-cell and microarray chip analysis revealed the underlying pathogenesis of ulcerative colitis and validated model genes in diagnosis and drug response. Hum Cell 2023;36:132-45. [PMID: 36445533 DOI: 10.1007/s13577-022-00801-6] [Reference Citation Analysis]
8 Şimşek-Onat P, Hizarcioglu-Gulsen H, Ergen YM, Gumus E, Özen H, Demir H, Özen S, Saltık-Temizel İN. Neutrophil-to-Lymphocyte Ratio: An Easy Marker for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Children. Dig Dis Sci 2023;68:233-9. [PMID: 35579794 DOI: 10.1007/s10620-022-07547-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Waqar M, Raguraj T, Chandradevan R. Literature Review of Inflammatory Bowel Disease in South Asian Populations. OJGas 2023;13:67-79. [DOI: 10.4236/ojgas.2023.132008] [Reference Citation Analysis]
10 Underhill J, Pinzon MCM, Ritz E, Grunvald M, Jochum S, Becerra A, Bhama A, Govekar H, Saclarides T, Hayden D. Defining diverticular fistula through inpatient admissions: a population study. Surg Endosc 2023;37:645-52. [PMID: 36006522 DOI: 10.1007/s00464-022-09504-3] [Reference Citation Analysis]
11 Alvestad L, Jelsness-Jørgensen LP, Goll R, Clancy A, Gressnes T, Valle PC, Broderstad AR. Health-related quality of life in inflammatory bowel disease: a comparison of patients receiving nurse-led versus conventional follow-up care. BMC Health Serv Res 2022;22:1602. [PMID: 36587197 DOI: 10.1186/s12913-022-08985-1] [Reference Citation Analysis]
12 Kondo K, Ono Y, Ohfuji S, Watanabe K, Yamagami H, Watanabe M, Nishiwaki Y, Fukushima W, Hirota Y, Suzuki Y; Japanese Case‐Control Study Group for Ulcerative Colitis. Smoking and drinking habits relating to development of ulcerative colitis in Japanese: A multicenter case-control study. JGH Open 2023;7:61-7. [PMID: 36660047 DOI: 10.1002/jgh3.12857] [Reference Citation Analysis]
13 Wang W, Wu Y, Wang Y, Wang R, Deng C, Yi L, Wang L, He M, Zhou W, Xie Y, Jin Q, Chen Y, Gao T, Zhang L, Xie M. Orally Administrable Aggregation-Induced Emission-Based Bionic Probe for Imaging and Ameliorating Dextran Sulfate Sodium-Induced Inflammatory Bowel Diseases. Adv Healthc Mater 2022;:e2202420. [PMID: 36575111 DOI: 10.1002/adhm.202202420] [Reference Citation Analysis]
14 Ren R, Zhao AQ, Chen L, Wu S, Hung WL, Wang B. Therapeutic effect of Lactobacillus plantarum JS19 on mice with dextran sulfate sodium induced acute and chronic ulcerative colitis. J Sci Food Agric 2022. [PMID: 36573836 DOI: 10.1002/jsfa.12414] [Reference Citation Analysis]
15 Khatib A.a. Al-ruweidi M, Khater N, Rashid Alkaabi H, Hasan M, C. Yalcin H. Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology. Immunology of the GI Tract - Recent Advances 2022. [DOI: 10.5772/intechopen.106184] [Reference Citation Analysis]
16 Suleiman AA, Goebel A, Bhatnagar S, D'Cunha R, Liu W, Pang Y. Population Pharmacokinetic and Exposure-Response Analyses for Efficacy and Safety of Risankizumab in Patients With Active Crohn's Disease. Clin Pharmacol Ther 2022. [PMID: 36534322 DOI: 10.1002/cpt.2831] [Reference Citation Analysis]
17 Narula N, Wong ECL, Pray C, Marshall JK, Rangarajan S, Islam S, Bahonar A, Alhabib KF, Kontsevaya A, Ariffin F, Co HU, Al Sharief W, Szuba A, Wielgosz A, Diaz ML, Yusuf R, Kruger L, Soman B, Li Y, Wang C, Yin L, Erkin M, Lanas F, Davletov K, Rosengren A, Lopez-Jaramillo P, Khatib R, Oguz A, Iqbal R, Yeates K, Avezum Á, Reinisch W, Moayyedi P, Yusuf S. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study. Clin Gastroenterol Hepatol 2022:S1542-3565(22)01129-6. [PMID: 36528284 DOI: 10.1016/j.cgh.2022.11.037] [Reference Citation Analysis]
18 Hu H, Zhang W, Xiong P, Song L, Jia B, Liu X. Anti-inflammatory and antioxidant activity of astragalus polysaccharide in ulcerative colitis: A systematic review and meta-analysis of animal studies. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1043236] [Reference Citation Analysis]
19 Ahmed-Khan MA, Moin K, Funk CM, Carmona-Pires F. A Rare Case of Pseudomembrane-Associated Ulcerative Colitis. Cureus 2022;14:e33152. [PMID: 36726919 DOI: 10.7759/cureus.33152] [Reference Citation Analysis]
20 Holman J, Hurd M, Moses PL, Mawe GM, Zhang T, Ishaq SL, Li Y. Interplay of broccoli/broccoli sprout bioactives with gut microbiota in reducing inflammation in inflammatory bowel diseases. J Nutr Biochem 2022;113:109238. [PMID: 36442719 DOI: 10.1016/j.jnutbio.2022.109238] [Reference Citation Analysis]
21 Deng LR, Han Q, Zou M, Chen FJ, Huang CY, Zhong YM, Wu QY, Tomlinson B, Li YH. Identification of potential immunomodulators from Pulsatilla decoction that act on therapeutic targets for ulcerative colitis based on pharmacological activity, absorbed ingredients, and in-silico molecular docking. Chin Med 2022;17:132. [PMID: 36434688 DOI: 10.1186/s13020-022-00684-7] [Reference Citation Analysis]
22 Wang L, Wang Y, Wang XE, Chen B, Zhang L, Lu X. Causal association between atopic eczema and inflammatory bowel disease: A two‐sample bidirectional Mendelian randomization study of the East Asian population. The Journal of Dermatology 2022. [DOI: 10.1111/1346-8138.16642] [Reference Citation Analysis]
23 Mohajeri S, Moayedi S, Mohajeri S, Yadegar A, Haririan I. Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1045575] [Reference Citation Analysis]
24 Pemmasani G, Loftus EV, Tremaine WJ. Prevalence of Pulmonary Diseases in Association with Inflammatory Bowel Disease. Dig Dis Sci 2022;67:5187-94. [PMID: 35142913 DOI: 10.1007/s10620-022-07385-z] [Reference Citation Analysis]
25 Bertilla XJ, Rupachandra S. Insights into current directions of protein and peptide-based hydrogel drug delivery systems for inflammation. Polym Bull 2022. [DOI: 10.1007/s00289-022-04527-1] [Reference Citation Analysis]
26 Cantero-Recasens G, Burballa C, Ohkawa Y, Fukuda T, Harada Y, Curwin AJ, Brouwers N, Thun GA, Gu J, Gut I, Taniguchi N, Malhotra V; IBD Character Consortium. The ulcerative colitis-associated gene FUT8 regulates the quantity and quality of secreted mucins. Proc Natl Acad Sci U S A 2022;119:e2205277119. [PMID: 36252012 DOI: 10.1073/pnas.2205277119] [Reference Citation Analysis]
27 Greywoode R, Cunningham C, Hollins M, Aroniadis O. Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease. J Clin Gastroenterol 2022. [PMID: 36227025 DOI: 10.1097/MCG.0000000000001782] [Reference Citation Analysis]
28 Wang Z, Iida N, Seishima J, Okafuji H, Yutani M, Fujinaga Y, Hashimoto Y, Tomita H, Mizukoshi E, Kaneko S. Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis. J Gastroenterol 2022;57:770-83. [PMID: 35882645 DOI: 10.1007/s00535-022-01905-4] [Reference Citation Analysis]
29 Dane B, Kernizan A, O'Donnell T, Petrocelli R, Rabbenou W, Bhattacharya S, Chang S, Megibow A. Crohn's disease active inflammation assessment with iodine density from dual-energy CT enterography: comparison with endoscopy and conventional interpretation. Abdom Radiol (NY) 2022;47:3406-13. [PMID: 35833999 DOI: 10.1007/s00261-022-03605-2] [Reference Citation Analysis]
30 Liu Y, Yan H, Yu B, He J, Mao X, Yu J, Zheng P, Huang Z, Luo Y, Luo J, Wu A, Chen D. Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties. Antioxidants 2022;11:1947. [DOI: 10.3390/antiox11101947] [Reference Citation Analysis]
31 Szymczak-tomczak A, Ratajczak AE, Kaczmarek-ryś M, Hryhorowicz S, Rychter AM, Zawada A, Słomski R, Dobrowolska A, Krela-kaźmierczak I. Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases. JCM 2022;11:5715. [DOI: 10.3390/jcm11195715] [Reference Citation Analysis]
32 Gadjalova I, Heinze JM, Goess MC, Hofmann J, Albers JJ, Spallek R, Blissenbach B, Buck A, Weber M, Scherer E, Kampick M, Öllinger R, Krut O, Rad R, Steiger K, Winter C, Janssen K, Neumann P, Geha RS, Ruland J, Keppler SJ. B/T cell crosstalk and aberrant inflammatory IgG exacerbate autoimmune intestinal inflammation.. [DOI: 10.1101/2022.09.12.507066] [Reference Citation Analysis]
33 Xiong D, Shi X, Han M, Zhang X, Wu N, Sheng X, Wang J. The regulatory mechanism and potential application of IL-23 in autoimmune diseases. Front Pharmacol 2022;13:982238. [DOI: 10.3389/fphar.2022.982238] [Reference Citation Analysis]
34 Kolahi SN, Salehi Z, Sasani ST, Mashayekhi F, Aminian K. Polymorphisms of miR-146a and susceptibility to ulcerative colitis risk: a case-control study. Nucleosides, Nucleotides & Nucleic Acids 2022. [DOI: 10.1080/15257770.2022.2118768] [Reference Citation Analysis]
35 Gordon BL, Galati JS, Yang S, Longman RS, Lukin D, Scherl EJ, Battat R. Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease. World J Gastroenterol 2022; 28(33): 4834-4845 [DOI: 10.3748/wjg.v28.i33.4834] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Alrubia S, Mao J, Chen Y, Barber J, Rostami-Hodjegan A. Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs. Clin Pharmacokinet 2022. [PMID: 36056298 DOI: 10.1007/s40262-022-01169-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Renuzza SSS, Vieira ER, Cornel CA, Lima MN, Ramos Junior O. INCIDENCE, PREVALENCE, AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN THE STATE OF PARANÁ IN SOUTHERN BRAZIL. Arq Gastroenterol 2022;59:327-333. [DOI: 10.1590/s0004-2803.202203000-60] [Reference Citation Analysis]
38 Alavinejad P, Nayebi M, Parsi A, Farsi F, Maghool F, Alipour Z, Alimadadi M, Ahmed MH, Cheraghian B, Hang DV, Shahrokh S, Emami MH, Hashemi SJ, Alboraie M, Dehnavi D, Riazi M, Seyedian SS, Emara MH, Lenz L, Tran QT, Shahinzadeh S, Daryani NE, Hajiani E, Moghaddam EK, Shahi MM, Rezvanifar M, Azimi T. IS DAIRY FOODS RESTRICTION MANDATORY FOR INFLAMMATORY BOWEL DISEASE PATIENTS: A MULTINATIONAL CROSS-SECTIONAL STUDY. Arq Gastroenterol 2022;59:358-364. [DOI: 10.1590/s0004-2803.202203000-65] [Reference Citation Analysis]
39 Asanuma N. Effect of Dietary Ceramide and Glucosylceramide on the Alleviation of Experimental Inflammatory Bowel Disease in Mice. J Oleo Sci 2022;71:1397-402. [PMID: 35965094 DOI: 10.5650/jos.ess22169] [Reference Citation Analysis]
40 Katsandegwaza B, Horsnell W, Smith K. Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease. Int J Mol Sci 2022;23:9344. [PMID: 36012618 DOI: 10.3390/ijms23169344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Shi Y, Feng S, Yan M, Wei S, Yang K, Feng Y. Inflammatory bowel disease and celiac disease: A bidirectional Mendelian randomization study. Front Genet 2022;13:928944. [DOI: 10.3389/fgene.2022.928944] [Reference Citation Analysis]
42 Stemmer M, Parmet Y, Ravid G. Identifying Patients With Inflammatory Bowel Disease on Twitter and Learning From Their Personal Experience: Retrospective Cohort Study. J Med Internet Res 2022;24:e29186. [PMID: 35917151 DOI: 10.2196/29186] [Reference Citation Analysis]
43 Halfvarson J, Ludvigsson JF, Bresso F, Askling J, Sachs MC, Olén O. Age determines the risk of familial inflammatory bowel disease-A nationwide study. Aliment Pharmacol Ther 2022;56:491-500. [PMID: 35460098 DOI: 10.1111/apt.16938] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Akbari H, Akbari A, Ghiasvand R, Tamizifar B, Saneei P, Feizi A, Pourmasoumi M. The association between dietary patterns and the risk of developing ulcerative colitis. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.08.009] [Reference Citation Analysis]
45 Dipasquale V, Romano C. Genes vs environment in inflammatory bowel disease: an update. Expert Rev Clin Immunol 2022. [PMID: 35912838 DOI: 10.1080/1744666X.2022.2108407] [Reference Citation Analysis]
46 Stavrou EF, Chatzopoulou F, Antonatos C, Pappa P, Makridou E, Oikonomou K, Kapsoritakis A, Potamianos PS, Karmiris K, Tzathas C, Chatzidimitriou D, Vizirianakis IS, Vasilopoulos Y. Pharmacogenetic analysis of canonical versus noncanonical pathway of NF-kB in Crohn's disease patients under anti-tumor necrosis factor-α treatment. Pharmacogenet Genomics 2022;32:235-41. [PMID: 35852914 DOI: 10.1097/FPC.0000000000000471] [Reference Citation Analysis]
47 Odeyinka O, Alhashimi R, Thoota S, Ashok T, Palyam V, Azam AT, Sange I. The Role of Capsule Endoscopy in Crohn's Disease: A Review. Cureus 2022. [DOI: 10.7759/cureus.27242] [Reference Citation Analysis]
48 Aslan Çin NN, Whelan K, Özçelik AÖ. Food-related quality of life in inflammatory bowel disease: measuring the validity and reliability of the Turkish version of FR-QOL-29. Health Qual Life Outcomes 2022;20. [DOI: 10.1186/s12955-022-02014-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Wang F, Li Q, Xu T, Li Z, Jiang Y, Ma Y, Li X, Wang W, Qian H. An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.07.002] [Reference Citation Analysis]
50 Shahid M, Raish M, Ahmad A, Bin Jardan YA, Ansari MA, Ahad A, Alkharfy KM, Alaofi AL, Al-jenoobi FI. Sinapic Acid Ameliorates Acetic Acid-Induced Ulcerative Colitis in Rats by Suppressing Inflammation, Oxidative Stress, and Apoptosis. Molecules 2022;27:4139. [DOI: 10.3390/molecules27134139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Shao S, Huang M, Zhang H, Peng G, Song M, Liu J, Xu D. A Retrospective Analysis of Clinical Features and Treatment of the Inflammatory Bowel Disease in China. J Inflamm Res 2022;15:3587-97. [PMID: 35757458 DOI: 10.2147/JIR.S353329] [Reference Citation Analysis]
52 D'Haens G, Danese S, Davies M, Watanabe M, Hibi T. A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease. J Crohns Colitis 2022;16:746-56. [PMID: 34758080 DOI: 10.1093/ecco-jcc/jjab201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
53 van Unen V, Ouboter LF, Li N, Schreurs M, Abdelaal T, Kooy-winkelaar Y, Beyrend G, Höllt T, Maljaars PWJ, Mearin ML, Mahfouz A, Witte AMC, Clemens CHM, Abraham S, Escher JC, Lelieveldt BPF, Pascutti MF, van der Meulen – de Jong AE, Koning F. Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease. Front Immunol 2022;13:893803. [DOI: 10.3389/fimmu.2022.893803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Peng L, Hu S, Yu Q, Chen Y. Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn's and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:S9-S15. [PMID: 34984463 DOI: 10.1093/ibd/izab344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Kedia S, Ahuja V. Does the road to primary prevention of inflammatory bowel disease start from childhood? JGH Open 2022;6:365-368. [DOI: 10.1002/jgh3.12782] [Reference Citation Analysis]
56 Li K, Feng C, Chen H, Feng Y, Li J. Trends in Worldwide Research in Inflammatory Bowel Disease Over the Period 2012–2021: A Bibliometric Study. Front Med 2022;9:880553. [DOI: 10.3389/fmed.2022.880553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Kitae H, Takagi T, Naito Y, Inoue R, Azuma Y, Torii T, Mizushima K, Doi T, Inoue K, Dohi O, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Konishi H, Itoh Y. Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis. Microorganisms 2022;10:1044. [DOI: 10.3390/microorganisms10051044] [Reference Citation Analysis]
58 De Sousa JFM, Paghdar S, Khan TM, Patel NP, Chandrasekaran S, Tsouklidis N. Stress and Inflammatory Bowel Disease: Clear Mind, Happy Colon. Cureus. [DOI: 10.7759/cureus.25006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Abd El-Wahab EW, Youssef EI, Hassouna E. Helicobacter pylori infection in patients with inflammatory bowel diseases: a single-centre, prospective, observational study in Egypt. BMJ Open 2022;12:e057214. [PMID: 35504642 DOI: 10.1136/bmjopen-2021-057214] [Reference Citation Analysis]
60 Yüksel B, Bayram S, Cindoruk M, Küçük H. İnflamatuvar bağırsak hastalıklarında hastalığa özgü aktivite indeksinin depresyon ve inflamatuvar belirteçler ile ilişkisi. Akademik Gastroenteroloji Dergisi 2022. [DOI: 10.17941/agd.1103710] [Reference Citation Analysis]
61 Nguyen J, Finkelman BS, Escobar D, Xue Y, Wolniak K, Pezhouh M. Over-expression of Programmed Death Ligand 1 (PD-L1) in Refractory Inflammatory Bowel Disease (IBD). Hum Pathol 2022:S0046-8177(22)00101-0. [PMID: 35489437 DOI: 10.1016/j.humpath.2022.04.011] [Reference Citation Analysis]
62 Zhou Z, Chen H, Shen Y, Huang H. Chinese Herb Injections in the Adjuvant Treatment for Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-17. [DOI: 10.1155/2022/3166416] [Reference Citation Analysis]
63 Pagani K, Lukac D, Bhukhan A, McGee JS. Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview. Am J Clin Dermatol 2022. [PMID: 35441942 DOI: 10.1007/s40257-022-00689-w] [Reference Citation Analysis]
64 Wang S, Bai M, Shu Q, Liu Z, Shao Y, Xu K, Xiong X, Liu H, Li Y. Modulating Effect of Paeonol on Piglets With Ulcerative Colitis. Front Nutr 2022;9:846684. [DOI: 10.3389/fnut.2022.846684] [Reference Citation Analysis]
65 Verstockt B, Bressler B, Martinez-Lozano H, McGovern D, Silverberg MS. Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management? Gastroenterology 2022;162:1370-82. [PMID: 34995534 DOI: 10.1053/j.gastro.2021.12.246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
66 Yao Y, Kim G, Shafer S, Chen Z, Kubo S, Ji Y, Luo J, Yang W, Perner SP, Kanellopoulou C, Park AY, Jiang P, Li J, Baris S, Aydiner EK, Ertem D, Mulder DJ, Warner N, Griffiths AM, Topf-Olivestone C, Kori M, Werner L, Ouahed J, Field M, Liu C, Schwarz B, Bosio CM, Ganesan S, Song J, Urlaub H, Oellerich T, Malaker SA, Zheng L, Bertozzi CR, Zhang Y, Matthews H, Montgomery W, Shih HY, Jiang J, Jones M, Baras A, Shuldiner A, Gonzaga-Jauregui C, Snapper SB, Muise AM, Shouval DS, Ozen A, Pan KT, Wu C, Lenardo MJ. Mucus sialylation determines intestinal host-commensal homeostasis. Cell 2022;185:1172-1188.e28. [PMID: 35303419 DOI: 10.1016/j.cell.2022.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
67 Li W, Yu J, Jin B, Zhang H, Zhang J. Protective Effects of Aminooxyacetic Acid on Colitis Induced in Mice with Dextran Sulfate Sodium. Biomed Res Int 2021;2021:1477345. [PMID: 35299827 DOI: 10.1155/2021/1477345] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Xu HM, Zhao HL, Guo GJ, Xu J, Zhou YL, Huang HL, Nie YQ. Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis. BMC Gastroenterol 2022;22:117. [PMID: 35272614 DOI: 10.1186/s12876-022-02191-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
69 White BA, Ramos GP, Kane S. The Impact of Alcohol in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2022;28:466-73. [PMID: 33988227 DOI: 10.1093/ibd/izab089] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
70 Beaman HT, Howes B, Ganesh P, Monroe MBB. Shape memory polymer hydrogels with cell-responsive degradation mechanisms for Crohn's fistula closure. J Biomed Mater Res A 2022. [PMID: 35218140 DOI: 10.1002/jbm.a.37376] [Reference Citation Analysis]
71 Pan L, Fu T, Cheng H, Mi J, Shang Q, Yu G. Polysaccharide from edible alga Gloiopeltis furcata attenuates intestinal mucosal damage by therapeutically remodeling the interactions between gut microbiota and mucin O-glycans. Carbohydr Polym 2022;278:118921. [PMID: 34973740 DOI: 10.1016/j.carbpol.2021.118921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
72 Babiker AM, Alkharraz AHA, Yusef Alsaeed HA, Aldubaiyan AAR. Mild Abdominal Trauma Complicated With Bowel Perforation in Patient With Crohn’s Disease: Clinical and Intraoperative Findings. Cureus. [DOI: 10.7759/cureus.21977] [Reference Citation Analysis]
73 Wang CJ, Byun MJ, Kim S, Park W, Park HH, Kim T, Lee JS, Park CG. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
74 Gilna GP, Saberi RA, O'neil CF, Ramsey W, Huerta CT, Langshaw AH, Parreco JP, Sola JE, Thorson CM, Perez EA. Disparities in Utilization of Laparoscopic Colectomies in Pediatric Crohn's Disease. Journal of Pediatric Surgery 2022. [DOI: 10.1016/j.jpedsurg.2022.01.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Lightner AL, Steele SR, McMichael JP, Jia X, Qazi T, Click BH, Church J. Pouch Function Over Time and With Advancing Age. Dis Colon Rectum 2022;65:254-63. [PMID: 34459447 DOI: 10.1097/DCR.0000000000002066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
76 Rivera AP, Flores Monar GV, Islam H, Puttagunta SM, Islam R, Kundu S, Jha SB, Sange I. Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation. Cureus 2022;14:e22636. [PMID: 35371788 DOI: 10.7759/cureus.22636] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Shi C, Dawulieti J, Shi F, Yang C, Qin Q, Shi T, Wang L, Hu H, Sun M, Ren L, Chen F, Zhao Y, Liu F, Li M, Mu L, Liu D, Shao D, Leong KW, She J. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Sci Adv 2022;8:eabj2372. [PMID: 35089791 DOI: 10.1126/sciadv.abj2372] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
78 Jelsness-Jørgensen LP, Moum B, Grimstad T, Jahnsen J, Hovde Ø, Frigstad SO, Bernklev T. The multidimensional fatigue inventory (MFI-20): psychometrical testing in a Norwegian sample of inflammatory bowel disease (IBD) patients. Scand J Gastroenterol 2022;:1-7. [PMID: 35076321 DOI: 10.1080/00365521.2022.2029939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Wang H, Vilches-moure JG, Bettinger T, Cherkaoui S, Lutz A, Paulmurugan R. Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α−/− Transgenic Mouse Model Using Targeted Microbubbles. Nanomaterials 2022;12:280. [DOI: 10.3390/nano12020280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Raoul P, Cintoni M, Palombaro M, Basso L, Rinninella E, Gasbarrini A, Mele MC. Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis. Microorganisms 2022;10:167. [PMID: 35056616 DOI: 10.3390/microorganisms10010167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
81 Honeycutt A, Breck A, Bass S, Esposito D. Impact analysis of expanding anti-TNF therapy for Crohn's disease. J Comp Eff Res 2022. [PMID: 35014551 DOI: 10.2217/cer-2021-0063] [Reference Citation Analysis]
82 Wiestler M, Seidler U. Mit Morbus Crohn und Colitis ulcerosa sicher durch die Schwangerschaft. Geburtshilfe Frauenheilkd 2022;82:34-8. [DOI: 10.1055/a-1430-4878] [Reference Citation Analysis]
83 CABI. Mycobacterium avium subsp. paratuberculosis as a foodborne pathogen. CABI Compendium 2022;CABI Compendium. [DOI: 10.1079/cabicompendium.59051] [Reference Citation Analysis]
84 Sun Q, Du M, Kang Y, Zhu MJ. Prebiotic effects of goji berry in protection against inflammatory bowel disease. Crit Rev Food Sci Nutr 2022;:1-25. [PMID: 34991393 DOI: 10.1080/10408398.2021.2015680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Bhurwal A, Minacapelli CD, Patel A, Mutneja H, Goel A, Shah I, Bansal V, Brahmbhatt B, Das KM. Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among Ethnicities. Inflamm Bowel Dis 2022;28:54-61. [PMID: 33534892 DOI: 10.1093/ibd/izab020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Łodyga M, Eder P, Gawron-Kiszka M, Dobrowolska A, Gonciarz M, Hartleb M, Kłopocka M, Małecka-Wojciesko E, Radwan P, Reguła J, Zagórowicz E, Rydzewska G. Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. Prz Gastroenterol 2021;16:257-96. [PMID: 34976235 DOI: 10.5114/pg.2021.110914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-κB signaling in inflammation and cancer. MedComm (2020) 2021;2:618-53. [PMID: 34977871 DOI: 10.1002/mco2.104] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 31.0] [Reference Citation Analysis]
88 Kienle P. Chronisch-entzündliche Darmerkrankungen: Morbus Crohn und Colitis ulcerosa. Allgemein- und Viszeralchirurgie II 2022. [DOI: 10.1016/b978-3-437-24812-2.00011-1] [Reference Citation Analysis]
89 Radhakrishanan A, Kakkar P, Tandon C, Srivastav R. Fecal Microbiome Transplantation: An Offhand Recipe for Microbiome Therapeutics. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00001-2] [Reference Citation Analysis]
90 Choi Y, Kim N. Inflammatory Bowel Diseases. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_19] [Reference Citation Analysis]
91 Fukuchi T, Kawashima K, Koga H, Utsunomiya R, Sugiyama K, Shimazu K, Eguchi T, Ishihara S. Induction of mucosal healing by intensive granulocyte/monocyte adsorptive apheresis (GMA) without use of corticosteroids in patients with ulcerative colitis: long-term remission maintenance after induction by GMA and efficacy of GMA re-treatment upon relapse. J Clin Biochem Nutr . [DOI: 10.3164/jcbn.21-112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Cicero G, Blandino A, D’angelo T, Mazziotti S. MR-Enterography Intestinal Findings in Crohn’s Disease. MR Enterography 2022. [DOI: 10.1007/978-3-031-11930-9_5] [Reference Citation Analysis]
93 Keshavarzi Z, Ashekar A, Vatanchian M, Abbaspour A, Bibak B, Behnamfar M, Barzegar S, Shakeri F. The effect of woody endocarpium of walnut alcoholic extract on acetic acid-induced ulcerative colitis in rats. Braz J Pharm Sci 2022;58:e19520. [DOI: 10.1590/s2175-97902022e19520] [Reference Citation Analysis]
94 Wu J, Shu P, He H, Li H, Tang Z, Sun Y, Liu F. Predictors of mortality in patients with acute small-bowel perforation transferred to ICU after emergency surgery: a single-centre retrospective cohort study. Gastroenterology Report 2021. [DOI: 10.1093/gastro/goab054] [Reference Citation Analysis]
95 Yan Z, Liu Y, Zhang T, Zhang F, Ren H, Zhang Y. Analysis of Microplastics in Human Feces Reveals a Correlation between Fecal Microplastics and Inflammatory Bowel Disease Status. Environ Sci Technol 2021. [PMID: 34935363 DOI: 10.1021/acs.est.1c03924] [Cited by in Crossref: 39] [Cited by in F6Publishing: 52] [Article Influence: 19.5] [Reference Citation Analysis]
96 Chen Y, Niu Y, Hao W, Zhang W, Lu J, Zhou J, Du L, Xie W. Pineapple Leaf Phenols Attenuate DSS-Induced Colitis in Mice and Inhibit Inflammatory Damage by Targeting the NF-κB Pathway. Molecules 2021;26:7656. [PMID: 34946738 DOI: 10.3390/molecules26247656] [Reference Citation Analysis]
97 Kye YJ, Lee SY, Kim HR, Lee BH, Park JH, Park MS, Ji GE, Sung MK. Lactobacillus acidophilus PIN7 paraprobiotic supplementation ameliorates DSS-induced colitis through anti-inflammatory and immune regulatory effects. J Appl Microbiol 2021. [PMID: 34878713 DOI: 10.1111/jam.15406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 van Gennep S, Gielen ME, Rietdijk ST, de Boer NKH, Duijvestein M, Gecse KB, Ponsioen CY, D'Haens GR, de Boer AGEM, Löwenberg M. Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study. Eur J Gastroenterol Hepatol 2021;33:e594-602. [PMID: 34014623 DOI: 10.1097/MEG.0000000000002178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
99 Sinh P, Tabibian JH, Biyani PS, Mehta K, Mansoor E, Loftus EV Jr, Dave M. Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction. Dig Dis Sci 2021;66:4169-77. [PMID: 33492533 DOI: 10.1007/s10620-020-06818-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
100 Cantero-recasens G, Burballa C, Ohkawa Y, Fukuda T, Harada Y, Curwin A, Brouwers N, Thun GA, Gu J, Gut I, Taniguchi N, Malhotra V, IBD Character Consortium. The ulcerative colitis associated gene FUT8 regulates the quantity and quality of secreted mucins.. [DOI: 10.1101/2021.11.30.469270] [Reference Citation Analysis]
101 Pathan MM, Kshirsagar AD. Estimation of Mesalamine in Human Plasma Using Rapid and Sensitive LC-ESI-MS/MS Method. Pharm Chem J 2021;55:835-44. [DOI: 10.1007/s11094-021-02504-y] [Reference Citation Analysis]
102 Goto Y, Uchino M, Horio Y, Kusunoki K, Minagawa T, Kuwahara R, Kimura K, Kataoka K, Beppu N, Ikeda M, Ikeuchi H. Delivery Mode after Ileal Pouch-Anal Anastomosis among Pregnant Women with Ulcerative Colitis. J Anus Rectum Colon 2021;5:419-25. [PMID: 34746507 DOI: 10.23922/jarc.2021-022] [Reference Citation Analysis]
103 Minaiyan M, Ghanadian SM, Hossaini M. Protective Effect of Apium graveolens L. (Celery) Seeds Extracts and Luteolin on Acetic Acid-Induced Colitis in Rats. Int J Prev Med 2021;12:100. [PMID: 34729134 DOI: 10.4103/ijpvm.IJPVM_651_20] [Reference Citation Analysis]
104 Krishna M, Engevik M, Queliza K, Britto S, Shah R, Ruan W, Wang H, Versalovic J, Kellermayer R. Maternal Lactobacillus reuteri supplementation shifts the intestinal microbiome in mice and provides protection from experimental colitis in female offspring. FASEB BioAdvances 2022;4:109-20. [DOI: 10.1096/fba.2021-00078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Larussa T, Suraci E, Marasco R, Imeneo M, Dumitrascu DL, Abenavoli L, Luzza F. Barriers and Facilitators in Conducting Clinical Trials in Inflammatory Bowel Disease: A Monocentric Italian Survey. Rev Recent Clin Trials 2020;15:137-44. [PMID: 32091346 DOI: 10.2174/1574887115666200224113520] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
106 Alborzi F, Ebrahimi Daryani N, Deihim T, Azizi Z, Azmoudeh Ardalan F, Teimouri A, Taslimi R, Roshan N, Mami M, Mirzade M, Aletaha N. Colonic Mucosal Infiltration of IgG4 Plasma Cells and Ulcerative Colitis: Determinant of Presence, Activity, Extension, and Duration of Disease. Middle East J Dig Dis 2021;13:287-93. [PMID: 36606008 DOI: 10.34172/mejdd.2021.237] [Reference Citation Analysis]
107 Riansuwan W, Limsrivilai J. Current status of IBD and surgery of Crohn's disease in Thailand. Ann Gastroenterol Surg 2021;5:597-603. [PMID: 34585044 DOI: 10.1002/ags3.12470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
108 Mitrev N, Huang H, Hannah B, Kariyawasam VC. Review of exclusive enteral therapy in adult Crohn's disease. BMJ Open Gastroenterol 2021;8:e000745. [PMID: 34580154 DOI: 10.1136/bmjgast-2021-000745] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
109 Kang ZP, Wang MX, Wu TT, Liu DY, Wang HY, Long J, Zhao HM, Zhong YB. Curcumin Alleviated Dextran Sulfate Sodium-Induced Colitis by Regulating M1/M2 Macrophage Polarization and TLRs Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:3334994. [PMID: 34567209 DOI: 10.1155/2021/3334994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
110 Montenegro-Burke JR, Kok BP, Guijas C, Domingo-Almenara X, Moon C, Galmozzi A, Kitamura S, Eckmann L, Saez E, Siuzdak GE, Wolan DW. Metabolomics activity screening of T cell-induced colitis reveals anti-inflammatory metabolites. Sci Signal 2021;14:eabf6584. [PMID: 34582249 DOI: 10.1126/scisignal.abf6584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Liao TH, Lin CL, Lin CH, Wu MC, Wei JC. Children with appendectomy have increased risk of future sepsis: Real-world data in Taiwan. Int J Clin Pract 2021;:e14912. [PMID: 34549868 DOI: 10.1111/ijcp.14912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
112 Gan RW, Sun D, Tatro AR, Cohen-Mekelburg S, Wiitala WL, Zhu J, Waljee AK. Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease. PLoS One 2021;16:e0257520. [PMID: 34543353 DOI: 10.1371/journal.pone.0257520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Barnes SE, Zera KA, Ivison GT, Buckwalter MS, Engleman EG. Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNFα as mediators of neuronal hyperexcitability. J Neuroinflammation 2021;18:199. [PMID: 34511110 DOI: 10.1186/s12974-021-02262-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
114 Wu X, Sun M, Yang Z, Lu C, Wang Q, Wang H, Deng C, Liu Y, Yang Y. The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases. Front Cell Dev Biol 2021;9:686548. [PMID: 34490243 DOI: 10.3389/fcell.2021.686548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
115 Foley SE, Tuohy C, Dunford M, Grey MJ, De Luca H, Cawley C, Szabady RL, Maldonado-Contreras A, Houghton JM, Ward DV, Mrsny RJ, McCormick BA. Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Microbiome 2021;9:183. [PMID: 34493329 DOI: 10.1186/s40168-021-01137-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
116 Arvanitakis KD, Arvanitaki AD, Karkos CD, Zintzaras EΑ, Germanidis GS. The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis. Ann Gastroenterol 2021;34:680-90. [PMID: 34475739 DOI: 10.20524/aog.2021.0631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Xu Y, Baylink DJ, Cao H, Xiao J, Abdalla MI, Wasnik S, Tang X. Inflammation- and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells. Int J Mol Sci 2021;22:9516. [PMID: 34502422 DOI: 10.3390/ijms22179516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Osakowicz C, Fletcher L, Caswell JL, Li J. Protective and Anti-Inflammatory Effects of Protegrin-1 on Citrobacter rodentium Intestinal Infection in Mice. Int J Mol Sci 2021;22:9494. [PMID: 34502403 DOI: 10.3390/ijms22179494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Liu S, Eisenstein S. State-of-the-art surgery for ulcerative colitis. Langenbecks Arch Surg 2021;406:1751-61. [PMID: 34453611 DOI: 10.1007/s00423-021-02295-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Gerçeker E, Cerrah S, Baykan A. Helicobacter pylori ve inflamatuvar bağırsak hastalığı arasındaki ilişki. Akademik Gastroenteroloji Dergisi 2021. [DOI: 10.17941/agd.975765] [Reference Citation Analysis]
121 Wang R, Yao Q, Chen W, Gao F, Li P, Wu J, Yu J, Cao H. Stem cell therapy for Crohn's disease: systematic review and meta-analysis of preclinical and clinical studies. Stem Cell Res Ther 2021;12:463. [PMID: 34407875 DOI: 10.1186/s13287-021-02533-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
122 Azizian-Farsani F, Osuchowski M, Abedpoor N, Forootan FS, Derakhshan M, Nasr-Esfahani MH, Sheikhha MH, Ghaedi K. Anti-inflammatory and -apoptotic effects of a long-term herbal extract treatment on DSS-induced colitis in mice fed with high AGEs-fat diet. Nutr Metab (Lond) 2021;18:77. [PMID: 34380504 DOI: 10.1186/s12986-021-00603-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Wang X, Ge X, Liao W, Cao Y, Li R, Zhang F, Zhao B, Du J. ZFP36 promotes VDR mRNA degradation to facilitate cell death in oral and colonic epithelial cells. Cell Commun Signal 2021;19:85. [PMID: 34380509 DOI: 10.1186/s12964-021-00765-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
124 Moreno LO, Fernández-tomé S, Abalo R. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions. Biologics 2021;1:189-210. [DOI: 10.3390/biologics1020012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
125 Rogers CC, Moutinho TJ Jr, Liu X, Valdez RS. Designing Consumer Health Information Technology to Support Biform and Articulation Work: A Qualitative Study of Diet and Nutrition Management as Patient Work. JMIR Hum Factors 2021;8:e27452. [PMID: 34383664 DOI: 10.2196/27452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Yao L, Guo J, Gui J, Bai F, Xin R, Deng Y, Wang S, Li H. ICOS+ follicular regulatory T cells are implicated in the pathogenesis of ulcerative colitis. Clin Exp Pharmacol Physiol 2021. [PMID: 34363223 DOI: 10.1111/1440-1681.13568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Signore MA, De Pascali C, Giampetruzzi L, Siciliano PA, Francioso L. Gut-on-Chip microphysiological systems: Latest advances in the integration of sensing strategies and adoption of mature detection mechanisms. Sensing and Bio-Sensing Research 2021;33:100443. [DOI: 10.1016/j.sbsr.2021.100443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
128 Bhattarai A, Kowalczyk W, Tran TN. A literature review on large intestinal hyperelastic constitutive modeling. Clin Biomech (Bristol, Avon) 2021;88:105445. [PMID: 34416632 DOI: 10.1016/j.clinbiomech.2021.105445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Lightner AL, Vaidya P, Holubar S, Warusavitarne J, Sahnan K, Carrano FM, Spinelli A, Zaghiyan K, Fleshner PR. Perioperative safety of tofacitinib in surgical ulcerative colitis patients. Colorectal Dis 2021;23:2085-90. [PMID: 33942470 DOI: 10.1111/codi.15702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
130 Goh K. Ulcerative colltis in the older patient‐ a treatment conundrum. JGH Open 2021;5:841-841. [DOI: 10.1002/jgh3.12620] [Reference Citation Analysis]
131 Hashiesh HM, Sharma C, Goyal SN, Jha NK, Ojha S. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist. Front Pharmacol 2021;12:702675. [PMID: 34393784 DOI: 10.3389/fphar.2021.702675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
132 Muse K, Johnson E, David AL. A Feeling of Otherness: A Qualitative Research Synthesis Exploring the Lived Experiences of Stigma in Individuals with Inflammatory Bowel Disease. Int J Environ Res Public Health 2021;18:8038. [PMID: 34360327 DOI: 10.3390/ijerph18158038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
133 Thiruvengadam M, Subramanian U, Venkidasamy B, Thirupathi P, Samynathan R, Shariati MA, Rebezov M, Chung IM, Rengasamy KRR. Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis. Crit Rev Food Sci Nutr 2021;:1-18. [PMID: 34319824 DOI: 10.1080/10408398.2021.1954874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
134 Xin X, Zhang Z, Zhang X, Chen J, Lin X, Sun P, Liu X. Bioresponsive nanomedicines based on dynamic covalent bonds. Nanoscale 2021;13:11712-33. [PMID: 34227639 DOI: 10.1039/d1nr02836g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Narula N, Wong ECL, Dehghan M, Mente A, Rangarajan S, Lanas F, Lopez-Jaramillo P, Rohatgi P, Lakshmi PVM, Varma RP, Orlandini A, Avezum A, Wielgosz A, Poirier P, Almadi MA, Altuntas Y, Ng KK, Chifamba J, Yeates K, Puoane T, Khatib R, Yusuf R, Boström KB, Zatonska K, Iqbal R, Weida L, Yibing Z, Sidong L, Dans A, Yusufali A, Mohammadifard N, Marshall JK, Moayyedi P, Reinisch W, Yusuf S. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ 2021;374:n1554. [PMID: 34261638 DOI: 10.1136/bmj.n1554] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
136 Benítez-Cabello A, Torres-Maravilla E, Bermúdez-Humarán L, Langella P, Martín R, Jiménez-Díaz R, Arroyo-López FN. Probiotic Properties of Lactobacillus Strains Isolated from Table Olive Biofilms. Probiotics Antimicrob Proteins 2020;12:1071-82. [PMID: 31788768 DOI: 10.1007/s12602-019-09604-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
137 Miller MO, Kashyap PC, Becker SL, Thomas RM, Hodin RA, Miller G, Hundeyin M, Pushalkar S, Cohen D, Saxena D, Shogan BD, Morris-Stiff GJ. SSAT State-of-the-Art Conference: Advancements in the Microbiome. J Gastrointest Surg 2021;25:1885-95. [PMID: 32989690 DOI: 10.1007/s11605-020-04551-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Balderramo D, Trakal J, Herrera Najum P, Vivas M, Gonzalez R, Benavidez A, López Villa D, Daino D, Raiden K, Germán A, Corzo MA, Ponce de León J, Ferrer L, Germán C, Bálzola S, Idoeta A, Zárate F, Defagó MR; Grupo Córdoba de Cooperación para el Manejo y Estudio de la Enfermedad Inflamatoria Intestinal (CEMEI Group). High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina. Dig Liver Dis 2021;53:852-7. [PMID: 33531211 DOI: 10.1016/j.dld.2021.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
139 Aluzaite K, Braund R, Seeley L, Amiesimaka OI, Schultz M. Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab056] [Reference Citation Analysis]
140 Kochar B, Jiang Y, Chen W, Bu Y, Barnes EL, Long MD. Home Infusions for Inflammatory Bowel Disease Are Safe: US Experience and Patient Perspectives. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab063] [Reference Citation Analysis]
141 Pemmasani G, Elgendy I, Mamas MA, Leighton JA, Aronow WS, Tremaine WJ. Epidemiology and Clinical Outcomes of Patients With Inflammatory Bowel Disease Presenting With Acute Coronary Syndrome. Inflamm Bowel Dis 2021;27:1017-25. [PMID: 32978941 DOI: 10.1093/ibd/izaa237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
142 Yu J, Liu Y, Zhang W, Yang X, Tang W, Liang H, Li S, Gao W, Yan J. Musculin Deficiency Aggravates Colonic Injury and Inflammation in Mice with Inflammatory Bowel Disease. Inflammation 2020;43:1455-63. [PMID: 32239394 DOI: 10.1007/s10753-020-01223-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 De Santis S, Scarano A, Liso M, Calabrese FM, Verna G, Cavalcanti E, Sila A, Lippolis A, De Angelis M, Santino A, Chieppa M. Polyphenol Enriched Diet Administration During Pregnancy and Lactation Prevents Dysbiosis in Ulcerative Colitis Predisposed Littermates. Front Cell Infect Microbiol 2021;11:622327. [PMID: 34178715 DOI: 10.3389/fcimb.2021.622327] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
144 Tulumović E, Salkić N, Tulumović D. Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up. World J Gastroenterol 2021; 27(20): 2630-2642 [PMID: 34092980 DOI: 10.3748/wjg.v27.i20.2630] [Reference Citation Analysis]
145 Deshmukh R. Development and In‑Vitro Evaluation of Colon Specific Indomethacin Matrix Tablet for the Treatment of Inflammatory Bowel Disease. RJPT 2021. [DOI: 10.52711/0974-360x.2021.00422] [Reference Citation Analysis]
146 Choi S, Moon W. [Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?]. Korean J Gastroenterol 2021;77:220-6. [PMID: 34035199 DOI: 10.4166/kjg.2021.067] [Reference Citation Analysis]
147 Mark-Christensen A, Lange A, Erichsen R, Frøslev T, Esen BÖ, Sørensen HT, Kappelman MD. Early-Life Exposure to Antibiotics and Risk for Crohn's Disease: A Nationwide Danish Birth Cohort Study. Inflamm Bowel Dis 2022;28:415-22. [PMID: 34000050 DOI: 10.1093/ibd/izab085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Huang X, Tan SS, Chen Y, Li T. Acquired Rectourethral and Rectovaginal Fistulas in Children: A Systematic Review. Front Pediatr 2021;9:657251. [PMID: 34026691 DOI: 10.3389/fped.2021.657251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Gerçeker E, Cerrah S, Baykan AR. İnflamatuar bağırsak hastalığında non-alkolik yağlı karaciğer hastalığı sıklığı. Akademik Gastroenteroloji Dergisi 2021. [DOI: 10.17941/agd.799316] [Reference Citation Analysis]
150 Xue G, Gao R, Liu Z, Xu N, Cao Y, Zhao B, Du J. Vitamin D/VDR signaling inhibits colitis by suppressing HIF-1α activation in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2021;320:G837-46. [PMID: 33759562 DOI: 10.1152/ajpgi.00061.2021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
151 Alrashdan MS, Safadi RA. Crohn's disease initially presenting with oral manifestations and managed with ustekinumab: A case report. Spec Care Dentist 2021;41:634-8. [PMID: 33905564 DOI: 10.1111/scd.12598] [Reference Citation Analysis]
152 Michel HK, Maltz RM, Boyle B, Donegan A, Dotson JL. Applying Telemedicine to Multidisciplinary Pediatric Inflammatory Bowel Disease Care. Children (Basel) 2021;8:315. [PMID: 33919417 DOI: 10.3390/children8050315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Al-Bawardy B, Shivashankar R, Proctor DD. Novel and Emerging Therapies for Inflammatory Bowel Disease. Front Pharmacol 2021;12:651415. [PMID: 33935763 DOI: 10.3389/fphar.2021.651415] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
154 Narayanan AP, Latika A, Nair AS, Ajeesh P, Kumar NS, Babu M. Role of Gut Microbiota in Human Health and Diseases. CNF 2021;17:374-383. [DOI: 10.2174/1573401316999200930130101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Dane B, Garada A, O'Donnell T, Chang S, Megibow A. Crohn Disease Prognostication With Semiautomatic Dual-Energy Computed Tomography Enterography-Derived Iodine Density. J Comput Assist Tomogr 2021;45:171-6. [PMID: 33661155 DOI: 10.1097/RCT.0000000000001135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Stemmer M, Parmet Y, Ravid G. Identifying Patients on Twitter and Learning from Their Personal Experience: The Case of IBD (Preprint).. [DOI: 10.2196/preprints.29186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Campmans-Kuijpers MJE, Dijkstra G. Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID). Nutrients 2021;13:1067. [PMID: 33806061 DOI: 10.3390/nu13041067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
158 Imširović B, Zerem E, Gušo E. Role of Imaging in Small Bowel Crohn’s Disease. Endoscopy in Small Bowel Diseases 2021. [DOI: 10.5772/intechopen.96098] [Reference Citation Analysis]
159 Almeida RSD, Lisboa ACR, Moura AR. Quality of life of patients with inflammatory bowel disease using immunobiological therapy. Journal of Coloproctology 2021;39:107-14. [DOI: 10.1016/j.jcol.2018.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Zhu Y, Yang S, Zhao N, Liu C, Zhang F, Guo Y, Liu H. CXCL8 chemokine in ulcerative colitis. Biomed Pharmacother 2021;138:111427. [PMID: 33706134 DOI: 10.1016/j.biopha.2021.111427] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
161 Barello S, Guida E, Leone S, Previtali E, Graffigna G. Does patient engagement affect IBD patients' health-related quality of life? Findings from a cross-sectional study among people with inflammatory bowel diseases. Health Qual Life Outcomes 2021;19:77. [PMID: 33678181 DOI: 10.1186/s12955-021-01724-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
162 Xie Y, Zhuang T, Ping Y, Zhang Y, Wang X, Yu P, Duan X. Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patients. Clin Chim Acta 2021;517:122-6. [PMID: 33662359 DOI: 10.1016/j.cca.2021.02.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
163 Romano-Keeler J, Zhang J, Sun J. The Life-Long Role of Nutrition on the Gut Microbiome and Gastrointestinal Disease. Gastroenterol Clin North Am 2021;50:77-100. [PMID: 33518170 DOI: 10.1016/j.gtc.2020.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Mocanu V, Rajaruban S, Dang J, Kung JY, Deehan EC, Madsen KL. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis. J Clin Med 2021;10:959. [PMID: 33804464 DOI: 10.3390/jcm10050959] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
165 Lo CH, Khalili H, Lochhead P, Song M, Lopes EW, Burke KE, Richter JM, Chan AT, Ananthakrishnan AN. Immune-mediated diseases and risk of Crohn's disease or ulcerative colitis: a prospective cohort study. Aliment Pharmacol Ther 2021;53:598-607. [PMID: 33280139 DOI: 10.1111/apt.16210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
166 Lightner AL, Jia X, Zaghiyan K, Fleshner PR. IPAA in Known Preoperative Crohn's Disease: A Systematic Review. Dis Colon Rectum 2021;64:355-64. [PMID: 33315711 DOI: 10.1097/DCR.0000000000001918] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
167 Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front Immunol 2021;12:578386. [PMID: 33717063 DOI: 10.3389/fimmu.2021.578386] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 58.0] [Reference Citation Analysis]
168 Sollai G, Melis M, Mastinu M, Paduano D, Chicco F, Magri S, Usai P, Hummel T, Barbarossa IT, Crnjar R. Olfactory Function in Patients with Inflammatory Bowel Disease (IBD) Is Associated with Their Body Mass Index and Polymorphism in the Odor Binding-Protein (OBPIIa) Gene. Nutrients 2021;13:703. [PMID: 33671721 DOI: 10.3390/nu13020703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
169 Zhang ZJ, Qu HL, Zhao N, Wang J, Wang XY, Hai R, Li B. Assessment of Causal Direction Between Gut Microbiota and Inflammatory Bowel Disease: A Mendelian Randomization Analysis. Front Genet 2021;12:631061. [PMID: 33679893 DOI: 10.3389/fgene.2021.631061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
170 de Barros PAC, da Silva AMR, Neto ML. The epidemiological profile of inflammatory bowel disease patients on biologic therapy at a public hospital in Alagoas. Journal of Coloproctology 2021;34:131-5. [DOI: 10.1016/j.jcol.2014.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
171 Niriella MA, Liyanage IK, Kodisinghe SK, De Silva AP, Jayatissa AVGAM, Navarathne NMM, Peiris RK, Kalubovila UP, Kumarasena SR, Jayasekara RW, de Silva HJ. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study. BMC Gastroenterol 2021;21:71. [PMID: 33593289 DOI: 10.1186/s12876-021-01644-5] [Reference Citation Analysis]
172 Yao Q, Li H, Fan L, Zhang Y, Zhao S, Zheng N, Wang J. Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease. Foods 2021;10:368. [PMID: 33567698 DOI: 10.3390/foods10020368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
173 Han Z, Wang H, Guo D, Zhang J. Integrative transcriptomic and metabonomic profiling analyses reveal the molecular mechanism of Chinese traditional medicine huankuile suspension on TNBS-induced ulcerative colitis. Aging (Albany NY) 2021;13:5087-103. [PMID: 33535180 DOI: 10.18632/aging.202427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
174 Barnes EL, Loftus EV Jr, Kappelman MD. Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases. Gastroenterology 2021;160:677-89. [PMID: 33098884 DOI: 10.1053/j.gastro.2020.08.064] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
175 Dall'Oglio VM, Balbinot RS, Muscope ALF, Castel MD, Souza TR, Macedo RS, Oliveira TB, Balbinot RA, Balbinot SS, Brambilla E, Soldera J. Epidemiological profile of inflammatory bowel disease in Caxias do Sul, Brazil: a cross-sectional study. Sao Paulo Med J 2020;138:530-6. [PMID: 33206912 DOI: 10.1590/1516-3180.2020.0179.R2.10092020] [Reference Citation Analysis]
176 Rogers CC, Moutinho Jr TJ, Liu X, Valdez RS. Designing Consumer Health Information Technology to Support Biform and Articulation Work: A Qualitative Study of Diet and Nutrition Management as Patient Work (Preprint).. [DOI: 10.2196/preprints.27452] [Reference Citation Analysis]
177 Ortega Moreno L, Fernández-Tomé S, Chaparro M, Marin AC, Mora-Gutiérrez I, Santander C, Baldan-Martin M, Gisbert JP, Bernardo D. Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:268-74. [PMID: 32548643 DOI: 10.1093/ibd/izaa151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
178 Zaltman C, Parra RS, Sassaki LY, Santana GO, Ferrari MLA, Miszputen SJ, Amarante HMBS, Kaiser Junior RL, Flores C, Catapani WR, Parente JML, Bafutto M, Ramos O, Gonçalves CD, Guimaraes IM, da Rocha JJR, Feitosa MR, Feres O, Saad-Hossne R, Penna FGC, Cunha PFS, Gomes TN, Nones RB, Faria MAG, Parente MPPD, Scotton AS, Caratin RF, Senra J, Chebli JM. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil. World J Gastroenterol 2021; 27(2): 208-223 [PMID: 33510560 DOI: 10.3748/wjg.v27.i2.208] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
179 Rodríguez LM, Izmirlian G, Young PE. A deeper dive into disparities in IBD: Data from the ACS NSQIP. Am J Surg 2021;221:666-7. [PMID: 33551117 DOI: 10.1016/j.amjsurg.2021.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
180 Yaser M. Rayyan, Tamara R. Qalqili, Awni T. Abu-sneineh, Reema F. Tayyem. Nutrients Consumed by the Inflammatory Bowel Disease Jordanian Patients. Ann Cancer Res Therap 2021;29:22-9. [DOI: 10.4993/acrt.29.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Cao Y, Su Q, Zhang B, Shen F, Li S. Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review. Stem Cell Res Ther 2021;12:32. [PMID: 33413661 DOI: 10.1186/s13287-020-02095-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
182 Hmar EBL, Paul S, Boruah N, Sarkar P, Borah S, Sharma HK. Apprehending Ulcerative Colitis Management With Springing Up Therapeutic Approaches: Can Nanotechnology Play a Nascent Role? Curr Pathobiol Rep 2021;9:9-32. [DOI: 10.1007/s40139-020-00218-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Hashimoto-hill S, Kelly D, Alenghat T. Epigenomics of intestinal disease. Medical Epigenetics 2021. [DOI: 10.1016/b978-0-12-823928-5.00018-9] [Reference Citation Analysis]
184 Rintala RJ, Pakarinen MP, Koivusalo A. Ulcerative Colitis. Pediatric Surgery 2021. [DOI: 10.1007/978-3-662-43559-5_106] [Reference Citation Analysis]
185 Varsakiya J, Goyal M, Kathad D, Kumari R. Efficacy of Ayurveda modalities in the management Raktaja pravahika (ulcerative colitis): A case report. J Ayurveda Case Rep 2021;4:115. [DOI: 10.4103/jacr.jacr_34_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
186 Gelfand JM, Noe MH. Pharmacovigilance. Comprehensive Dermatologic Drug Therapy 2021. [DOI: 10.1016/b978-0-323-61211-1.00007-3] [Reference Citation Analysis]
187 Sapci I, Click B, Steele SR. The Economics of IBD: Is There a Future for a Medical Home? Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-81780-0_14] [Reference Citation Analysis]
188 Stemmer M, Parmet Y, Ravid G. What Are IBD Patients Talking About on Twitter? ICT for Health, Accessibility and Wellbeing 2021. [DOI: 10.1007/978-3-030-94209-0_18] [Reference Citation Analysis]
189 Sekar V. Role of Cancer Stem Cells in Colitis-Associated Colorectal Cancer. Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer 2021. [DOI: 10.4018/978-1-7998-3580-6.ch009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Halegoua-de Marzio D, Arastu S. Gastrointestinal diseases: Sex and gender evidence in liver lesions, gastroesophageal reflux, and inflammatory bowel disease. How Sex and Gender Impact Clinical Practice 2021. [DOI: 10.1016/b978-0-12-816569-0.00007-3] [Reference Citation Analysis]
191 Lo CH, Khalili H, Song M, Lochhead P, Burke KE, Richter JM, Giovannucci EL, Chan AT, Ananthakrishnan AN. Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:87-95.e4. [PMID: 32142939 DOI: 10.1016/j.cgh.2020.02.047] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 16.5] [Reference Citation Analysis]
192 İnanç BB. Different Point of View to the Autoimmune Diseases and Treatment with Acupuncture. J Pharmacopuncture 2020;23:187-93. [PMID: 33408894 DOI: 10.3831/KPI.2020.23.4.187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
193 Liu K, Jia B, Zhou L, Xing L, Wu L, Li Y, Lu J, Zhang L, Guan S. Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics and Lipidomics Identify Biomarkers for Efficacy Evaluation of Mesalazine in a Dextran Sulfate Sodium-Induced Ulcerative Colitis Mouse Model. J Proteome Res 2021;20:1371-81. [PMID: 33356298 DOI: 10.1021/acs.jproteome.0c00757] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
194 Popa SL, Pop C, Dumitrascu DL. Diet Advice for Crohn's Disease: FODMAP and Beyond. Nutrients 2020;12:E3751. [PMID: 33291329 DOI: 10.3390/nu12123751] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
195 Wiestler M, Seidler U. Mit Morbus Crohn und Colitis ulcerosa sicher durch die Schwangerschaft. Der Klinikarzt 2020;49:545-549. [DOI: 10.1055/a-1317-2725] [Reference Citation Analysis]
196 Lepp J, Höög C, Forsell A, Fyrhake U, Lördal M, Almer S. Rapid weight gain in infliximab treated Crohn's disease patients is sustained over time: real-life data over 12 months. Scand J Gastroenterol 2020;55:1411-8. [PMID: 33108226 DOI: 10.1080/00365521.2020.1837929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
197 Chibbar R, Moss AC. Mesalamine in the Initial Therapy of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:689-704. [PMID: 33121689 DOI: 10.1016/j.gtc.2020.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
198 Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Z Gastroenterol 2020;58:e241-326. [PMID: 33260237 DOI: 10.1055/a-1296-3444] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
199 Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:643-54. [PMID: 33121686 DOI: 10.1016/j.gtc.2020.07.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 21.3] [Reference Citation Analysis]
200 Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:740-54. [PMID: 32901108 DOI: 10.1038/s41575-020-0354-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
201 Wong ECL, Buffone E, Lee SJ, Dulai PS, Marshall JK, Reinisch W, Narula N. End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease. J Crohns Colitis 2021;15:1114-9. [PMID: 33245751 DOI: 10.1093/ecco-jcc/jjaa242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
202 Ogawa T, Okumura R, Nagano K, Minemura T, Izumi M, Motooka D, Nakamura S, Iida T, Maeda Y, Kumanogoh A, Tsutsumi Y, Takeda K. Oral intake of silica nanoparticles exacerbates intestinal inflammation. Biochem Biophys Res Commun 2021;534:540-6. [PMID: 33239174 DOI: 10.1016/j.bbrc.2020.11.047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
203 Kochar B. Inflammatory Bowel Diseases in South Asian Patients: Underappreciated and Understudied. Inflamm Bowel Dis 2020;26:1943-4. [PMID: 32115646 DOI: 10.1093/ibd/izaa040] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
204 Sharma S, Suresh Ahire D, Prasad B. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States. The Journal of Clinical Pharmacology 2020;60. [DOI: 10.1002/jcph.1709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
205 Holik D, Bezdan A, Marković M, Orkić Ž, Milostić-Srb A, Mikšić Š, Včev A. The Association between Drinking Water Quality and Inflammatory Bowel Disease-A Study in Eastern Croatia. Int J Environ Res Public Health 2020;17:E8495. [PMID: 33207850 DOI: 10.3390/ijerph17228495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
206 Merk LN, Shur AS, Pandey A, Murray RM, Green LN. Engineering Logical Inflammation Sensing Circuit for Gut Modulation.. [DOI: 10.1101/2020.11.10.377085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
207 Ali MF, He H, Friedel D. Inflammatory bowel disease and pregnancy: fertility, complications and treatment. Ann Gastroenterol 2020;33:579-90. [PMID: 33162735 DOI: 10.20524/aog.2020.0536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
208 Kupka T, Svoboda P, Bojková M, Blaho M, Vašura A, Hrabovský V, Dítě P. Bone metabolism in inflammatory bowel diseases 1. Vnitr Lek 2020;66:e3-e7. [DOI: 10.36290/vnl.2020.131] [Reference Citation Analysis]
209 Gökden Y, Ogutmen Koc D. Evaluation of potential early life risk factors for ulcerative colitis. Journal of Surgery and Medicine 2020;4:1013-1017. [DOI: 10.28982/josam.826501] [Reference Citation Analysis]
210 Corradi G, Garcia-Garzon E, Barrada JR. The Development of a Public Bathroom Perception Scale. Int J Environ Res Public Health 2020;17:E7817. [PMID: 33114539 DOI: 10.3390/ijerph17217817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
211 Santiago M, Magro F, Correia L, Portela F, Ministro P, Lago P, Trindade E, Dias CC. Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence. Clin Transl Gastroenterol 2020;11:e00227. [PMID: 33094955 DOI: 10.14309/ctg.0000000000000227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
212 James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int J Mol Sci 2020;21:E7893. [PMID: 33114313 DOI: 10.3390/ijms21217893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
213 Murate K, Maeda K, Nakamura M, Sugiyama D, Wada H, Yamamura T, Sawada T, Mizutani Y, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Miyahara R, Ishigami M, Nishikawa H, Fujishiro M. Endoscopic Activity and Serum TNF-α Level at Baseline Are Associated With Clinical Response to Ustekinumab in Crohn's Disease Patients. Inflamm Bowel Dis 2020;26:1669-81. [PMID: 32405651 DOI: 10.1093/ibd/izaa086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
214 Nguyen TT, Trinh NT, Tran HN, Tran HT, Le PQ, Ngo DN, Tran-Van H, Van Vo T, Vong LB, Nagasaki Y. Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease. J Control Release 2021;331:515-24. [PMID: 33616078 DOI: 10.1016/j.jconrel.2020.10.042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
215 Letsinger AC, Menon R, Iyer AR, Vellers HL, Granados JZ, Jayaraman A, Lightfoot JT. A High Fat/High Sugar Diet Alters the Gastrointestinal Metabolome in a Sex Dependent Manner. Metabolites 2020;10:E421. [PMID: 33092034 DOI: 10.3390/metabo10100421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
216 Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol 2020;17:597-617. [PMID: 32710014 DOI: 10.1038/s41575-020-0331-7] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 22.0] [Reference Citation Analysis]
217 Ma C, Smith MK, Guizzetti L, Panaccione R, Kaplan GG, Novak KL, Lu C, Khanna R, Feagan BG, Singh S, Jairath V, Ananthakrishnan AN. Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016). Clin Gastroenterol Hepatol 2020;18:2500-2509.e1. [PMID: 31988046 DOI: 10.1016/j.cgh.2020.01.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
218 Kunyeit L, K A AA, Rao RP. Application of Probiotic Yeasts on Candida Species Associated Infection. J Fungi (Basel) 2020;6:E189. [PMID: 32992993 DOI: 10.3390/jof6040189] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
219 Yin R, Neyens DM. Online Health Resource Use by Individuals With Inflammatory Bowel Disease: Analysis Using the National Health Interview Survey. J Med Internet Res 2020;22:e15352. [PMID: 32969831 DOI: 10.2196/15352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
220 Qiu Y, Ren W, Liu Y, Chen WE, Pan XH, Ren JJ. Disease burden of inflammatory bowel disease in China from 1990 to 2017: Findings from the global burden of diseases 2017. EClinicalMedicine 2020;27:100544. [PMID: 33150321 DOI: 10.1016/j.eclinm.2020.100544] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
221 Wu PB, Wu XM, Qian R, Hong C, Yitian G, Zhang G, Yu YJ. Association between IL12B polymorphisms and inflammatory bowel disease in Caucasian population: A meta-analysis. Cytokine 2020;136:155296. [PMID: 32947150 DOI: 10.1016/j.cyto.2020.155296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
222 Shields BE, Richardson C, Arkin L, Kornik R. Vulvar Crohn disease: Diagnostic challenges and approach to therapy. Int J Womens Dermatol 2020;6:390-4. [PMID: 33898705 DOI: 10.1016/j.ijwd.2020.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
223 Dane B, O'Donnell T, Ream J, Chang S, Megibow A. Novel Dual-Energy Computed Tomography Enterography Iodine Density Maps Provide Unique Depiction of Crohn Disease Activity. J Comput Assist Tomogr 2020;44:772-9. [PMID: 32936579 DOI: 10.1097/RCT.0000000000001009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
224 Cho J, Kim D, Kang H. Exercise Preconditioning Attenuates the Response to Experimental Colitis and Modifies Composition of Gut Microbiota in Wild-Type Mice. Life (Basel). 2020;10. [PMID: 32937846 DOI: 10.3390/life10090200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
225 Torricelli FC, Reichard C, Monga M. Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition. Int Urol Nephrol 2021;53:205-9. [PMID: 32915375 DOI: 10.1007/s11255-020-02649-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
226 Roberts SE, Thorne K, Thapar N, Broekaert I, Benninga MA, Dolinsek J, Mas E, Miele E, Orel R, Pienar C, Ribes-Koninckx C, Thomson M, Tzivinikos C, Morrison-Rees S, John A, Williams JG. A Systematic Review and Meta-analysis of Paediatric Inflammatory Bowel Disease Incidence and Prevalence Across Europe. J Crohns Colitis 2020;14:1119-48. [PMID: 32115645 DOI: 10.1093/ecco-jcc/jjaa037] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 14.0] [Reference Citation Analysis]
227 Lo CH, Lochhead P, Khalili H, Song M, Tabung FK, Burke KE, Richter JM, Giovannucci EL, Chan AT, Ananthakrishnan AN. Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis. Gastroenterology 2020;159:873-883.e1. [PMID: 32389666 DOI: 10.1053/j.gastro.2020.05.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 18.3] [Reference Citation Analysis]
228 Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;8:CD000544. [PMID: 32856298 DOI: 10.1002/14651858.CD000544.pub5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
229 Arai K. Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists. Pediatr Gastroenterol Hepatol Nutr 2020;23:411-22. [PMID: 32953636 DOI: 10.5223/pghn.2020.23.5.411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
230 Yan X, Ma F, Yu Y, Du D, Wang Z, Chen C, Zhang X, Sun X, Dong Z, Ma Y, Ma Y. Effects of herb-partitioned moxibustion for ulcerative colitis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21319. [PMID: 32756115 DOI: 10.1097/MD.0000000000021319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
231 Ranjan K. Intestinal Immune Homeostasis and Inflammatory Bowel Disease: A Perspective on Intracellular Response Mechanisms. GastrointestDisord 2020;2:246-66. [DOI: 10.3390/gidisord2030024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
232 Sood A, Kaur K, Singh A, Midha V, Mahajan R, Bansal N, Mehta V, Singh D. Trends of inflammatory bowel disease at a tertiary care center in northern India. Intest Res 2021;19:282-90. [PMID: 32806872 DOI: 10.5217/ir.2020.00010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
233 Goss M, Weinheimer K, Weinheimer RA, Schade MA, Davis CM 3rd, Garner MR. Septic Arthritis of the Hip and Enterocutaneous Fistula Formation After Hip Arthroscopy: A Case Report of Psoas Abscess Misdiagnosed as Labral Pathology. JBJS Case Connect 2019;9:e0505. [PMID: 31815807 DOI: 10.2106/JBJS.CC.18.00505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
234 Murray A, Nguyen TM, Parker CE, Feagan BG, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;8:CD000543. [PMID: 32786164 DOI: 10.1002/14651858.CD000543.pub5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
235 Bilski J, Wojcik D, Danielak A, Mazur-bialy A, Magierowski M, Tønnesen K, Brzozowski B, Surmiak M, Magierowska K, Pajdo R, Ptak-belowska A, Brzozowski T. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products. CPD 2020;26:2936-50. [DOI: 10.2174/1381612826666200427090127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
236 Akkol EK, Karpuz B, Sobarzo-Sánchez E, Khan H. A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitis. Food Chem Toxicol 2020;144:111628. [PMID: 32738379 DOI: 10.1016/j.fct.2020.111628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
237 Nadeem MS, Kumar V, Al-abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020;64:51-60. [DOI: 10.1016/j.semcancer.2019.05.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 24.0] [Reference Citation Analysis]
238 Hellmann J, Andersen H, Fei L, Linn A, Bezold R, Lake K, Jackson K, Meyer D, Dirksing K, Bonkowski E, Ollberding NJ, Haslam DB, Denson L. Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease. Inflamm Bowel Dis 2020;26:1212-21. [PMID: 31725875 DOI: 10.1093/ibd/izz263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
239 Iwatani S, Iijima H, Otake Y, Amano T, Tani M, Yoshihara T, Tashiro T, Tsujii Y, Inoue T, Hayashi Y, Takeda K, Hayashi A, Fujita S, Shinzaki S, Takehara T. Novel mass spectrometry-based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease. J Gastroenterol Hepatol 2020;35:1355-64. [PMID: 32285970 DOI: 10.1111/jgh.15067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
240 Hodnik JJ, Ježek J, Starič J. A review of vitamin D and its importance to the health of dairy cattle. J Dairy Res 2020;87:84-7. [PMID: 33213577 DOI: 10.1017/S0022029920000424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
241 Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol 2020; 26(28): 3998-4017 [PMID: 32821067 DOI: 10.3748/wjg.v26.i28.3998] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
242 Malesza IJ, Malesza M, Krela-Kaźmierczak I, Zielińska A, Souto EB, Dobrowolska A, Eder P. Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults. Int J Mol Sci 2020;21:E5223. [PMID: 32718006 DOI: 10.3390/ijms21155223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
243 Li L, Xu P, Zhang Z, Zhou X, Chen C, Lu C. Platelets can reflect the severity of Crohn's disease without the effect of anemia. Clinics (Sao Paulo) 2020;75:e1596. [PMID: 32667493 DOI: 10.6061/clinics/2020/e1596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
244 Johnson LM, White SK, Schmidt RL. Are calprotectin and lactoferrin equivalent screening tests for inflammatory bowel disease? Clin Chim Acta 2020;510:191-5. [PMID: 32673669 DOI: 10.1016/j.cca.2020.07.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
245 Snell A, Segal J, Limdi J, Banerjee R. Inflammatory bowel disease in India: challenges and opportunities. Frontline Gastroenterol 2021;12:390-6. [PMID: 35401961 DOI: 10.1136/flgastro-2020-101500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
246 Plevinsky JM, Maddux MH, Fishman LN, Kahn SA, Greenley RN. Perceived effect of pediatric inflammatory bowel diseases on academics, college planning, and college adjustment. Journal of American College Health. [DOI: 10.1080/07448481.2020.1781869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
247 Domazetovic V, Iantomasi T, Bonanomi AG, Stio M. Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling. Int J Colorectal Dis 2020;35:1231-42. [PMID: 32314188 DOI: 10.1007/s00384-020-03576-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
248 Barberio J, Kim SC, Roh M, Lewis JD, Desai RJ. Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy. Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otaa041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
249 Bourgonje AR, Feelisch M, Faber KN, Pasch A, Dijkstra G, van Goor H. Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease. Trends Mol Med 2020;26:1034-46. [PMID: 32620502 DOI: 10.1016/j.molmed.2020.06.006] [Cited by in Crossref: 67] [Cited by in F6Publishing: 76] [Article Influence: 22.3] [Reference Citation Analysis]
250 Rankala R, Kosonen J, Mattila K, Tuominen R, Voutilainen M, Mustonen A. Direct costs of inflammatory bowel diseases in a Finnish tertiary-level clinic. Frontline Gastroenterol 2021;12:385-9. [PMID: 35401962 DOI: 10.1136/flgastro-2020-101466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
251 Taborelli M, Sozzi M, Del Zotto S, Toffolutti F, Montico M, Zanier L, Serraino D. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy. PLoS One 2020;15:e0235142. [PMID: 32574216 DOI: 10.1371/journal.pone.0235142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
252 Bademci R, Erdoğan MA, Kara AY, Yiğittürk G, Erbaş O. Therapeutic effects of vitamin D on acetic acid-induced colitis in rats. Acta Cir Bras 2020;35:e202000404. [PMID: 32555936 DOI: 10.1590/s0102-865020200040000004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
253 Editorial A. CROHN'S DISEASE. CLINICAL RECOMMENDATIONS (PRELIMINARY VERSION). Koloproktologiâ 2020;19:8-38. [DOI: 10.33878/2073-7556-2020-19-2-8-38] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
254 Crowley E, Warner N, Pan J, Khalouei S, Elkadri A, Fiedler K, Foong J, Turinsky AL, Bronte-Tinkew D, Zhang S, Hu J, Tian D, Li D, Horowitz J, Siddiqui I, Upton J, Roifman CM, Church PC, Wall DA, Ramani AK, Kotlarz D, Klein C, Uhlig H, Snapper SB, Gonzaga-Jauregui C, Paterson AD, McGovern DPB, Brudno M, Walters TD, Griffiths AM, Muise AM. Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center. Gastroenterology 2020;158:2208-20. [PMID: 32084423 DOI: 10.1053/j.gastro.2020.02.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
255 Burisch J, Eigner W, Schreiber S, Aletaha D, Weninger W, Trauner M, Reinisch W, Narula N. Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis. PLoS One 2020;15:e0233781. [PMID: 32459816 DOI: 10.1371/journal.pone.0233781] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
256 Cohen JB, Comer DM, Yabes JG, Ragni MV. Inflammatory Bowel Disease and Thrombosis: A National Inpatient Sample Study. TH Open 2020;4:e51-8. [PMID: 32435723 DOI: 10.1055/s-0040-1710506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
257 Eliadou E, Moleiro J, Ribaldone DG, Astegiano M, Rothfuss K, Taxonera C, Ghalim F, Carbonnel F, Verstockt B, Festa S, Maia L, Berrozpe A, Zagorowicz E, Savarino E, Ellul P, Vavricka SR, Calvo M, Koutroubakis I, Hoentjen F, Salazar LF, Callela F, Cañete Pizarro F, Soufleris K, Sonnenberg E, Cavicchi M, Wypych J, Hommel C, Ghiani A, Fiorino G; ECCO CONFER COMMITTEE. Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients. J Crohns Colitis 2020;14:480-9. [PMID: 31602473 DOI: 10.1093/ecco-jcc/jjz165] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
258 Kunovszki P, Milassin Á, Gimesi-Országh J, Takács P, Szántó K, Bálint A, Farkas K, Borsi A, Lakatos PL, Szamosi T, Molnár T. Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study. PLoS One 2020;15:e0233238. [PMID: 32407408 DOI: 10.1371/journal.pone.0233238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
259 Lopez-Siles M, Aldeguer X, Sabat-Mir M, Serra-Pagès M, Duncan SH, Flint HJ, Garcia-Gil LJ, Martinez-Medina M. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification. World J Gastrointest Pathophysiol 2020; 11(3): 64-77 [PMID: 32435523 DOI: 10.4291/wjgp.v11.i3.64] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
260 Pykov MI, Vrublevskaya AM. ECHOGRAPHY IN THE DIAGNOSTICS OF INFLAMMATORY BOWEL DISEASES IN CHILDREN. Det hir 2020;24:101-107. [DOI: 10.18821/1560-9510-2020-24-2-101-107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
261 Al Qudah M, Alfaqih M, Al-Shboul O, Saadeh R, Al-Dwairi A. Effect of cytokine treatment on the expression and secretion of brain derived neurotrophic factor in the smooth muscle of the rat colon. Biomed Rep 2020;13:55-60. [PMID: 32440350 DOI: 10.3892/br.2020.1302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
262 Stephens M, von der Weid PY. Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner. Gut Microbes 2020;11:421-32. [PMID: 31203717 DOI: 10.1080/19490976.2019.1629235] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
263 Wang MH, Mousa OY, Friton JJ, Raffals LE, Leighton JA, Pasha SF, Picco MF, Cushing KC, Monroe K, Nix BD, Newberry RD, Faubion WA. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. Inflamm Bowel Dis 2020;26:774-9. [PMID: 31626701 DOI: 10.1093/ibd/izz209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
264 Nardone OM, Iacucci M, Ghosh S, Castiglione F. Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? Dig Liver Dis 2020;52:516-27. [PMID: 32234418 DOI: 10.1016/j.dld.2020.02.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
265 Wei M, Gao X, Liu L, Li Z, Wan Z, Dong Y, Chen X, Niu Y, Zhang J, Yang G. Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice. ACS Nano 2020;14:5099-110. [PMID: 32275391 DOI: 10.1021/acsnano.0c01860] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
266 Silva NOE, de Brito BB, da Silva FAF, Santos MLC, de Melo FF. Probiotics in inflammatory bowel disease: Does it work? World J Meta-Anal 2020; 8(2): 54-66 [DOI: 10.13105/wjma.v8.i2.54] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
267 Peters V, Tigchelaar-Feenstra EF, Imhann F, Dekens JAM, Swertz MA, Franke LH, Wijmenga C, Weersma RK, Alizadeh BZ, Dijkstra G, Campmans-Kuijpers MJE. Habitual dietary intake of IBD patients differs from population controls: a case-control study. Eur J Nutr 2021;60:345-56. [PMID: 32333097 DOI: 10.1007/s00394-020-02250-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
268 Gill GS, Fernandez SJ, Malhotra N, Mete M, Garcia-Garcia HM. Major acute cardiovascular events in patients with inflammatory bowel disease. Coron Artery Dis 2021;32:73-7. [PMID: 32310848 DOI: 10.1097/MCA.0000000000000899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
269 Agliata I, Fernandez-Jimenez N, Goldsmith C, Marie JC, Bilbao JR, Dante R, Hernandez-Vargas H. The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cells. Epigenetics 2020;15:1068-82. [PMID: 32281463 DOI: 10.1080/15592294.2020.1748916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
270 Santus P, Radovanovic D, Raiteri D, Pini S, Spagnolo G, Maconi G, Rizzi M. The effect of a multidisciplinary approach for smoking cessation in patients with Crohn's disease: Results from an observational cohort study. Tob Induc Dis 2020;18:29. [PMID: 32336967 DOI: 10.18332/tid/119161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
271 Heidari N, Abbasi H, بقایی ک, Namaki S, Hashemi SM, Immunology Dept., Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Immunology Dept., Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Basic and Molecular Epidemiology of Gastrointestinal Disorder Research Center, Research Institute for Gastroenterology and Liver Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Immunology Dept., Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Dept. of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Application of extracellular vesicles in the treatment of inflammatory bowel disease. Koomesh 2020;22:209-219. [DOI: 10.29252/koomesh.22.2.209] [Reference Citation Analysis]
272 Rajaram RB, Hilmi IN, Roslani AC. Low Acceptance of Surgery Results in High Morbidity and Mortality Among Asian Patients With IBD. Dis Colon Rectum 2020;63:415-7. [PMID: 32132461 DOI: 10.1097/DCR.0000000000001606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
273 Doulabi MSH, Moghaddam RG, Salehzadeh A. Associations between an MDM2 gene polymorphism and ulcerative colitis by ARMS-PCR. Genomics Inform 2020;18:e9. [PMID: 32224842 DOI: 10.5808/GI.2020.18.1.e9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
274 Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients 2020;12:E944. [PMID: 32235316 DOI: 10.3390/nu12040944] [Cited by in Crossref: 89] [Cited by in F6Publishing: 96] [Article Influence: 29.7] [Reference Citation Analysis]
275 Marin-Jimenez I, Bastida G, Forés A, Garcia-Planella E, Argüelles-Arias F, Sarasa P, Tagarro I, Fernández-Nistal A, Montoto C, Aguas M, Santos-Fernández J, Bosca-Watts MM, Ferreiro R, Merino O, Aldeguer X, Cortés X, Sicilia B, Mesonero F, Barreiro-de Acosta M. Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study. BMJ Open Gastroenterol 2020;7:e000351. [PMID: 32337054 DOI: 10.1136/bmjgast-2019-000351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
276 Li Y, Langhorst J, Koch AK, Demircioglu A, Schaarschmidt B, Theysohn JM, Martin O, Herrmann K, Catalano O, Umutlu L. Comparison of acceptance of PET/MR enterography and ileocolonoscopy in patients with inflammatory bowel diseases. Clin Imaging 2020;64:11-7. [PMID: 32200275 DOI: 10.1016/j.clinimag.2020.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
277 Cochran KE, Lamson NG, Whitehead KA. Expanding the utility of the dextran sulfate sodium (DSS) mouse model to induce a clinically relevant loss of intestinal barrier function. PeerJ. 2020;8:e8681. [PMID: 32195049 DOI: 10.7717/peerj.8681] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
278 Monogioudi E, Zegers I. Certified Reference Materials and their need for the diagnosis of autoimmune diseases. Mediterr J Rheumatol 2019;30:26-32. [PMID: 32185339 DOI: 10.31138/mjr.30.1.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
279 Kwak MS, Cha JM, Ahn JH, Chae MK, Jeong S, Lee HH. Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease: A nationwide population-based study. Medicine (Baltimore) 2020;99:e18925. [PMID: 32150045 DOI: 10.1097/MD.0000000000018925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
280 Shivaji UN, Nardone OM, Cannatelli R, Smith SC, Ghosh S, Iacucci M. Small molecule oral targeted therapies in ulcerative colitis. Lancet Gastroenterol Hepatol 2020;5:850-61. [PMID: 32171056 DOI: 10.1016/S2468-1253(19)30414-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
281 Foulon A, Chevreau J, Yzet C, Gondry J, Fumery M. [IBD and pregnancy: From conception to birth]. Gynecol Obstet Fertil Senol 2020;48:514-9. [PMID: 32145453 DOI: 10.1016/j.gofs.2020.02.013] [Reference Citation Analysis]
282 Iheozor-Ejiofor Z, Kaur L, Gordon M, Baines PA, Sinopoulou V, Akobeng AK. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;3:CD007443. [PMID: 32128794 DOI: 10.1002/14651858.CD007443.pub3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
283 Kaur L, Gordon M, Baines PA, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;3:CD005573. [PMID: 32128795 DOI: 10.1002/14651858.CD005573.pub3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
284 Kelsen JR, Sullivan KE, Rabizadeh S, Singh N, Snapper S, Elkadri A, Grossman AB. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Evaluation and Management for Patients With Very Early-onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:389-403. [PMID: 32079889 DOI: 10.1097/MPG.0000000000002567] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 16.3] [Reference Citation Analysis]
285 Algethmi W, Baumann C, Alnajjar W, Sroji A, Alsahafi M, Jawa H, Qari Y, Peyrin-Biroulet L, Saadah OI, Mosli M. Environmental exposures and the risk of inflammatory bowel disease: a case-control study from Saudi Arabia. Eur J Gastroenterol Hepatol 2020;32:358-64. [PMID: 31851095 DOI: 10.1097/MEG.0000000000001619] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
286 Björk A, Mofors J, Wahren-Herlenius M. Environmental factors in the pathogenesis of primary Sjögren's syndrome. J Intern Med 2020;287:475-92. [PMID: 32107824 DOI: 10.1111/joim.13032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
287 Benninghoff AD, Hintze KJ, Monsanto SP, Rodriguez DM, Hunter AH, Phatak S, Pestka JJ, Wettere AJV, Ward RE. Consumption of the Total Western Diet Promotes Colitis and Inflammation-Associated Colorectal Cancer in Mice. Nutrients 2020;12:E544. [PMID: 32093192 DOI: 10.3390/nu12020544] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
288 Argollo MC, Allocca M, Furfaro F, Peyrin-Biroulet L, Danese S. Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease? Curr Pharm Des 2019;25:25-31. [PMID: 31092171 DOI: 10.2174/1381612825666190313140811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
289 Chen HT, Huang HL, Xu HM, Luo QL, He J, Li YQ, Zhou YL, Nie YQ, Zhou YJ. Fecal microbiota transplantation ameliorates active ulcerative colitis. ExpTher Med. 2020;19:2650-2660. [PMID: 32256746 DOI: 10.3892/etm.2020.8512] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
290 Snyder J, Wang C, Zhang AQ, Li Y, Luchan J, Hosic S, Koppes R, Carrier RL, Koppes A. Materials and Microenvironments for Engineering the Intestinal Epithelium. Ann Biomed Eng 2020;48:1916-40. [DOI: 10.1007/s10439-020-02470-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
291 Melis M, Mastinu M, Sollai G, Paduano D, Chicco F, Magrì S, Usai P, Crnjar R, Tepper BJ, Barbarossa IT. Taste Changes in Patients with Inflammatory Bowel Disease: Associations with PROP Phenotypes and polymorphisms in the salivary protein, Gustin and CD36 Receptor Genes. Nutrients 2020;12:E409. [PMID: 32033224 DOI: 10.3390/nu12020409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
292 Dard L, Blanchard W, Hubert C, Lacombe D, Rossignol R. Mitochondrial functions and rare diseases. Mol Aspects Med 2020;71:100842. [PMID: 32029308 DOI: 10.1016/j.mam.2019.100842] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
293 Marinelli C, Zingone F, Inferrera M, Lorenzon G, Rigo A, Facchin S, Caccaro R, D'Incà R, Savarino EV. Factors associated with disability in patients with ulcerative colitis: A cross-sectional study. J Dig Dis 2020;21:81-7. [PMID: 31859432 DOI: 10.1111/1751-2980.12837] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
294 Majeed M, Agrawal R, Attar BM, Kamal S, Patel P, Omar YA, Demetria M, Agrawal P, Gandhi S. Fragility index: how fragile is the data that support the American College of Gastroenterology guidelines for the management of Crohn's disease? Eur J Gastroenterol Hepatol 2020;32:193-8. [PMID: 31851082 DOI: 10.1097/MEG.0000000000001635] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
295 Lage AC, Oliveira CC, Batalha APDB, Araújo AF, Czuber-dochan W, Chebli JMF, Cabral LA, Malaguti C. THE INFLAMMATORY BOWEL DISEASE-FATIGUE PATIENT SELF-ASSESSMENT SCALE: TRANSLATION, CROSS-CULTURAL ADAPTATION AND PSYCHOMETRIC PROPERTIES OF THE BRAZILIAN VERSION (IBD-F BRAZIL). Arq Gastroenterol 2020;57:50-63. [DOI: 10.1590/s0004-2803.202000000-10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
296 Zhang G, Liu M, Song M, Wang J, Cai J, Lin C, Li Y, Jin X, Shen C, Chen Z, Cai D, Gao Y, Zhu C, Lin C, Liu C. Patchouli alcohol activates PXR and suppresses the NF-κB-mediated intestinal inflammatory. Journal of Ethnopharmacology 2020;248:112302. [DOI: 10.1016/j.jep.2019.112302] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
297 Deshmukh R, Harwansh RK, Paul SD, Shukla R. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. Journal of Drug Delivery Science and Technology 2020;55:101495. [DOI: 10.1016/j.jddst.2019.101495] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
298 Ciapponi A, Virgilio SA, Berrueta M, Soto NC, Ciganda Á, Rojas Illanes MF, Rubio Martinez B, Gamba J, González Salazar CA, Rocha Rodríguez JN, Scarpellini B, Bravo Perdomo AM, Machnicki G, Aldunate L, De Paula J, Bardach A. Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study. PLoS One 2020;15:e0228256. [PMID: 31986191 DOI: 10.1371/journal.pone.0228256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Davies SC, Hussein IM, Nguyen TM, Parker CE, Khanna R, Jairath V. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;1:CD012381. [PMID: 31984480 DOI: 10.1002/14651858.CD012381.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
300 Atay K, Eyvazov H, Bozcan S, Eşkazan T, Demir N, Hatemi İ, Erzin Y, Çelik AF. The effect of concomitant ankylosing spondylitis on long-term outcome of patients with inflammatory bowel disease. Turk J Gastroenterol 2019;30:599-604. [PMID: 31290746 DOI: 10.5152/tjg.2019.17291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
301 Bookwalter DB, Roenfeldt KA, LeardMann CA, Kong SY, Riddle MS, Rull RP. Posttraumatic stress disorder and risk of selected autoimmune diseases among US military personnel. BMC Psychiatry 2020;20:23. [PMID: 31941473 DOI: 10.1186/s12888-020-2432-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
302 Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019;94:1357-1373. [PMID: 31272578 DOI: 10.1016/j.mayocp.2019.01.018] [Cited by in Crossref: 119] [Cited by in F6Publishing: 126] [Article Influence: 39.7] [Reference Citation Analysis]
303 Horgan L, Richards H, Joy A. The Young Adult Male's Perception of Life with Inflammatory Bowel Disease and a Stoma: A Qualitative Examination. J Clin Psychol Med Settings 2020;27:560-71. [PMID: 31912424 DOI: 10.1007/s10880-019-09695-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
304 Farahmand F, Ahmadi M, Khodadad A, Najafi M, Fallahi G, Motamed F, Movahedi M, Aghamohammadi A, Rezaei N, Javaherizadeh H. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis. Clin Exp Hepatol 2019;5:285-8. [PMID: 31893239 DOI: 10.5114/ceh.2019.89119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
305 Fernández-ávila DG, Bernal-macías S, Parra-izquierdo V, Rincón-riaño DN, Gutiérrez JM, Rosselli D. Prevalencia en Colombia de la enfermedad inflamatoria intestinal y el compromiso articular asociado, según información del Sistema Integral de Información de la Protección Social. Revista Colombiana de Reumatología 2020;27:3-8. [DOI: 10.1016/j.rcreu.2019.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
306 Takenaka K, Kitazume Y, Fujii T, Tsuchiya K, Watanabe M, Ohtsuka K. Objective evaluation for treat to target in Crohn's disease. J Gastroenterol 2020;55:579-87. [PMID: 32130521 DOI: 10.1007/s00535-020-01678-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
307 Shepitko KV. APPLICATION OF CRYOPRESERVED PLACENTA PREPARATIONS IN THE SMALL INTESTINE PATHOLOGIES IN RATS FOR THEIR FURTHER USE IN EXIGENT CONDITIONS. VPBM 2020;4:56. [DOI: 10.29254/2077-4214-2019-4-2-154-56-61] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
308 Plevinsky JM, Greenley RN. Inflammatory bowel disease and gastrointestinal disorders. Adherence and Self-Management in Pediatric Populations 2020. [DOI: 10.1016/b978-0-12-816000-8.00011-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
309 Javad Hosseinzadeh-attar M, Sharifi A, Nedjat S, Mohamadkhani A, Vahedi H. The Effect of Vitamin D on Serum Asymmetric Dimethylarginine in Patients with Mild to Moderate Ulcerative Colitis. International Journal for Vitamin and Nutrition Research 2020;90:17-22. [DOI: 10.1024/0300-9831/a000303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
310 Kelsen J, Boztug K. Autoinflammatory diseases predominantly affecting the gastrointestinal tract. Stiehm's Immune Deficiencies 2020. [DOI: 10.1016/b978-0-12-816768-7.00030-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
311 Rintala RJ, Pakarinen MP, Koivusalo A. Ulcerative Colitis (General Pediatric Surgery of Abdomen). Pediatric Surgery 2020. [DOI: 10.1007/978-3-642-38482-0_106-1] [Reference Citation Analysis]
312 Kee BP, Ng JG, Ng CC, Hilmi I, Goh KL, Chua KH. Genetic polymorphisms of ATG16L1 and IRGM genes in Malaysian patients with Crohn's disease. J Dig Dis 2020;21:29-37. [PMID: 31654602 DOI: 10.1111/1751-2980.12829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
313 Dane B, Duenas S, Han J, Oʼdonnell T, Ream J, Chang S, Megibow A. Crohnʼs Disease Activity Quantified by Iodine Density Obtained From Dual-Energy Computed Tomography Enterography: . Journal of Computer Assisted Tomography 2020;44:242-7. [DOI: 10.1097/rct.0000000000000986] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
314 Pyeritz RE. Inflammatory Bowel Disease. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics 2020. [DOI: 10.1016/b978-0-12-812532-8.00018-5] [Reference Citation Analysis]
315 Fernández-ávila DG, Bernal-macías S, Parra-izquierdo V, Rincón-riaño DN, Gutiérrez JM, Rosselli D. Prevalence of inflammatory bowel disease and related arthritis in Colombia, according to information from the Health and Social Protection Data System. Revista Colombiana de Reumatología (English Edition) 2020;27:3-8. [DOI: 10.1016/j.rcreue.2019.10.005] [Reference Citation Analysis]
316 Frickenstein AN, Jones MA, Behkam B, McNally LR. Imaging Inflammation and Infection in the Gastrointestinal Tract. Int J Mol Sci 2019;21:E243. [PMID: 31905812 DOI: 10.3390/ijms21010243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
317 Ben-Ami Shor D, Lachnish J, Bashi T, Dahan S, Shemer A, Segal Y, Shovman O, Halpert G, Volkov A, Barshack I, Amital H, Blank M, Shoenfeld Y. Immunomodulation of Murine Chronic DSS-Induced Colitis by Tuftsin-Phosphorylcholine. J Clin Med 2019;9:E65. [PMID: 31888063 DOI: 10.3390/jcm9010065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
318 Menta PLR, Andrade MER, Leocádio PCL, Fraga JR, Dias MTS, Cara DC, Cardoso VN, Borges LF, Capettini LSA, Aguilar EC, Alvarez-Leite JI. Wheat gluten intake increases the severity of experimental colitis and bacterial translocation by weakening of the proteins of the junctional complex. Br J Nutr 2019;121:361-73. [PMID: 30554574 DOI: 10.1017/S0007114518003422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
319 Kamarlı Altun H, Akal Yıldız E, Akın M. Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study. Turk J Gastroenterol 2019;30:313-20. [PMID: 30666969 DOI: 10.5152/tjg.2019.18356] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
320 Yang H, Li Y, Shen S, Gan D, Han C, Wu J, Wang Z. Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis. Evid Based Complement Alternat Med 2019;2019:7870424. [PMID: 31976001 DOI: 10.1155/2019/7870424] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
321 Jain A, Marrie RA, Shafer LA, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Fisk JD, Bernstein CN. Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review. Crohns Colitis 360 2020;2:otz053. [PMID: 32003760 DOI: 10.1093/crocol/otz053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
322 Taghipour N, Mosaffa N, Aghdaei HA, Rostami-Nejad M, Weinstock JV, Shahnavaz S, Zali MR. Immunomodulatory effect of Syphacia obvelata in treatment of experimental DSS-induced colitis in mouse model. Sci Rep 2019;9:19127. [PMID: 31836772 DOI: 10.1038/s41598-019-55552-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
323 Chen Y, Wang Y, Shen J. Role of environmental factors in the pathogenesis of Crohn's disease: a critical review. Int J Colorectal Dis 2019;34:2023-34. [PMID: 31732875 DOI: 10.1007/s00384-019-03441-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
324 Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, Brzozowski T. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.Biomolecules. 2019;9. [PMID: 31779136 DOI: 10.3390/biom9120780] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
325 Sontheimer-Phelps A, Chou DB, Tovaglieri A, Ferrante TC, Duckworth T, Fadel C, Frismantas V, Sutherland AD, Jalili-Firoozinezhad S, Kasendra M, Stas E, Weaver JC, Richmond CA, Levy O, Prantil-Baun R, Breault DT, Ingber DE. Human Colon-on-a-Chip Enables Continuous In Vitro Analysis of Colon Mucus Layer Accumulation and Physiology. Cell Mol Gastroenterol Hepatol 2020;9:507-26. [PMID: 31778828 DOI: 10.1016/j.jcmgh.2019.11.008] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 19.5] [Reference Citation Analysis]
326 Takemura A, Egawa T, Tanaka T, Kuramoto T, Hayashi T, Ishihara A. Effects of Exposure to Mild Hyperbaric Oxygen on DSS-Induced Colonic Inflammation and Diarrhea in Rats. J Inflamm Res 2019;12:293-9. [PMID: 31754309 DOI: 10.2147/JIR.S220586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
327 Click B, Regueiro M. The Inflammatory Bowel Disease Medical Home: From Patients to Populations. Inflamm Bowel Dis 2019;25:1881-5. [PMID: 30934057 DOI: 10.1093/ibd/izz062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
328 Jin L, Li L, Hu C, Paez-Cortez J, Bi Y, Macoritto M, Cao S, Tian Y. Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies. Inflamm Bowel Dis 2019;25:1906-18. [PMID: 31173627 DOI: 10.1093/ibd/izz111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
329 Zhu J, Wang Z, Chen F, Liu C. Identification of genes and functional coexpression modules closely related to ulcerative colitis by gene datasets analysis. PeerJ 2019;7:e8061. [PMID: 31741804 DOI: 10.7717/peerj.8061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
330 Peters V, Alizadeh BZ, de Vries JH, Dijkstra G, Campmans-Kuijpers MJ. Nutritional Assessment in Inflammatory Bowel Disease (IBD)-Development of the Groningen IBD Nutritional Questionnaires (GINQ). Nutrients 2019;11:E2739. [PMID: 31726688 DOI: 10.3390/nu11112739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
331 Weber AT, Shah ND, Sauk J, Limketkai BN. Popular Diet Trends for Inflammatory Bowel Diseases: Claims and Evidence. Curr Treat Options Gastroenterol 2019;17:564-76. [PMID: 31705371 DOI: 10.1007/s11938-019-00248-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
332 Ghaly S, Hart PH, Lawrance IC. Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome. Expert Rev Gastroenterol Hepatol 2019;13:1039-48. [PMID: 31657973 DOI: 10.1080/17474124.2019.1685874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
333 Nader A, Stodtmann S, Friedel A, Mohamed MF, Othman AA. Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical Trials. The Journal of Clinical Pharmacology 2019;60:528-39. [DOI: 10.1002/jcph.1550] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
334 Hernandez-Nieto C, Sekhon L, Lee J, Gounko D, Copperman A, Sandler B. Infertile patients with inflammatory bowel disease have comparable in vitro fertilization clinical outcomes to the general infertile population. Gynecol Endocrinol 2020;36:554-7. [PMID: 31691606 DOI: 10.1080/09513590.2019.1684465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
335 Gao Y, Uffenheimer M, Ashamallah M, Grimaldi G, Swaminath A, Sultan K. Presentation and outcomes among inflammatory bowel disease patients with concurrent pneumatosis intestinalis: a case series and systematic review. Intest Res 2020;18:289-96. [PMID: 31671928 DOI: 10.5217/ir.2019.00073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
336 Wang T, Yang JY, Buse JB, Pate V, Tang H, Barnes EL, Sandler RS, Stürmer T. Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults. Diabetes Care 2019;42:2065-74. [PMID: 31471377 DOI: 10.2337/dc19-0162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
337 Berens S, Schaefert R, Baumeister D, Gauss A, Eich W, Tesarz J. Does symptom activity explain psychological differences in patients with irritable bowel syndrome and inflammatory bowel disease? Results from a multi-center cross-sectional study. Journal of Psychosomatic Research 2019;126:109836. [DOI: 10.1016/j.jpsychores.2019.109836] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
338 Goldiș A, Lupușoru R, Gheorghe L, Gheorghe C, Trifan A, Dobru D, Cijevschi C, Tanțău A, Constantinescu G, Iacob R, Goldiș R, Diculescu M. Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania. Medicina (Kaunas) 2019;55:E704. [PMID: 31635181 DOI: 10.3390/medicina55100704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
339 Nameirakpam J, Rikhi R, Rawat SS, Sharma J, Suri D. Genetics on early onset inflammatory bowel disease: An update. Genes Dis 2020;7:93-106. [PMID: 32181280 DOI: 10.1016/j.gendis.2019.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
340 Parra RS, Chebli JM, Amarante HM, Flores C, Parente JM, Ramos O, Fernandes M, Rocha JJ, Feitosa MR, Feres O, Scotton AS, Nones RB, Lima MM, Zaltman C, Goncalves CD, Guimaraes IM, Santana GO, Sassaki LY, Hossne RS, Bafutto M, Junior RL, Faria MA, Miszputen SJ, Gomes TN, Catapani WR, Faria AA, Souza SC, Caratin RF, Senra JT, Ferrari ML. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World J Gastroenterol 2019; 25(38): 5862-5882 [PMID: 31636478 DOI: 10.3748/wjg.v25.i38.5862] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
341 Han W, Xie B, Li Y, Shi L, Wan J, Chen X, Wang H. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer. Theranostics 2019;9:7458-73. [PMID: 31695780 DOI: 10.7150/thno.38081] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 11.5] [Reference Citation Analysis]
342 Ge Y, Shi Q, Yao W, Cheng Y, Ma G. The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis 2020;23:53-8. [PMID: 31591455 DOI: 10.1038/s41391-019-0177-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
343 Ehrhardt K, Steck N, Kappelhoff R, Stein S, Rieder F, Gordon IO, Boyle EC, Braubach P, Overall CM, Finlay BB, Grassl GA. Persistent Salmonella enterica Serovar Typhimurium Infection Induces Protease Expression During Intestinal Fibrosis. Inflamm Bowel Dis 2019;25:1629-43. [PMID: 31066456 DOI: 10.1093/ibd/izz070] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
344 Mckim JM, Willoughby JA, Blakemore WR, Weiner ML. A Critical Review of “A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity (Nutr. Healthy Aging. 2017; 4(2): 181–192).”. NHA 2019;5:149-58. [DOI: 10.3233/nha-180051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
345 Chang Y, Lo H, Cheng S, Chang K, Lin X, Lee S, Ma J, Kuo M, Hsieh M, Chan C. Therapeutic Efficacy of Subcutaneous and Intraperitoneal Injections of a Single Dose of Human Umbilical Mesenchymal Stem Cells in Acute and Chronic Colitis in a Mouse Model. J Med Biol Eng 2020;40:82-90. [DOI: 10.1007/s40846-019-00494-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
346 Truong A, Zaghiyan K, Fleshner P. Anorectal Crohn's Disease. Surg Clin North Am. 2019;99:1151-1162. [PMID: 31676054 DOI: 10.1016/j.suc.2019.08.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
347 Rather IA, Bajpai VK, Ching LL, Majumder R, Nam GJ, Indugu N, Singh P, Kumar S, Hajrah NH, Sabir JSM, Kamli MR, Park YH. Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model. Saudi J Biol Sci 2020;27:261-70. [PMID: 31889846 DOI: 10.1016/j.sjbs.2019.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
348 Burr NE, Lord R, Hull MA, Subramanian V. Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013. Clin Gastroenterol Hepatol 2019;17:2042-2049.e4. [PMID: 30583051 DOI: 10.1016/j.cgh.2018.12.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
349 Karmele EP, Pasricha TS, Ramalingam TR, Thompson RW, Gieseck RL 3rd, Knilans KJ, Hegen M, Farmer M, Jin F, Kleinman A, Hinds DA, Almeida Pereira T, de Queiroz Prado R, Bing N, Tchistiakova L, Kasaian MT, Wynn TA, Vannella KM; 23andMe Research Team. Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease. Mucosal Immunol 2019;12:1174-86. [PMID: 31308480 DOI: 10.1038/s41385-019-0189-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
350 Ludvigsson JF, Andersson M, Bengtsson J, Eberhardson M, Fagerberg UL, Grip O, Halfvarson J, Hjortswang H, Jäghult S, Karling P, Nordenvall C, Olén O, Olsson M, Rejler M, Strid H, Myrelid P. Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register. Scand J Gastroenterol 2019;54:1089-101. [PMID: 31498717 DOI: 10.1080/00365521.2019.1660799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
351 Andreozzi M, Giugliano FP, Strisciuglio T, Pirozzi E, Papparella A, Caprio AM, Miele E, Strisciuglio C, Perrone Filardi P. The Role of Inflammation in the Endothelial Dysfunction in a Cohort of Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:330-5. [PMID: 31169657 DOI: 10.1097/MPG.0000000000002374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
352 Carrasco-Labra A, Lytvyn L, Falck-Ytter Y, Surawicz CM, Chey WD. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D). Gastroenterology 2019;157:859-80. [PMID: 31351880 DOI: 10.1053/j.gastro.2019.06.014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis]
353 Chandra N, Srivastava A, Kumar S. Bacterial biofilms in human gastrointestinal tract: An intricate balance between health and inflammatory bowel diseases. World J Pharmacol 2019; 8(3): 26-40 [DOI: 10.5497/wjp.v8.i3.26] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
354 Sontheimer-phelps A, Chou DB, Tovaglieri A, Ferrante TC, Duckworth T, Fadel C, Frismantas V, Jalili-firoozinezhad S, Kasendra M, Stas E, Weaver JC, Richmond CA, Levy O, Prantil-baun R, Breault DT, Ingber DE. Human colon-on-a-chip enables continuous in vitro analysis of colon mucus layer accumulation and physiology.. [DOI: 10.1101/740423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
355 Wang H, Vilches-Moure JG, Cherkaoui S, Tardy I, Alleaume C, Bettinger T, Lutz A, Paulmurugan R. Chronic Model of Inflammatory Bowel Disease in IL-10-/- Transgenic Mice: Evaluation with Ultrasound Molecular Imaging. Theranostics 2019;9:6031-46. [PMID: 31534535 DOI: 10.7150/thno.37397] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
356 Yamada A, Wang J, Komaki Y, Komaki F, Micic D, Sakuraba A. Systematic review with meta-analysis: risk of new onset IBD with the use of anti-interleukin-17 agents. Aliment Pharmacol Ther 2019;50:373-85. [PMID: 31309607 DOI: 10.1111/apt.15397] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
357 Silva MC, Sales-Campos H, Oliveira CJF, Silva TL, França FBF, Oliveira F, Mineo TWP, Mineo JR. Treatment with a Zinc Metalloprotease Purified from Bothrops moojeni Snake Venom (BmooMP-Alpha-I) Reduces the Inflammation in an Experimental Model of Dextran Sulfate Sodium-Induced Colitis. Mediators Inflamm 2019;2019:5195134. [PMID: 31467484 DOI: 10.1155/2019/5195134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
358 Sharifi A, Vahedi H, Nedjat S, Rafiei H, Hosseinzadeh-Attar MJ. Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial. APMIS 2019;127:681-7. [PMID: 31274211 DOI: 10.1111/apm.12982] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 15.0] [Reference Citation Analysis]
359 Huang J, Chen T, Liu Y, Lyu L, Li X, Yue W. How would serum 25(OH)D level change in patients with inflammatory bowel disease depending on intestinal mucosa vitamin D receptor (VDR) and vitamin D1-α hydroxylase (CYP27B1)? Turk J Gastroenterol 2019;30:132-8. [PMID: 30429108 DOI: 10.5152/tjg.2018.17828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
360 Lee S, Crowe M, Seow CH, Kotze PG, Kaplan GG, Metcalfe A, Ricciuto A, Benchimol EI, Kuenzig ME. The impact of surgical therapies for inflammatory bowel disease on female fertility. Cochrane Database Syst Rev 2019;7:CD012711. [PMID: 31334846 DOI: 10.1002/14651858.CD012711.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
361 Chen D, Ma J, Ben Q, Lu L, Wan X. Prior Appendectomy and the Onset and Course of Crohn's Disease in Chinese Patients. Gastroenterol Res Pract 2019;2019:8463926. [PMID: 31396275 DOI: 10.1155/2019/8463926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
362 Yamamoto-Furusho JK, Sarmiento-Aguilar A, Toledo-Mauriño JJ, Bozada-Gutiérrez KE, Bosques-Padilla FJ, Martínez-Vázquez MA, Marroquín-Jiménez V, García-Figueroa R, Jaramillo-Buendía C, Miranda-Cordero RM, Valenzuela-Pérez JA, Cortes-Aguilar Y, Jacobo-Karam JS, Bermudez-Villegas EF; EPIMEX Study Group. Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017). Medicine (Baltimore) 2019;98:e16291. [PMID: 31277162 DOI: 10.1097/MD.0000000000016291] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
363 Figueroa C. Epidemiología de la enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019;30:257-61. [DOI: 10.1016/j.rmclc.2019.06.003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
364 Wen Z, Liu W, Li X, Chen W, Liu Z, Wen J, Liu Z. A Protective Role of the NRF2-Keap1 Pathway in Maintaining Intestinal Barrier Function. Oxid Med Cell Longev 2019;2019:1759149. [PMID: 31346356 DOI: 10.1155/2019/1759149] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 11.8] [Reference Citation Analysis]
365 Song G, Fiocchi C, Achkar JP. Acupuncture in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1129-39. [PMID: 30535303 DOI: 10.1093/ibd/izy371] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
366 Quinn CC, Chard S, Roth EG, Eckert JK, Russman KM, Cross RK. The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants' Perceptions. J Med Internet Res 2019;21:e14165. [PMID: 31162128 DOI: 10.2196/14165] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
367 Hosseini RS, Mansour-ghanaei F, Shafaghi A, Hojati A, Joukar F, Roushan ZA, Hosseini FA, Mavaddati S. Exacerbation causes among inflammatory bowel disease patients in Guilan Province north of Iran. Journal of Coloproctology 2019;39:138-144. [DOI: 10.1016/j.jcol.2018.11.005] [Reference Citation Analysis]
368 Holik D, Včev A, Milostić-Srb A, Salinger Ž, Ivanišević Z, Včev I, Miškulin M. THE EFFECT OF DAILY PHYSICAL ACTIVITY ON THE ACTIVITY OF INFLAMMATORY BOWEL DISEASES IN THERAPY-FREE PATIENTS. Acta Clin Croat 2019;58:202-12. [PMID: 31819315 DOI: 10.20471/acc.2019.58.02.02] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
369 Khan N, Trivedi C, Kavani H, Medvedeva E, Lewis J, Yang YX. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2019;17:1341-7. [PMID: 30326303 DOI: 10.1016/j.cgh.2018.10.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
370 Chu KF, Moran CJ, Wu K, Kaplan JL, Savarino JR, Board T, Israel EJ, Winter HS, Gee MS. Performance of Surveillance MR Enterography (MRE) in Asymptomatic Children and Adolescents With Crohn's Disease. J Magn Reson Imaging 2019;50:1955-63. [DOI: 10.1002/jmri.26811] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
371 Chen X, Yang K, Xu Y, Li K. Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis. Medicine (Baltimore) 2019;98:e15718. [PMID: 31096525 DOI: 10.1097/MD.0000000000015718] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
372 Hu Q, Yuan B, Wu X, Du H, Gu M, Han Y, Yang W, Song M, Xiao H. Dietary Intake of Pleurotus eryngii Ameliorated Dextran‐Sodium‐Sulfate‐Induced Colitis in Mice. Mol Nutr Food Res 2019;63:1801265. [DOI: 10.1002/mnfr.201801265] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
373 Cury DB, Oliveira R, Cury MS. Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003-2017). J Inflamm Res 2019;12:127-35. [PMID: 31213873 DOI: 10.2147/JIR.S190929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
374 Shannahan SE, Erlich JM, Peppercorn MA. Insights into the treatment of inflammatory bowel disease in pregnancy. Therap Adv Gastroenterol 2019;12:1756284819852231. [PMID: 31191713 DOI: 10.1177/1756284819852231] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
375 Lin R, Piao M, Song Y. Dietary Quercetin Increases Colonic Microbial Diversity and Attenuates Colitis Severity in Citrobacter rodentium-Infected Mice. Front Microbiol 2019;10:1092. [PMID: 31156598 DOI: 10.3389/fmicb.2019.01092] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
376 D'Amico F, Parigi TL, Fiorino G, Peyrin-Biroulet L, Danese S. Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience. Therap Adv Gastroenterol 2019;12:1756284819848631. [PMID: 31205486 DOI: 10.1177/1756284819848631] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
377 Naramala S, Konala VM, Adapa S, Amudala P, Castillo RC, Agrawal N, Dhingra H. Recurrent Inflammatory Myositis as an Extra-Intestinal Manifestation of Dormant Ulcerative Colitis in a Patient on Long-Term Mesalamine. Case Rep Gastrointest Med 2019;2019:2090379. [PMID: 31080678 DOI: 10.1155/2019/2090379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
378 Yao Q, Li E, Shen B. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity 2019;52:48-56. [PMID: 31084224 DOI: 10.1080/08916934.2019.1613382] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
379 Rizzello F, Spisni E, Giovanardi E, Imbesi V, Salice M, Alvisi P, Valerii MC, Gionchetti P. Implications of the Westernized Diet in the Onset and Progression of IBD. Nutrients 2019;11:E1033. [PMID: 31072001 DOI: 10.3390/nu11051033] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 20.5] [Reference Citation Analysis]
380 Permpoon V, Pongpirul K, Anuras S. Five-year clinical outcomes of Crohn's disease: a report of 287 multiethnic cases from an International Hospital in Thailand. Clin Exp Gastroenterol 2019;12:203-8. [PMID: 31190947 DOI: 10.2147/CEG.S197255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
381 Waljee AK, Chaisidhivej N, Saini SD, Higgins PDR. De-escalation of IBD Therapy: When, Who, and How? Crohn's & Colitis 360 2019;1. [DOI: 10.1093/crocol/otz008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
382 Vij P, Chen D, Hsu CH, Pandit V, Omesiete P, Elquza E, Scott A, Cruz A, Nfonsam V. Racial disparities in the incidence of colon cancer in patients with inflammatory bowel disease. J Gastrointest Oncol 2019;10:254-8. [PMID: 31032092 DOI: 10.21037/jgo.2019.01.06] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
383 Tripathi K, Feuerstein JD. New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance. Drugs Context 2019;8:212572. [PMID: 31065290 DOI: 10.7573/dic.212572] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 13.0] [Reference Citation Analysis]
384 Cheng B, Liang X, Wen Y, Li P, Zhang L, Ma M, Cheng S, Du Y, Liu L, Ding M, Zhao Y, Zhang F. Integrative analysis of transcriptome‐wide association study data and messenger RNA expression profiles identified candidate genes and pathways for inflammatory bowel disease. J Cell Biochem 2019;120:14831-7. [DOI: 10.1002/jcb.28744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
385 Candan G, Kahraman R, Ergen A. Irak-4 rs4251481 gene variant: as a risk factor on inflammatory bowel disease. Turk J Med Sci 2019;49:478-82. [PMID: 30997787 DOI: 10.3906/sag-1807-279] [Reference Citation Analysis]
386 Teruel AH, Pérez-esteve É, González-álvarez I, González-álvarez M, Costero AM, Ferri D, Gaviña P, Merino V, Martínez-máñez R, Sancenón F. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease. Mol Pharmaceutics 2019;16:2418-29. [DOI: 10.1021/acs.molpharmaceut.9b00041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
387 Lam WC, Zhao C, Ma WJ, Yao L. The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis. Gastroenterol Res Pract 2019;2019:1287493. [PMID: 31178906 DOI: 10.1155/2019/1287493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
388 Zheng X, Zhang Z, Wang B, Li J, Qiu C, Zhang Q, Wang X. Efficacy and safety of once daily versus twice daily mesalazine for mild-to-moderate ulcerative colitis: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2019;98:e15113. [PMID: 30946380 DOI: 10.1097/MD.0000000000015113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
389 Mikocka-Walus A, Prady SL, Pollok J, Esterman AJ, Gordon AL, Knowles S, Andrews JM. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database Syst Rev 2019;4:CD012680. [PMID: 30977111 DOI: 10.1002/14651858.CD012680.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
390 Chang YL, Lo HY, Cheng SP, Chang KT, Lin XF, Lee SP, Hsieh MF, Chan CK. Therapeutic effects of a single injection of human umbilical mesenchymal stem cells on acute and chronic colitis in mice. Sci Rep 2019;9:5832. [PMID: 30967579 DOI: 10.1038/s41598-019-41910-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
391 Dai Y, Pei G, Zhao Z, Jia P. A Convergent Study of Genetic Variants Associated With Crohn's Disease: Evidence From GWAS, Gene Expression, Methylation, eQTL and TWAS. Front Genet 2019;10:318. [PMID: 31024628 DOI: 10.3389/fgene.2019.00318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
392 Pantazi E, Powell N. Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?! Front Immunol 2019;10:676. [PMID: 31024537 DOI: 10.3389/fimmu.2019.00676] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
393 Nazarko L. Prescribing for patients with inflammatory bowel disease. Practice Nursing 2019;30:184-188. [DOI: 10.12968/pnur.2019.30.4.184] [Reference Citation Analysis]
394 Nazarko L. Prescribing for patients with inflammatory bowel disease. Practice Nursing 2019;30:132-136. [DOI: 10.12968/pnur.2019.30.4.132] [Reference Citation Analysis]
395 Magro F, Coelho R, Peixoto A. Can We Extrapolate Data from One Immune-Mediated Inflammatory Disease to Another One? Curr Med Chem 2019;26:248-58. [PMID: 30381062 DOI: 10.2174/0929867325666181101114937] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
396 Lin YS, Cheng SW, Wang YH, Chen KH, Fang CJ, Chen C. Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn's disease. Aliment Pharmacol Ther 2019;49:966-77. [PMID: 30864199 DOI: 10.1111/apt.15184] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
397 Orr N, Wahl K, Joannou A, Hartmann D, Valle L, Yong P; International Society for the Study of Women’s Sexual Health’s (ISSWSH) Special Interest Group on Sexual Pain. Deep Dyspareunia: Review of Pathophysiology and Proposed Future Research Priorities. Sex Med Rev 2020;8:3-17. [PMID: 30928249 DOI: 10.1016/j.sxmr.2018.12.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
398 Larussa T, Imeneo M, Luzza F. Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better. Int J Mol Sci 2019;20:E1390. [PMID: 30897691 DOI: 10.3390/ijms20061390] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
399 Fahmy CA, Gamal-Eldeen AM, El-Hussieny EA, Raafat BM, Mehanna NS, Talaat RM, Shaaban MT. Bifidobacterium longum Suppresses Murine Colorectal Cancer through the Modulation of oncomiRs and Tumor Suppressor miRNAs. Nutr Cancer 2019;71:688-700. [PMID: 30862187 DOI: 10.1080/01635581.2019.1577984] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
400 Chartier LC, Howarth GS, Mashtoub S. Combined Nutraceuticals: A Novel Approach to Colitis-Associated Colorectal Cancer? Nutr Cancer 2019;71:199-206. [PMID: 30862196 DOI: 10.1080/01635581.2019.1578391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
401 Alegbeleye BJ. Crohn's disease in a developing African mission hospital: a case report. J Med Case Rep. 2019;13:80. [PMID: 30846003 DOI: 10.1186/s13256-019-1971-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
402 Han Y, Song M, Gu M, Ren D, Zhu X, Cao X, Li F, Wang W, Cai X, Yuan B, Goulette T, Zhang G, Xiao H. Dietary Intake of Whole Strawberry Inhibited Colonic Inflammation in Dextran-Sulfate-Sodium-Treated Mice via Restoring Immune Homeostasis and Alleviating Gut Microbiota Dysbiosis. J Agric Food Chem 2019;67:9168-77. [PMID: 30810035 DOI: 10.1021/acs.jafc.8b05581] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
403 Ahn J, Son S, Oliveira SC, Barber GN. STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis. Cell Rep 2017;21:3873-84. [PMID: 29281834 DOI: 10.1016/j.celrep.2017.11.101] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 17.0] [Reference Citation Analysis]
404 Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65:100851. [PMID: 30837080 DOI: 10.1016/j.disamonth.2019.02.004] [Cited by in Crossref: 117] [Cited by in F6Publishing: 129] [Article Influence: 29.3] [Reference Citation Analysis]
405 Nazarko L. Prescribing for patients with inflammatory bowel disease. Journal of Prescribing Practice 2019;1:124-128. [DOI: 10.12968/jprp.2019.1.3.124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
406 van der Waal MB, Flach J, Browne PD, Besseling-van der Vaart I, Claassen E, van de Burgwal LH. Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective. PharmaNutrition 2019;7:100139. [DOI: 10.1016/j.phanu.2018.100139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
407 Kao L, Lin H, Lee H. Inflammatory bowel disease and bipolar disorder: A population-based cross-sectional study. Journal of Affective Disorders 2019;247:120-4. [DOI: 10.1016/j.jad.2019.01.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
408 Agliata I, Fernandez-jimenez N, Goldsmith C, Marie JC, Bilbao JR, Dante R, Hernandez-vargas H. The DNA Methylome of Inflammatory Bowel Disease (IBD) reflects intrinsic and extrinsic factors in intestinal epithelial cells.. [DOI: 10.1101/565200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
409 Kredel LI, Schneidereit O, Hoffmann JC, Siegmund B, Preiß JC. Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey. Int J Colorectal Dis 2019;34:431-40. [PMID: 30523398 DOI: 10.1007/s00384-018-3215-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
410 Alagón Fernández Del Campo P, De Orta Pando A, Straface JI, López Vega JR, Toledo Plata D, Niezen Lugo SF, Alvarez Hernández D, Barrientos Fortes T, Gutiérrez-Kobeh L, Solano-Gálvez SG, Vázquez-López R. The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Med Sci (Basel) 2019;7:E33. [PMID: 30813381 DOI: 10.3390/medsci7020033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
411 Carvalho D, Viana C, Marques I, Costa C, Martins SF. Sarcopenia is associated with Postoperative Outcome in Patients with Crohn’s Disease Undergoing Bowel Resection. GastrointestDisord 2019;1:201-9. [DOI: 10.3390/gidisord1010015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
412 Camkerten G, Erdoğan H, Ural DA, Camkerten İ, Erdoğan S, Ural K. Levels of Serum 25 (OH) D3 in Naturally Infected Lambs With Giardia duodenalis. Kocatepe Veterinary Journal 2019. [DOI: 10.30607/kvj.492805] [Reference Citation Analysis]
413 Ait-oudhia S, Lien YTK, Basu S, Lesko L, Schmidt S. Application of Pharmacometrics and Systems Pharmacology to Current and Emerging Biologics in Inflammatory Bowel Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases 2019. [DOI: 10.1002/9781119289234.ch10] [Reference Citation Analysis]
414 Bhaskar N, Narasimhulu CA, Keewan E, Rohr M, Parthasarathy S. Proinflammatory Properties of Peroxidized Fat May Contribute to the Etiology of Crohn's Disease. Journal of Medicinal Food 2019;22:162-9. [DOI: 10.1089/jmf.2018.0132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
415 Campbell EL, Colgan SP. Control and dysregulation of redox signalling in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2019;16:106-20. [PMID: 30443019 DOI: 10.1038/s41575-018-0079-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 16.3] [Reference Citation Analysis]
416 Payne SC, Furness JB, Stebbing MJ. Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms. Nat Rev Gastroenterol Hepatol 2019;16:89-105. [PMID: 30390018 DOI: 10.1038/s41575-018-0078-6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 18.0] [Reference Citation Analysis]
417 Erdmann P, Bruckmueller H, Martin P, Busch D, Haenisch S, Müller J, Wiechowska-kozlowska A, Partecke LI, Heidecke C, Cascorbi I, Drozdzik M, Oswald S. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis. Journal of Pharmaceutical Sciences 2019;108:1035-46. [DOI: 10.1016/j.xphs.2018.09.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
418 Keller DS, Windsor A, Cohen R, Chand M. Colorectal cancer in inflammatory bowel disease: review of the evidence. Tech Coloproctol 2019;23:3-13. [PMID: 30701345 DOI: 10.1007/s10151-019-1926-2] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 24.5] [Reference Citation Analysis]
419 Di Cagno R, Filannino P, Vincentini O, Cantatore V, Cavoski I, Gobbetti M. Fermented Portulaca oleracea L. Juice: A Novel Functional Beverage with Potential Ameliorating Effects on the Intestinal Inflammation and Epithelial Injury. Nutrients 2019;11:E248. [PMID: 30678049 DOI: 10.3390/nu11020248] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
420 Iglesias N, Galbis E, Díaz-Blanco MJ, Lucas R, Benito E, de-Paz MV. Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release. Int J Mol Sci 2019;20:E398. [PMID: 30669264 DOI: 10.3390/ijms20020398] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
421 Assadsangabi A, Evans CA, Corfe BM, Lobo A. Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives. Gastroenterol Res Pract 2019;2019:1426954. [PMID: 30774653 DOI: 10.1155/2019/1426954] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
422 Siracusa F, Schaltenberg N, Villablanca EJ, Huber S, Gagliani N. Dietary Habits and Intestinal Immunity: From Food Intake to CD4+ T H Cells. Front Immunol 2018;9:3177. [PMID: 30697217 DOI: 10.3389/fimmu.2018.03177] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
423 Sadr M, Moazzami B, Soleimanifar N, Elhamian N, Rezaei A, Ebrahimi Daryani N, Rezaei N. Single Nucleotide Polymorphisms of PTPN22 Gene in Iranian Patients with Ulcerative Colitis. Fetal Pediatr Pathol 2019;38:8-13. [PMID: 30636557 DOI: 10.1080/15513815.2018.1543371] [Reference Citation Analysis]
424 Shim JO. Recent Advance in Very Early Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2019;22:41-9. [PMID: 30671372 DOI: 10.5223/pghn.2019.22.1.41] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
425 Espí-López GV, Inglés M, Soliva-Cazabán I, Serra-Añó P. Effect of the soft-tissue techniques in the quality of life in patients with Crohn's disease: A randomized controlled trial. Medicine (Baltimore) 2018;97:e13811. [PMID: 30572544 DOI: 10.1097/MD.0000000000013811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
426 Erden A, Kuru Öz D, Gürsoy Çoruh A, Erden İ, Özalp Ateş FS, Törüner M. Backwash ileitis in ulcerative colitis: Are there MR enterographic features that distinguish it from Crohn disease? Eur J Radiol 2019;110:212-8. [PMID: 30599862 DOI: 10.1016/j.ejrad.2018.11.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
427 Bhushan B, Singh BP, Kumari M, Mishra V, Saini K, Singh D. Microbes, Their Metabolites, and Effector Molecules: A Pharmacological Perspective for Host-Microbiota Interaction. Environmental Chemistry for a Sustainable World 2019. [DOI: 10.1007/978-3-030-04675-0_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
428 Guandalini S, Sansotta N. Probiotics in the Treatment of Inflammatory Bowel Disease. Adv Exp Med Biol 2019;1125:101-7. [PMID: 30632114 DOI: 10.1007/5584_2018_319] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
429 Zhang L, Wu T. Inflammatory Bowel Disease. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases 2019. [DOI: 10.1007/978-3-030-15573-5_15] [Reference Citation Analysis]
430 Yeoh S, Hua H, Yepes JF, Peterson DE. Oral Manifestations of Systemic Diseases and Their Treatments. Contemporary Oral Medicine 2019. [DOI: 10.1007/978-3-319-72303-7_18] [Reference Citation Analysis]
431 Farhadi E, Mahmoudi M. Epigenetics of autoimmune diseases. Prognostic Epigenetics 2019. [DOI: 10.1016/b978-0-12-814259-2.00009-1] [Reference Citation Analysis]
432 Reveille JD. Spondyloarthritis. Clinical Immunology 2019. [DOI: 10.1016/b978-0-7020-6896-6.00057-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
433 Falloon K, Lazarev M. A Primer on IBD: Phenotypes, Diagnosis, Treatment, and Clinical Challenges. Molecular Genetics of Inflammatory Bowel Disease 2019. [DOI: 10.1007/978-3-030-28703-0_1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
434 Halfvarson J. Genetic Epidemiology of Inflammatory Bowel Disease, Early Twin and Family Studies. Molecular Genetics of Inflammatory Bowel Disease 2019. [DOI: 10.1007/978-3-030-28703-0_2] [Reference Citation Analysis]
435 Segal I. Characteristics of Inflammatory Bowel Disease in Sub-Saharan Africa. Digestive Diseases in Sub-Saharan Africa 2019. [DOI: 10.1016/b978-0-12-815677-3.00012-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
436 Ghattargi VC, Sape K, Kumbhare SV, Shouche YS. Mining Human Microbiome for Therapeutics. Microbial Diversity in Ecosystem Sustainability and Biotechnological Applications 2019. [DOI: 10.1007/978-981-13-8315-1_18] [Reference Citation Analysis]
437 Gibson JA, Odze RD. Tissue Sampling, Specimen Handling, and Laboratory Processing. Clinical Gastrointestinal Endoscopy 2019. [DOI: 10.1016/b978-0-323-41509-5.00005-0] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
438 Dotson JL, Kappelman MD, Bricker J, Andridge R, Chisolm DJ, Crandall WV. Multicenter Evaluation of Emergency Department Treatment for Children and Adolescents With Crohn's Disease According to Race/Ethnicity and Insurance Payor Status. Inflamm Bowel Dis 2019;25:194-203. [PMID: 29850811 DOI: 10.1093/ibd/izy192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
439 Shen B. Women’s Health Issues and Ileal Pouch Surgery. Pouchitis and Ileal Pouch Disorders 2019. [DOI: 10.1016/b978-0-12-809402-0.00042-3] [Reference Citation Analysis]
440 Cheah M, Khanna R. Current Medical Therapies for Ulcerative Colitis. Pouchitis and Ileal Pouch Disorders 2019. [DOI: 10.1016/b978-0-12-809402-0.00001-0] [Reference Citation Analysis]
441 Khorasanizadeh MH, Eskian M, Camargo CA, Rezaei N. Vitamin D and the Immune System. Nutrition and Immunity 2019. [DOI: 10.1007/978-3-030-16073-9_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
442 Cauley C, Hodin R. Crohn Disease and Its Surgical Management. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00075-3] [Reference Citation Analysis]
443 Farkas NG, Welman TJP, Ross T, Brown S, Smith JJ, Pawa N. Unusual causes of large bowel obstruction. Curr Probl Surg 2019;56:49-90. [PMID: 30777150 DOI: 10.1067/j.cpsurg.2018.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
444 Davoren MJ, Liu J, Castellanos J, Rodríguez-Malavé NI, Schiestl RH. A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period. Gut Microbes 2019;10:458-80. [PMID: 30580660 DOI: 10.1080/19490976.2018.1547612] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
445 Mosquera-klinger GA, Ucroz Benavides A. Enfermedad de Crohn vs tuberculosis intestinal: un diagnóstico diferencial desafiante. Revisión de tema. Rev Colomb Gastroenterol 2018;33:423. [DOI: 10.22516/25007440.172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
446 Nigam GB, Limdi JK, Vasant DH. Current perspectives on the diagnosis and management of functional anorectal disorders in patients with inflammatory bowel disease. Therap Adv Gastroenterol 2018;11:1756284818816956. [PMID: 30574193 DOI: 10.1177/1756284818816956] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
447 Purewal S, Chapman S, Czuber-Dochan W, Selinger C, Steed H, Brookes MJ. Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients' reproductive health. Aliment Pharmacol Ther 2018;48:1202-12. [PMID: 30411389 DOI: 10.1111/apt.15019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
448 Calderón M, Minckas N, Nuñez S, Ciapponi A. Inflammatory Bowel Disease in Latin America: A Systematic Review. Value in Health Regional Issues 2018;17:126-34. [DOI: 10.1016/j.vhri.2018.03.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
449 Do J, Woo J. From Gut to Brain: Alteration in Inflammation Markers in the Brain of Dextran Sodium Sulfate-induced Colitis Model Mice. Clin Psychopharmacol Neurosci 2018;16:422-33. [PMID: 30466215 DOI: 10.9758/cpn.2018.16.4.422] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
450 Moon SY, Shin SA, Oh YS, Park HH, Lee CS. Understanding the Role of the BAI Subfamily of Adhesion G Protein-Coupled Receptors (GPCRs) in Pathological and Physiological Conditions. Genes (Basel) 2018;9:E597. [PMID: 30513696 DOI: 10.3390/genes9120597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
451 DeLong CG, Kulaylat AN, Kulaylat AS, Hollenbeak CS, Cilley RE, Rocourt DV. Trends and Attributable Costs of Anorectal Involvement in Pediatric Crohn's Disease. J Surg Res 2018;232:113-20. [PMID: 30463706 DOI: 10.1016/j.jss.2018.06.013] [Reference Citation Analysis]
452 Nevulis MG, Baker C, Lebovics E, Frishman WH. Overview of Link Between Inflammatory Bowel Disease and Cardiovascular Disease. Cardiol Rev 2018;26:287-93. [PMID: 30277903 DOI: 10.1097/CRD.0000000000000214] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
453 Shim JO. Recent advance in very early-onset inflammatory bowel disease. Intest Res 2019;17:9-16. [PMID: 30419637 DOI: 10.5217/ir.2018.00130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
454 Chen D, Ma J, Luo S, Lu L, Wan X, Ben Q. Effects of Appendectomy on the Onset and Course of Ulcerative Colitis in Chinese Patients. Gastroenterol Res Pract 2018;2018:2927891. [PMID: 30524476 DOI: 10.1155/2018/2927891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
455 Sassi F, Tamone C, D'Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients 2018;10:E1656. [PMID: 30400332 DOI: 10.3390/nu10111656] [Cited by in Crossref: 312] [Cited by in F6Publishing: 332] [Article Influence: 62.4] [Reference Citation Analysis]
456 Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology. J Can Assoc Gastroenterol 2019;2:S6-S16. [PMID: 31294381 DOI: 10.1093/jcag/gwy054] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 11.4] [Reference Citation Analysis]
457 Regueiro M, Click B, Anderson A, Shrank W, Kogan J, McAnallen S, Szigethy E. Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home. Clin Gastroenterol Hepatol 2018;16:1777-85. [PMID: 29654918 DOI: 10.1016/j.cgh.2018.04.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 10.0] [Reference Citation Analysis]
458 Baker KT, Salk JJ, Brentnall TA, Risques RA. Precancer in ulcerative colitis: the role of the field effect and its clinical implications. Carcinogenesis 2018;39:11-20. [PMID: 29087436 DOI: 10.1093/carcin/bgx117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
459 Metzger CE, Narayanan SA, Zawieja DC, Bloomfield SA. A moderately elevated soy protein diet mitigates inflammatory changes in gut and in bone turnover during chronic TNBS-induced inflammatory bowel disease. Appl Physiol Nutr Metab 2019;44:595-605. [PMID: 30352170 DOI: 10.1139/apnm-2018-0514] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
460 Kreuter R, Wankell M, Ahlenstiel G, Hebbard L. The role of obesity in inflammatory bowel disease. Biochim Biophys Acta Mol Basis Dis 2019;1865:63-72. [PMID: 30352258 DOI: 10.1016/j.bbadis.2018.10.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
461 Kim YS, Kim SH, Ryu HS, Han JK. Iodine Quantification on Spectral Detector-Based Dual-Energy CT Enterography: Correlation with Crohn's Disease Activity Index and External Validation. Korean J Radiol 2018;19:1077-88. [PMID: 30386139 DOI: 10.3348/kjr.2018.19.6.1077] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
462 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
463 Ouldali N, Hugot JP, Viala J, Damir M, Martinez-Vinson C, Meinzer U. Early Arthritis Is Associated With Failure of Immunosuppressive Drugs and Severe Pediatric Crohn's Disease Evolution. Inflamm Bowel Dis 2018;24:2423-30. [PMID: 29788152 DOI: 10.1093/ibd/izy137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
464 Ko KH, Kim YS, Lee BK, Choi JH, Woo YM, Kim JY, Moon JS. Vitamin D deficiency is associated with disease activity in patients with Crohn's disease. Intest Res 2019;17:70-7. [PMID: 30301338 DOI: 10.5217/ir.2018.00022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
465 Ponce de León-rodríguez MDC, Guyot J, Laurent-babot C. Intestinal in vitro cell culture models and their potential to study the effect of food components on intestinal inflammation. Critical Reviews in Food Science and Nutrition 2019;59:3648-66. [DOI: 10.1080/10408398.2018.1506734] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
466 Kaur M, Singapura P, Kalakota N, Cruz G, Shukla R, Ahsan S, Tansel A, Thrift AP, El-Serag HB. Factors That Contribute to Indeterminate Results From the QuantiFERON-TB Gold In-Tube Test in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2018;16:1616-1621.e1. [PMID: 29175527 DOI: 10.1016/j.cgh.2017.11.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
467 Sham HP, Bazett M, Bosiljcic M, Yang H, Luk B, Law HT, Morampudi V, Yu HB, Pankovich J, Sutcliffe S, Bressler B, Marshall JK, Fedorak RN, Chen J, Jones M, Gunn H, Kalyan S, Vallance BA. Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis. Front Immunol 2018;9:2211. [PMID: 30319652 DOI: 10.3389/fimmu.2018.02211] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
468 McKay R, Ghodasra M, Schardt J, Quan D, Pottash AE, Shang W, Jay SM, Payne GF, Chang MW, March JC, Bentley WE. A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease. Bioeng Transl Med 2018;3:209-21. [PMID: 30377661 DOI: 10.1002/btm2.10113] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
469 Spasic S, Brcic I, Freire R, Garcia-buitrago MT, Rosenberg AE. Epithelioid Hemangioendothelioma of the Bowel in Crohn’s Disease: The First Reported Case. Int J Surg Pathol 2019;27:423-6. [DOI: 10.1177/1066896918801527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
470 Kelly D, Kotliar M, Woo V, Jagannathan S, Whitt J, Moncivaiz J, Aronow BJ, Dubinsky MC, Hyams JS, Markowitz JF, Baldassano RN, Stephens MC, Walters TD, Kugathasan S, Haberman Y, Sundaram N, Rosen MJ, Helmrath M, Karns R, Barski A, Denson LA, Alenghat T. Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's disease. JCI Insight 2018;3:122104. [PMID: 30232290 DOI: 10.1172/jci.insight.122104] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
471 Yu Y, Zhu S, Li P, Min L, Zhang S. Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis 2018;9:961. [PMID: 30237392 DOI: 10.1038/s41419-018-0982-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
472 Coppell KJ, Galts CP, Huizing FY, Norton JK, Gray AR, Schultz K, Hobbs CE, Aluzaite K, Schultz M. Annual Incidence and Phenotypic Presentation of IBD in Southern New Zealand: An 18-Year Epidemiological Analysis. Inflamm Intest Dis 2018;3:32-9. [PMID: 30505840 DOI: 10.1159/000492615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
473 Krela-Kazmierczak I, Szymczak-Tomczak A, Tomczak M, Lykowska-Szuber L, Eder P, Kucharski MA, Stawczyk-Eder K, Waszak K, Karczewski J, Dobrowolska A. Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease? Arch Med Sci 2021;17:662-74. [PMID: 34025836 DOI: 10.5114/aoms.2018.78009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
474 Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut 2018;67:1726-38. [PMID: 29777041 DOI: 10.1136/gutjnl-2017-315866] [Cited by in Crossref: 175] [Cited by in F6Publishing: 150] [Article Influence: 35.0] [Reference Citation Analysis]
475 Zawadka-Kunikowska M, Słomko J, Kłopocka M, Liebert A, Tafil-Klawe M, Klawe JJ, Newton JL, Zalewski P. Cardiac and autonomic function in patients with Crohn's disease during remission. Adv Med Sci 2018;63:334-40. [PMID: 30053718 DOI: 10.1016/j.advms.2018.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
476 Ananthakrishnan AN. Making sense of clinical predictors. J Gastroenterol Hepatol 2018;33 Suppl 3:7-8. [PMID: 30187548 DOI: 10.1111/jgh.14417] [Reference Citation Analysis]
477 Kim H, Krenek KA, Fang C, Minamoto Y, Markel ME, Suchodolski JS, Talcott ST, Mertens-talcott SU. Polyphenolic derivatives from mango (Mangifera Indica L.) modulate fecal microbiome, short-chain fatty acids production and the HDAC1/AMPK/LC3 axis in rats with DSS-induced colitis. Journal of Functional Foods 2018;48:243-51. [DOI: 10.1016/j.jff.2018.07.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
478 Olamilosoye KP, Akomolafe RO, Akinsomisoye OS, Adefisayo MA, Alabi QK. The aqueous extract of Ocimum gratissimum leaves ameliorates acetic acid-induced colitis via improving antioxidant status and hematological parameters in male Wistar rats. Egyptian Journal of Basic and Applied Sciences 2018;5:220-7. [DOI: 10.1016/j.ejbas.2018.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
479 Chakradeo PS, Keshavarzian A, Singh S, Dera AE, Esteban JPG, Lee AA, Burgess HJ, Fogg L, Swanson GR. Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease. Sleep Med 2018;52:188-95. [PMID: 30243610 DOI: 10.1016/j.sleep.2018.08.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
480 Carrott P, Pearlman M, Allen K, Suwanabol P. Disease-Specific Diets in Surgical Diseases. Curr Surg Rep 2018;6. [DOI: 10.1007/s40137-018-0214-9] [Reference Citation Analysis]
481 Kho ZY, Lal SK. The Human Gut Microbiome - A Potential Controller of Wellness and Disease. Front Microbiol 2018;9:1835. [PMID: 30154767 DOI: 10.3389/fmicb.2018.01835] [Cited by in Crossref: 451] [Cited by in F6Publishing: 474] [Article Influence: 90.2] [Reference Citation Analysis]
482 Cozzi D, Moroni C, Addeo G, Danti G, Lanzetta MM, Cavigli E, Falchini M, Marra F, Piccolo CL, Brunese L, Miele V. Radiological Patterns of Lung Involvement in Inflammatory Bowel Disease. Gastroenterol Res Pract 2018;2018:5697846. [PMID: 30158965 DOI: 10.1155/2018/5697846] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
483 Shajib MS, Chauhan U, Adeeb S, Chetty Y, Armstrong D, Halder SLS, Marshall JK, Khan WI. Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease. J Can Assoc Gastroenterol. 2019;2:132-140. [PMID: 31294376 DOI: 10.1093/jcag/gwy039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
484 Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP, Huppertz-Hauss G, Hovde Ø, Bernklev T, Moum B, Jelsness-Jørgensen LP. Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients. World J Gastroenterol 2018; 24(29): 3293-3301 [PMID: 30090009 DOI: 10.3748/wjg.v24.i29.3293] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
485 Nelson SM, Nguyen TM, McDonald JW, MacDonald JK. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2018;8:CD006097. [PMID: 30068022 DOI: 10.1002/14651858.CD006097.pub3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
486 Franklin J. Crohn’s disease. InnovAiT 2018;11:435-442. [DOI: 10.1177/1755738018772321] [Reference Citation Analysis]
487 Akhuemonkhan E, Parian A, Carson KA, Hutfless S. Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014. Inflamm Bowel Dis 2018;24:1801-7. [PMID: 29669068 DOI: 10.1093/ibd/izy063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
488 Wang H, Hyvelin JM, Felt SA, Guracar I, Vilches-Moure JG, Cherkaoui S, Bettinger T, Tian L, Lutz AM, Willmann JK. US Molecular Imaging of Acute Ileitis: Anti-Inflammatory Treatment Response Monitored with Targeted Microbubbles in a Preclinical Model. Radiology 2018;289:90-100. [PMID: 30040040 DOI: 10.1148/radiol.2018172600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
489 Giacalone M, Agata Z, Cozzucoli PC, Alibrandi A. Bonferroni-Holm and permutation tests to compare health data: methodological and applicative issues. BMC Med Res Methodol 2018;18:81. [PMID: 30029629 DOI: 10.1186/s12874-018-0540-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
490 Abron JD, Singh NP, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP. Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis. PLoS One. 2018;13:e0199631. [PMID: 30024891 DOI: 10.1371/journal.pone.0199631] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
491 Azer SA, Azer S. What can we learn from top-cited articles in inflammatory bowel disease? A bibliometric analysis and assessment of the level of evidence. BMJ Open. 2018;8:e021233. [PMID: 30002009 DOI: 10.1136/bmjopen-2017-021233] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
492 Lightner AL. A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease-Entering an Era of Regenerative Medicine. Inflamm Bowel Dis 2018;24:1689-94. [PMID: 29788100 DOI: 10.1093/ibd/izy084] [Reference Citation Analysis]
493 Diederen K, Krom H, Koole JCD, Benninga MA, Kindermann A. Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population. Inflamm Bowel Dis 2018;24:1632-40. [PMID: 29697827 DOI: 10.1093/ibd/izy027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
494 Samaan MA, Pavlidis P, Digby-Bell J, Johnston EL, Dhillon A, Paramsothy R, Akintimehin AO, Medcalf L, Chung-Faye G, DuBois P, Koumoutsos I, Powell N, Anderson SHC, Sanderson J, Hayee BH, Irving PM. Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Frontline Gastroenterol 2018;9:221-31. [PMID: 30047549 DOI: 10.1136/flgastro-2017-100895] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
495 Skowron KB, Shogan BD, Rubin DT, Hyman NH. The New Frontier: the Intestinal Microbiome and Surgery. J Gastrointest Surg 2018;22:1277-85. [PMID: 29633119 DOI: 10.1007/s11605-018-3744-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
496 Son JH, Kim SH, Cho EY, Ryu KH. Comparison of diagnostic performance between 1 millisievert CT enterography and half-standard dose CT enterography for evaluating active inflammation in patients with Crohn's disease. Abdom Radiol (NY) 2018;43:1558-66. [PMID: 29038856 DOI: 10.1007/s00261-017-1359-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
497 Valluru N, Kang L, Gaidos JKJ. Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System. Dig Dis Sci 2018;63:1782-6. [PMID: 29736836 DOI: 10.1007/s10620-018-5093-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
498 Goshayeshi L, Bahari A, Torabian F, Molooghi K, Mohammadi EM, Sahranavard M, Maleki HH, Noughabi ZS, Hoseini B. Association between carotid intima-media thickness and ulcerative colitis: a systematic review and meta-analysis. Electron Physician 2018;10:6956-64. [PMID: 30034664 DOI: 10.19082/6956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
499 Friesen P, Blease C. Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection. J Med Ethics 2018;44:774-81. [PMID: 29936435 DOI: 10.1136/medethics-2018-104811] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
500 Long Y, Li S, Qin J, Xie L, Gan L, Jie F, Wu Y, Li Y, Du Q. Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats. Biomed Pharmacother. 2018;105:781-788. [PMID: 29909346 DOI: 10.1016/j.biopha.2018.06.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
501 Dubé PE, Liu CY, Girish N, Washington MK, Polk DB. Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice. Sci Rep 2018;8:9119. [PMID: 29904166 DOI: 10.1038/s41598-018-27353-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
502 Jean L, Audrey M, Beauchemin C, Consortium OBOTI. Economic Evaluations of Treatments for Inflammatory Bowel Diseases: A Literature Review. Can J Gastroenterol Hepatol 2018;2018:7439730. [PMID: 30009158 DOI: 10.1155/2018/7439730] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
503 Olayanju A, Jones L, Greco K, Goldring CE, Ansari T. Application of porcine gastrointestinal organoid units as a potential in vitro tool for drug discovery and development: Porcine GI organoids as a potential in vitro tool for drug development. J Appl Toxicol 2019;39:4-15. [DOI: 10.1002/jat.3641] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
504 Veerisetty SS, Eschete SO, Uhlhorn AP, De Felice KM. Women's Health in Inflammatory Bowel Disease. Am J Med Sci 2018;356:227-33. [PMID: 30286817 DOI: 10.1016/j.amjms.2018.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
505 Hanaei S, Sadr M, Rezaei A, Shahkarami S, Ebrahimi Daryani N, Bidoki AZ, Rezaei N. Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study. Clin Res Hepatol Gastroenterol 2018;42:269-75. [PMID: 29102545 DOI: 10.1016/j.clinre.2017.09.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
506 Waljee AK, Liu B, Sauder K, Zhu J, Govani SM, Stidham RW, Higgins PDR. Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn's Disease. Inflamm Bowel Dis 2018;24:1185-92. [PMID: 29668915 DOI: 10.1093/ibd/izy031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
507 Schultz BM, Salazar GA, Paduro CA, Pardo-Roa C, Pizarro DP, Salazar-Echegarai FJ, Torres J, Riedel CA, Kalergis AM, Álvarez-Lobos MM, Bueno SM. Persistent Salmonella enterica serovar Typhimurium Infection Increases the Susceptibility of Mice to Develop Intestinal Inflammation. Front Immunol 2018;9:1166. [PMID: 29896196 DOI: 10.3389/fimmu.2018.01166] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
508 Mendis M, Leclerc E, Simsek S. Arabinoxylan hydrolyzates as immunomodulators in Caco-2 and HT-29 colon cancer cell lines. Food Funct 2017;8:220-31. [PMID: 27966731 DOI: 10.1039/c6fo00866f] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
509 Leiman DA, Kochar B, Posner S, Fan C, Patel A, Shaheen O, Keller CY, Koutlas NT, Eluri S, Dellon ES. A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums. Dis Esophagus 2018;31. [PMID: 29800243 DOI: 10.1093/dote/doy008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
510 Fiorino G, D'Amico F, Italia A, Gilardi D, Furfaro F, Danese S. JAK inhibitors: Novel developments in management of ulcerative colitis. Best Pract Res Clin Gastroenterol 2018;32-33:89-93. [PMID: 30060943 DOI: 10.1016/j.bpg.2018.05.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
511 Gao Y, Huang Y, Zhao Y, Hu Y, Li Z, Guo Q, Zhao K, Lu N. LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling. Oncotarget 2016;7:63981-94. [PMID: 27590510 DOI: 10.18632/oncotarget.11742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
512 Schneider A, Hirth M, Weiss C, Weidner P, Antoni C, Thomann A, Reindl W, Ebert MP, Pfützer RH. Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis. Z Gastroenterol 2018;56:469-78. [PMID: 29734447 DOI: 10.1055/s-0043-123881] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
513 Dash AP, Kar SS. VITAMIN D AND PAIN: THE LINK- A STUDY IN ODISHA AMONGST URBAN POPULATION. jebmh 2018;5:1533-1536. [DOI: 10.18410/jebmh/2018/322] [Reference Citation Analysis]
514 Mahadevan U, Silverberg MS. Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review. Gastroenterology 2018;154:1555-8. [PMID: 29550591 DOI: 10.1053/j.gastro.2017.12.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
515 Can G, Poşul E, Yılmaz B, Can H, Korkmaz U, Ermiş F, Kurt M, Dağlı Ü. Epidemiologic features of ınflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study. Korean J Intern Med 2019;34:519-29. [PMID: 29695147 DOI: 10.3904/kjim.2015.310] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
516 Alabi QK, Akomolafe RO, Omole JG, Adefisayo MA, Ogundipe OL, Aturamu A, Sanya JO. Polyphenol-rich extract of Ocimum gratissimum leaves ameliorates colitis via attenuating colonic mucosa injury and regulating pro-inflammatory cytokines production and oxidative stress. Biomed Pharmacother 2018;103:812-22. [PMID: 29684860 DOI: 10.1016/j.biopha.2018.04.071] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
517 Ghattamaneni NKR, Panchal SK, Brown L. Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease. Pharmacol Res 2018;132:99-107. [PMID: 29680446 DOI: 10.1016/j.phrs.2018.04.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
518 Bhandari S, Larson ME, Kumar N, Stein D. Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study. Gut Liver. 2017;11:512-519. [PMID: 28395506 DOI: 10.5009/gnl16347] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
519 Yu HC, Chen TP, Chang YC. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database. J Dent Sci 2018;13:242-7. [PMID: 30895127 DOI: 10.1016/j.jds.2018.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
520 Naser A, Qasem A, Naser SA. Mycobacterial infection influences bone biomarker levels in patients with Crohn's disease. Can J Physiol Pharmacol. 2018;96:662-667. [PMID: 29638140 DOI: 10.1139/cjpp-2017-0700] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
521 Chandan JS, Thomas T. The impact of inflammatory bowel disease on oral health. Br Dent J 2017;222:549-53. [PMID: 28387295 DOI: 10.1038/sj.bdj.2017.318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
522 Yamamoto-furusho J, Gutiérrez-grobe Y, López-gómez J, Bosques-padilla F, Rocha-ramírez J. The Mexican consensus on the diagnosis and treatment of ulcerative colitis. Revista de Gastroenterología de México (English Edition) 2018;83:144-67. [DOI: 10.1016/j.rgmxen.2018.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
523 Kim JW, Lee CK, Rhee SY, Oh CH, Shim JJ, Kim HJ. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study. J Gastroenterol Hepatol 2018;33:847-54. [PMID: 29055148 DOI: 10.1111/jgh.14027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
524 Borren NZ, Conway G, Garber JJ, Khalili H, Budree S, Mallick H, Yajnik V, Xavier RJ, Ananthakrishnan AN. Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases. J Crohns Colitis 2018;12:525-31. [PMID: 29145572 DOI: 10.1093/ecco-jcc/jjx154] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
525 Burke KE, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H. Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women. J Crohns Colitis 2018;12:559-67. [PMID: 29370359 DOI: 10.1093/ecco-jcc/jjy005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
526 Yamamoto-furusho J, Gutiérrez-grobe Y, López-gómez J, Bosques-padilla F, Rocha-ramírez J. Consenso mexicano para el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Revista de Gastroenterología de México 2018;83:144-67. [DOI: 10.1016/j.rgmx.2017.08.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
527 Govani SM, Higgins PDR, Rubenstein JH, Stidham RW, Waljee AK. CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital. PLoS One 2018;13:e0195022. [PMID: 29596461 DOI: 10.1371/journal.pone.0195022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
528 Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J, Higgins PD, Kotze PG, Meissner J, O'Connor M, Ran ZH, Siegel CA, Terry H, van Deen WK, van der Woude CJ, Weaver A, Yang SK, Sands BE, Vermeire S, Travis SP. Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus. J Crohns Colitis 2018;12:408-18. [PMID: 29216349 DOI: 10.1093/ecco-jcc/jjx161] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 16.8] [Reference Citation Analysis]
529 Viennois E, Pujada A, Zen J, Merlin D. Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease. Compr Physiol 2018;8:731-60. [PMID: 29687900 DOI: 10.1002/cphy.c170032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
530 Payne SC, Shepherd RK, Sedo A, Fallon JB, Furness JB. An objective in vivo diagnostic method for inflammatory bowel disease. R Soc Open Sci 2018;5:180107. [PMID: 29657828 DOI: 10.1098/rsos.180107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
531 Rondags A, Arends S, Wink FR, Horváth B, Spoorenberg A. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation. Semin Arthritis Rheum 2019;48:611-7. [PMID: 29751976 DOI: 10.1016/j.semarthrit.2018.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
532 Park HJ, Kim J, Saima FT, Rhee KJ, Hwang S, Kim MY, Baik SK, Eom YW, Kim HS. Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2. Biochem Biophys Res Commun 2018;498:988-95. [PMID: 29550474 DOI: 10.1016/j.bbrc.2018.03.096] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
533 Kappelman MD, Lange A, Randell RL, Basta PV, Sandler RS, Laugesen K, Byrjalsen A, Christensen T, Frøslev T, Erichsen R. Feasibility of salivary DNA collection in a population-based case-control study: a pilot study of pediatric Crohn's disease. Clin Epidemiol 2018;10:215-22. [PMID: 29535554 DOI: 10.2147/CLEP.S143322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
534 Peng YJ, Shen TL, Chen YS, Mersmann HJ, Liu BH, Ding ST. Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease. J Biomed Sci 2018;25:24. [PMID: 29540173 DOI: 10.1186/s12929-018-0419-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
535 Radavelli BL, Zanella PB, Silva AS, Dall’alba V. Diet, microbiota and inflammatory bowel disease: review. NFS 2018;48:259-271. [DOI: 10.1108/nfs-07-2017-0156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
536 Tan CX, Brand HS, de Boer NK, Forouzanfar T. Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis. Br Dent J. 2017;222:53-57. [PMID: 28084352 DOI: 10.1038/sj.bdj.2017.37] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
537 Zhong XS, Winston JH, Luo X, Kline KT, Nayeem SZ, Cong Y, Savidge TC, Dashwood RH, Powell DW, Li Q. Neonatal Colonic Inflammation Epigenetically Aggravates Epithelial Inflammatory Responses to Injury in Adult Life. Cell Mol Gastroenterol Hepatol 2018;6:65-78. [PMID: 29928672 DOI: 10.1016/j.jcmgh.2018.02.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
538 Atreja A, Otobo E, Ramireddy K, Deorocki A. Remote Patient Monitoring in IBD: Current State and Future Directions. Curr Gastroenterol Rep. 2018;20:6. [PMID: 29516186 DOI: 10.1007/s11894-018-0611-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
539 Cardoso A, Gil Castro A, Martins AC, Carriche GM, Murigneux V, Castro I, Cumano A, Vieira P, Saraiva M. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:400. [PMID: 29545807 DOI: 10.3389/fimmu.2018.00400] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
540 Waljee AK, Liu B, Sauder K, Zhu J, Govani SM, Stidham RW, Higgins PDR. Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis. Aliment Pharmacol Ther 2018;47:763-72. [PMID: 29359519 DOI: 10.1111/apt.14510] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
541 He L, Liu T, Shi Y, Tian F, Hu H, Deb DK, Chen Y, Bissonnette M, Li YC. Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis. Endocrinology 2018;159:967-79. [PMID: 29228157 DOI: 10.1210/en.2017-00748] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 11.4] [Reference Citation Analysis]
542 Ramos-rodriguez AJ, Timerman D, Khan A, Bonomo L, Hunjan MK, Lemor A. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014. Int J Dermatol 2018;57:547-52. [DOI: 10.1111/ijd.13932] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
543 Neumann U, Louis S, Gille A, Derwenskus F, Schmid-staiger U, Briviba K, Bischoff SC. Anti-inflammatory effects of Phaeodactylum tricornutum extracts on human blood mononuclear cells and murine macrophages. J Appl Phycol 2018;30:2837-46. [DOI: 10.1007/s10811-017-1352-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 4.2] [Reference Citation Analysis]
544 Taylor K, Scruggs PW, Balemba OB, Wiest MM, Vella CA. Associations between physical activity, resilience, and quality of life in people with inflammatory bowel disease. Eur J Appl Physiol. 2018;118:829-836. [PMID: 29411129 DOI: 10.1007/s00421-018-3817-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
545 Hamabata T, Nakamura T, Masuko S, Maeda S, Murata T. Production of lipid mediators across different disease stages of dextran sodium sulfate-induced colitis in mice. J Lipid Res 2018;59:586-95. [PMID: 29414763 DOI: 10.1194/jlr.M079095] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
546 Govani SM, Noureldin M, Higgins PDR, Heisler M, Saini SD, Stidham RW, Waljee JF, Waljee AK. Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases. Am J Gastroenterol 2018;113:276-82. [PMID: 29231192 DOI: 10.1038/ajg.2017.438] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
547 Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clin Gastroenterol Hepatol 2018;16:190-197.e11. [PMID: 28603049 DOI: 10.1016/j.cgh.2017.05.047] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 12.6] [Reference Citation Analysis]
548 Cirillo F, Lazzeroni P, Catellani C, Sartori C, Amarri S, Street ME. MicroRNAs link chronic inflammation in childhood to growth impairment and insulin-resistance. Cytokine & Growth Factor Reviews 2018;39:1-18. [DOI: 10.1016/j.cytogfr.2017.12.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
549 Rohr M, Narasimhulu CA, Sharma D, Doomra M, Riad A, Naser S, Parthasarathy S. Inflammatory Diseases of the Gut. J Med Food 2018;21:113-26. [PMID: 29389238 DOI: 10.1089/jmf.2017.0138] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
550 Verstockt B, Smith KG, Lee JC. Genome-wide association studies in Crohn's disease: Past, present and future. Clin Transl Immunology. 2018;7:e1001. [PMID: 29484179 DOI: 10.1002/cti2.1001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 10.8] [Reference Citation Analysis]
551 Burton-Freeman BM, Sandhu AK, Edirisinghe I. Mangos and their bioactive components: adding variety to the fruit plate for health. Food Funct 2017;8:3010-32. [PMID: 28612853 DOI: 10.1039/c7fo00190h] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]
552 Davis SC, Robinson BL, Vess J, Lebel JS. Primary care management of ulcerative colitis. The Nurse Practitioner 2018;43:11-9. [DOI: 10.1097/01.npr.0000527565.05934.14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
553 Rodríguez FJ, Becerra C, Gabela MC. Imaging of Retinal and Choroidal Manifestations of Gastrointestinal Disease. Retinal and Choroidal Imaging in Systemic Diseases 2018. [DOI: 10.1007/978-981-10-5461-7_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
554 Skrastins O, Fletcher PC. “It Just Is What It Is”: The Positive and Negative Effects of Living With Inflammatory Bowel Disease and Irritable Bowel Syndrome. Clin Nurse Spec 2018;32:43-51. [DOI: 10.1097/nur.0000000000000345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
555 Valpiani D, Manzi I, Mercuriali M, Giuliani O, Ravaioli A, Colamartini A, Bucchi L, Falcini F, Ricci E. A model of an inflammatory bowel disease population-based registry: The Forlì experience (1993-2013). Dig Liver Dis 2018;50:32-6. [PMID: 28988755 DOI: 10.1016/j.dld.2017.09.120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
556 Levine YA, Simon J, Faltys M, Zitnik R. Bioelectronic Therapy for the Treatment of Rheumatoid Arthritis and Inflammatory Bowel Disease. Neuromodulation 2018. [DOI: 10.1016/b978-0-12-805353-9.00127-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
557 Chen JD, Jin H, Yin J. Vagal Nerve Stimulation Versus Sacral Nerve Stimulation for Control of Inflammation. Neuromodulation 2018. [DOI: 10.1016/b978-0-12-805353-9.00128-5] [Reference Citation Analysis]
558 Gu P, Kapur A, Li D, Haritunians T, Vasiliauskas E, Shih DQ, Targan SR, Spiegel BM, Mcgovern DP, Black JT, Melmed GY. Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease. J Dig Dis 2018;19:15-23. [PMID: 29251413 DOI: 10.1111/1751-2980.12566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
559 Myklebust-Hansen T, Aamodt G, Haugen M, Brantsæter AL, Vatn MH, Bengtson MB. Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa). Inflamm Bowel Dis 2017;24:12-24. [PMID: 29272477 DOI: 10.1093/ibd/izx006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
560 Yeoh S, Hua H, Yepes JF, Peterson DE. Oral Manifestations of Systemic Diseases and their Treatments. Contemporary Oral Medicine 2018. [DOI: 10.1007/978-3-319-28100-1_18-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
561 Waljee AK, Lipson R, Wiitala WL, Zhang Y, Liu B, Zhu J, Wallace B, Govani SM, Stidham RW, Hayward R, Higgins PDR. Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning. Inflamm Bowel Dis 2017;24:45-53. [PMID: 29272474 DOI: 10.1093/ibd/izx007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 13.0] [Reference Citation Analysis]
562 Capri S, Russo A. I costi dei pazienti con patologie infiammatorie dell’intestino (Malattia di Crohn e colite ulcerosa). Studio real world in Italia. Global & Regional Health Technology Assessment 2018;2018:228424031879328. [DOI: 10.1177/2284240318793281] [Reference Citation Analysis]
563 Cvejić S, Filipović S, Pavićević P, Vukadinović V. Ultrasound and magnetic resonance enterography in diagnosis of Crohn's disease in children. Medicinski podmladak 2018;69:12-9. [DOI: 10.5937/mp69-15443] [Reference Citation Analysis]
564 Laroia ST. Advances in Imaging of Inflammatory Bowel Disease. GI Surgery Annual 2018. [DOI: 10.1007/978-981-13-0161-2_3] [Reference Citation Analysis]
565 Kelsen JR, Sullivan KE. Inflammatory Bowel Disease in Primary Immunodeficiencies. Curr Allergy Asthma Rep 2017;17:57. [PMID: 28755025 DOI: 10.1007/s11882-017-0724-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
566 Bähler C, Vavricka SR, Schoepfer AM, Brüngger B, Reich O. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014. BMC Gastroenterol 2017;17:138. [PMID: 29197335 DOI: 10.1186/s12876-017-0681-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
567 Trigo-Vicente C, Gimeno-Ballester V, Montoiro-Allué R, López-Del Val A. Cost-effectiveness analysis of infliximab, adalimumab, golimumab and vedolizumab for moderate to severe ulcerative colitis in Spain. Expert Rev Pharmacoecon Outcomes Res 2018;18:321-9. [PMID: 29192530 DOI: 10.1080/14737167.2018.1411193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
568 Koplay M, Guneyli S, Cebeci H, Korkmaz H, Emiroglu H, Sekmenli T, Paksoy Y. Magnetic resonance enterography with oral mannitol solution: Diagnostic efficacy and image quality in Crohn disease. Diagnostic and Interventional Imaging 2017;98:893-9. [DOI: 10.1016/j.diii.2017.06.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
569 Argollo M, Fiorino G, Hindryckx P, Peyrin-biroulet L, Danese S. Novel therapeutic targets for inflammatory bowel disease. Journal of Autoimmunity 2017;85:103-16. [DOI: 10.1016/j.jaut.2017.07.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 11.3] [Reference Citation Analysis]
570 Rasmussen HE, Hamaker BR. Prebiotics and Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:783-95. [PMID: 29173521 DOI: 10.1016/j.gtc.2017.08.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
571 Lane ER, Lee D, Suskind DL. Dietary Therapies in Pediatric Inflammatory Bowel Disease: An Evolving Inflammatory Bowel Disease Paradigm. Gastroenterol Clin North Am 2017;46:731-44. [PMID: 29173518 DOI: 10.1016/j.gtc.2017.08.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
572 Tocia C, Achim AC, Alexandrescu L, Dumitru E. Inflammatory Bowel Diseases: focus on epidemiology. ARS Medica Tomitana 2017;23:204-211. [DOI: 10.1515/arsm-2017-0038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
573 Wang H, Felt SA, Guracar I, Taviani V, Zhou J, Sigrist RMS, Zhang H, Liau J, Vilches-Moure JG, Tian L, Saenz Y, Bettinger T, Hargreaves BA, Lutz AM, Willmann JK. Anatomical Road Mapping Using CT and MR Enterography for Ultrasound Molecular Imaging of Small Bowel Inflammation in Swine. Eur Radiol 2018;28:2068-76. [PMID: 29170798 DOI: 10.1007/s00330-017-5148-6] [Reference Citation Analysis]
574 Pittman ME, Jessurun J, Yantiss RK. Differentiating Posttransplant Inflammatory Bowel Disease and Other Colitides in Renal Transplant Patients. Am J Surg Pathol. 2017;41:1666-1674. [PMID: 28786879 DOI: 10.1097/pas.0000000000000921] [Cited by in Crossref: 13] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
575 Mikocka-Walus A, Bampton P, Hetzel D, Hughes P, Esterman A, Andrews JM. Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial. Int J Behav Med. 2017;24:127-135. [PMID: 27432441 DOI: 10.1007/s12529-016-9580-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
576 Zhang Z, Yang L, Wang B, Zhang L, Zhang Q, Li D, Zhang S, Gao H, Wang X. Protective role of liriodendrin in mice with dextran sulphate sodium-induced ulcerative colitis. International Immunopharmacology 2017;52:203-10. [DOI: 10.1016/j.intimp.2017.09.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
577 Besson JCF, de Carvalho Picoli C, Matioli G, Natali MRM. Methyl jasmonate: a phytohormone with potential for the treatment of inflammatory bowel diseases. J Pharm Pharmacol 2018;70:178-90. [PMID: 29072315 DOI: 10.1111/jphp.12839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
578 Hibi T, Imai Y, Murata Y, Matsushima N, Zheng R, Gasink C. Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies. Intest Res 2017;15:475-86. [PMID: 29142515 DOI: 10.5217/ir.2017.15.4.475] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
579 Gomes JP, Watad A, Shoenfeld Y. Nicotine and autoimmunity: The lotus' flower in tobacco. Pharmacol Res 2018;128:101-9. [PMID: 29051105 DOI: 10.1016/j.phrs.2017.10.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
580 Nelson EL, Yadrich DM, Thompson N, Wright S, Stone K, Adams N, Werkowitch M, Smith CE. Telemedicine Support Groups for Home Parenteral Nutrition Users. Nutr Clin Pract 2017;32:789-98. [PMID: 29016235 DOI: 10.1177/0884533617735527] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
581 Ruiz MA, Kaiser RL Jr, de Quadros LG, Piron-Ruiz L, Peña-Arciniegas T, Faria MAG, Siqueira RC, Pirozzi FF, Kaiser FSL, Burt RK. Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn's disease. BMC Res Notes 2017;10:495. [PMID: 28985769 DOI: 10.1186/s13104-017-2824-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
582 Nakamura H, Lim T, Puri P. Inflammatory bowel disease in patients with Hirschsprung's disease: a systematic review and meta-analysis. Pediatr Surg Int 2018;34:149-54. [PMID: 28983688 DOI: 10.1007/s00383-017-4182-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
583 Zhang C, Zhang S, He W, Lu J, Xu Y, Yang J, Liu D. Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression. Life Sciences 2017;186:125-32. [DOI: 10.1016/j.lfs.2017.08.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
584 Mudireddy P, Scott F, Feathers A, Lichtenstein GR. Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions. Inflamm Bowel Dis 2017;23:1832-9. [PMID: 28858068 DOI: 10.1097/MIB.0000000000001242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
585 Eriksson C, Cao Y, Rundquist S, Zhulina Y, Henriksson I, Montgomery S, Halfvarson J. Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010. Aliment Pharmacol Ther 2017;46:748-57. [PMID: 28833287 DOI: 10.1111/apt.14268] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
586 Ishige T, Tomomasa T, Hatori R, Tatsuki M, Igarashi Y, Sekine K, Arakawa H. Temporal Trend of Pediatric Inflammatory Bowel Disease: Analysis of National Registry Data 2004 to 2013 in Japan. J Pediatr Gastroenterol Nutr 2017;65:e80-2. [PMID: 28207475 DOI: 10.1097/MPG.0000000000001547] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
587 Dubois-Camacho K, Ottum PA, Franco-Muñoz D, De la Fuente M, Torres-Riquelme A, Díaz-Jiménez D, Olivares-Morales M, Astudillo G, Quera R, Hermoso MA. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. World J Gastroenterol 2017; 23(36): 6628-6638 [PMID: 29085208 DOI: 10.3748/wjg.v23.i36.6628] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 75] [Article Influence: 12.5] [Reference Citation Analysis]
588 Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev. 2017;30:191-231. [PMID: 27856521 DOI: 10.1128/cmr.00049-16] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
589 Burke KE, Boumitri C, Ananthakrishnan AN. Modifiable Environmental Factors in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2017;19:21. [PMID: 28397132 DOI: 10.1007/s11894-017-0562-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
590 Kosinski LR, Brill J, Regueiro M. Making a Medical Home for IBD Patients. Curr Gastroenterol Rep 2017;19:20. [PMID: 28397131 DOI: 10.1007/s11894-017-0561-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
591 Shivashankar R, Lewis JD. The Role of Diet in Inflammatory Bowel Disease. Curr Gastroenterol Rep 2017;19:22. [PMID: 28397133 DOI: 10.1007/s11894-017-0563-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
592 Bibi S, Kang Y, Du M, Zhu MJ. Dietary red raspberries attenuate dextran sulfate sodium-induced acute colitis. J Nutr Biochem. 2018;51:40-46. [PMID: 29091813 DOI: 10.1016/j.jnutbio.2017.08.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
593 Seo H, Lee S, So H, Kim D, Kim SO, Soh JS, Bae JH, Lee SH, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD. Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis. World J Gastroenterol 2017; 23(34): 6306-6314 [PMID: 28974897 DOI: 10.3748/wjg.v23.i34.6306] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
594 Böttcher B, Wildt L. Autoimmunerkrankungen und orale Kontrazeption. Gynäkologische Endokrinologie 2017;15:225-234. [DOI: 10.1007/s10304-017-0148-9] [Reference Citation Analysis]
595 Hubbard TD, Murray IA, Nichols RG, Cassel K, Podolsky M, Kuzu G, Tian Y, Smith P, Kennett MJ, Patterson AD, Perdew GH. Dietary Broccoli Impacts Microbial Community Structure and Attenuates Chemically Induced Colitis in Mice in an Ah receptor dependent manner. J Funct Foods 2017;37:685-98. [PMID: 29242716 DOI: 10.1016/j.jff.2017.08.038] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
596 Garg SK, Velayos FS, Kisiel JB. Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease. Gastroenterol Clin North Am 2017;46:515-29. [PMID: 28838412 DOI: 10.1016/j.gtc.2017.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
597 MacManus CF, Collins CB, Nguyen TT, Alfano RW, Jedlicka P, de Zoeten EF. VEN-120, a Recombinant Human Lactoferrin, Promotes a Regulatory T Cell [Treg] Phenotype and Drives Resolution of Inflammation in Distinct Murine Models of Inflammatory Bowel Disease. J Crohns Colitis 2017;11:1101-12. [PMID: 28472424 DOI: 10.1093/ecco-jcc/jjx056] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
598 Taher M, Ebrahimi Daryani N, Hedayat M, Eslamian M, Farhadi E, Mahmoudi M, Shirzad S, Nouri Taromlou MK, Chaharmahali M, Nicknam MH, Bashashati M, Rezaei N. Association analysis of RAC1 single nucleotide polymorphisms with ulcerative colitis. Clin Res Hepatol Gastroenterol 2017;41:487-9. [PMID: 28412192 DOI: 10.1016/j.clinre.2017.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
599 Cirillo F, Lazzeroni P, Sartori C, Street ME. Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate. Int J Mol Sci 2017;18:E1878. [PMID: 28858208 DOI: 10.3390/ijms18091878] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
600 Niewiadomski O, Studd C, Wilson J, Williams J, Hair C, Knight R, Prewett E, Dabkowski P, Alexander S, Allen B, Dowling D, Connell W, Desmond P, Bell S. Influence of food and lifestyle on the risk of developing inflammatory bowel disease. Intern Med J 2016;46:669-76. [PMID: 27059169 DOI: 10.1111/imj.13094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 8.2] [Reference Citation Analysis]
601 Al-Bawardy B. Inflammatory bowel disease: Clinical screening and transition of care. Saudi J Gastroenterol 2017;23:213-5. [PMID: 28721973 DOI: 10.4103/sjg.SJG_294_17] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
602 Tamzaourte M, Errabih I, Krami H, Maha F, Maria L, Benzzoubeir N, Ouazzani L, Sefiani A, Ouazzani H. [NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease]. Pan Afr Med J 2017;27:116. [PMID: 28819537 DOI: 10.11604/pamj.2017.27.116.9187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
603 Williams WV. Hormonal contraception and the development of autoimmunity: A review of the literature. Linacre Q 2017;84:275-95. [PMID: 28912620 DOI: 10.1080/00243639.2017.1360065] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
604 Conley S, Proctor DD, Jeon S, Sandler RS, Redeker NS. Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health 2017;40:424-34. [PMID: 28833284 DOI: 10.1002/nur.21813] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
605 Bahreyni A, Samani SS, Khazaei M, Ryzhikov M, Avan A, Hassanian SM. Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives. J Cell Physiol 2018;233:2733-40. [DOI: 10.1002/jcp.26073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
606 Greish K, Taha S, Jasim A, Elghany SA, Sultan A, AlKhateeb A, Othman M, Jun F, Taurin S, Bakhiet M. Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease. Clin Transl Med 2017;6:28. [PMID: 28770521 DOI: 10.1186/s40169-017-0157-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
607 Knoepp US, Mazza MB, Chong ST, Wasnik AP. MR Imaging of Pelvic Emergencies in Women. Magnetic Resonance Imaging Clinics of North America 2017;25:503-19. [DOI: 10.1016/j.mric.2017.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
608 Parian A, Limketkai B, Koh J, Brant SR, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro MD, Rioux JD, Schumm P, Taylor KD, Silverberg MS, Steinhart AH, Hernaez R, Lazarev M. Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis. Gut 2017;66:1390-7. [PMID: 27196594 DOI: 10.1136/gutjnl-2016-311550] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
609 Cohn HM, Dave M, Loftus EV Jr. Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:1301-15. [PMID: 28708806 DOI: 10.1097/MIB.0000000000001199] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
610 Takeyama H, Mizushima T, Uemura M, Haraguchi N, Nishimura J, Hata T, Matsuda C, Takemasa I, Ikenaga M, Murata K, Yamamoto H, Doki Y, Mori M. Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β. Dig Dis Sci 2017;62:1963-74. [PMID: 28434074 DOI: 10.1007/s10620-017-4578-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
611 Wu J, Cheng Y, Zhang R, Shen H, Ma L, Yang J, Zhang Y, Zhang J. Evaluating the Association of Common Variants of the SLC44A4 Gene with Ulcerative Colitis Susceptibility in the Han Chinese Population. Genet Test Mol Biomarkers 2017;21:555-9. [PMID: 28753073 DOI: 10.1089/gtmb.2017.0010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
612 El-Salhy M, Solomon T, Hausken T, Gilja OH, Hatlebakk JG. Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World J Gastroenterol 2017; 23(28): 5068-5085 [PMID: 28811704 DOI: 10.3748/wjg.v23.i28.5068] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
613 Raffals LE, Chang EB. Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel. Gut Liver 2016;10:502-8. [PMID: 27377740 DOI: 10.5009/gnl15491] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
614 Taylor J, Neff C. Social considerations of inflammatory bowel disease in Southern Israel. BMJ Case Rep 2017;2017:bcr-2017-219941. [PMID: 28716774 DOI: 10.1136/bcr-2017-219941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
615 Abdulla M, Al Saeed M, Fardan RH, Alalwan HF, Ali Almosawi ZS, Almahroos AF, Al Qamish J. Inflammatory bowel disease in Bahrain: single-center experience. Clin Exp Gastroenterol 2017;10:133-45. [PMID: 28765713 DOI: 10.2147/CEG.S127909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
616 Dart RJ, Irving PM. Optimising use of thiopurines in inflammatory bowel disease. Expert Review of Clinical Immunology 2017;13:877-88. [DOI: 10.1080/1744666x.2017.1351298] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
617 Li M, Wang B, Sun X, Tang Y, Wei X, Ge B, Tang Y, Deng Y, He C, Yuan J, Li X. Upregulation of Intestinal Barrier Function in Mice with DSS-Induced Colitis by a Defined Bacterial Consortium Is Associated with Expansion of IL-17A Producing Gamma Delta T Cells. Front Immunol. 2017;8:824. [PMID: 28747917 DOI: 10.3389/fimmu.2017.00824] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
618 Mikocka-walus A, Fielder A, Prady SL, Esterman AJ, Knowles S, Andrews JM; Cochrane IBD Group. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
619 Crowe M, Lee S, Seow CH, Kaplan GG, Metcalfe A, Benchimol EI, Kuenzig ME. The impact of surgical therapies for inflammatory bowel disease on female fertility. Cochrane Database of Systematic Reviews 2017. [DOI: 10.1002/14651858.cd012711] [Reference Citation Analysis]
620 Akhuemonkhan E, Parian A, Miller K, Hanauer S, Hutfless S. Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014. BMJ Open Gastroenterol. 2017;4:e000155. [PMID: 28944071 DOI: 10.1136/bmjgast-2017-000155] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
621 Ruiz PA, Morón B, Becker HM, Lang S, Atrott K, Spalinger MR, Scharl M, Wojtal KA, Fischbeck-Terhalle A, Frey-Wagner I, Hausmann M, Kraemer T, Rogler G. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut 2017;66:1216-24. [PMID: 26848183 DOI: 10.1136/gutjnl-2015-310297] [Cited by in Crossref: 169] [Cited by in F6Publishing: 164] [Article Influence: 28.2] [Reference Citation Analysis]
622 Goh KL. Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). J Clin Gastroenterol 2017;51:479-85. [PMID: 28591070 DOI: 10.1097/MCG.0000000000000847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
623 Ananthakrishnan AN, Sakuraba A, Barnes EL, Pekow J, Raffals L, Long MD, Sandler RS. The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease. Aliment Pharmacol Ther 2017;46:162-8. [PMID: 28470787 DOI: 10.1111/apt.14125] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
624 Valer P, Algaba A, Santos D, Fuentes ME, Nieto E, Gisbert JP, López P, Quintanilla E, García-Alonso FJ, Guerra I, Páez Á, Bermejo F. Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:1144-53. [PMID: 28520588 DOI: 10.1097/MIB.0000000000001081] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
625 Article E. CLINICAL GUIDE OF RUSSIAN ASSOCIATION OF GASTROENTEROLOGY AND RUSSIAN ASSOCIATION OF COLOPROCTOLOGY ON DIAGNOSTICS AND TREATMENT OF CROHN'S DISEASE. Koloproktologiâ 2017. [DOI: 10.33878/2073-7556-2017-0-2-7-29] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
626 Zobeiri M, Bashiri H, Askari L, Keshavars AA, Tavvafzadeh R, Fatahi K, Najafi F. Epidemiologic Characteristics of Patients with Inflammatory Bowel Disease in Kermanshah, Iran. Middle East J Dig Dis. 2017;9:164-169. [PMID: 28894519 DOI: 10.15171/mejdd.2017.68] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
627 Ding H, Dupont AW, Singhal S, Scott LD, Guha S, Younes M, Bi X. In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy. Biomed Opt Express 2017;8:3426-39. [PMID: 28717578 DOI: 10.1364/BOE.8.003426] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
628 Tubbs AL, Liu B, Rogers TD, Sartor RB, Miao EA. Dietary Salt Exacerbates Experimental Colitis. J Immunol. 2017;199:1051-1059. [PMID: 28637899 DOI: 10.4049/jimmunol.1700356] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
629 Sharma P, Aguilar R, Siddiqui OA, Nader MA. Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis. Ann Gastroenterol 2017;30:504-11. [PMID: 28845105 DOI: 10.20524/aog.2017.0168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
630 Ali I, Suhail M, Alothman ZA, Alwarthan A. Chiral separation and modeling of baclofen, bupropion, and etodolac profens on amylose reversed phase chiral column. Chirality 2017;29:386-97. [DOI: 10.1002/chir.22717] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
631 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Intest Res. 2017;15:266-284. [PMID: 28670225 DOI: 10.5217/ir.2017.15.3.266] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
632 Lane ER, Zisman TL, Suskind DL. The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res. 2017;10:63-73. [PMID: 28652796 DOI: 10.2147/jir.s116088] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 20.3] [Reference Citation Analysis]
633 Feuerstein JD, Cheifetz AS. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clin Proc. 2017;92:1088-1103. [PMID: 28601423 DOI: 10.1016/j.mayocp.2017.04.010] [Cited by in Crossref: 171] [Cited by in F6Publishing: 184] [Article Influence: 28.5] [Reference Citation Analysis]
634 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zagórowicz E, Raine T, Harbord M, Rieder F; European Crohn’s and Colitis Organisation [ECCO]. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis 2017;11:649-70. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 1024] [Cited by in F6Publishing: 1019] [Article Influence: 170.7] [Reference Citation Analysis]
635 Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010. Clin Gastroenterol Hepatol 2017;15:857-63. [PMID: 27856364 DOI: 10.1016/j.cgh.2016.10.039] [Cited by in Crossref: 252] [Cited by in F6Publishing: 260] [Article Influence: 42.0] [Reference Citation Analysis]
636 Kordbacheh H, Baliyan V, Serrao J, Gee MS, Yajnik V, Sahani DV, Kambadakone AR. Imaging in Patients with Crohn's Disease: Trends in Abdominal CT/MRI Utilization and Radiation Exposure Considerations over a 10-Year Period. Inflamm Bowel Dis 2017;23:1025-33. [PMID: 28426472 DOI: 10.1097/MIB.0000000000001088] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
637 Cramer H, Schäfer M, Schöls M, Köcke J, Elsenbruch S, Lauche R, Engler H, Dobos G, Langhorst J. Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis. Aliment Pharmacol Ther 2017;45:1379-89. [PMID: 28378342 DOI: 10.1111/apt.14062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
638 Qasem A, Naser AE, Naser SA. The alternate effects of anti-TNFα therapeutics and their role in mycobacterial granulomatous infection in Crohn's disease. Expert Rev Anti Infect Ther 2017;15:637-43. [PMID: 28481651 DOI: 10.1080/14787210.2017.1328276] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
639 Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, Dallel R, Guttmann A, Clavelou P, Buisson A. Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study. Eur J Pain 2017;21:1550-60. [DOI: 10.1002/ejp.1056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
640 Gale HI, Sharatz SM, Taphey M, Bradley WF, Nimkin K, Gee MS. Comparison of CT enterography and MR enterography imaging features of active Crohn disease in children and adolescents. Pediatr Radiol 2017;47:1321-8. [DOI: 10.1007/s00247-017-3876-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
641 Lee AD, Spiegel BM, Hays RD, Melmed GY, Bolus R, Khanna D, Khanna PP, Chang L. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population. Neurogastroenterol Motil 2017;29. [PMID: 27981684 DOI: 10.1111/nmo.13003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
642 Bounthavong M, Li M, Watanabe JH. An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013. Research in Social and Administrative Pharmacy 2017;13:530-8. [DOI: 10.1016/j.sapharm.2016.05.042] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
643 Foulon A, Dupas JL, Sabbagh C, Chevreau J, Rebibo L, Brazier F, Bouguen G, Gondry J, Fumery M. Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis 2017;23:712-20. [PMID: 28426452 DOI: 10.1097/MIB.0000000000001112] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
644 Uygun A, Ozturk K, Demirci H, Oger C, Avci IY, Turker T, Gulsen M. Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis. Medicine (Baltimore) 2017;96:e6479. [PMID: 28422836 DOI: 10.1097/MD.0000000000006479] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
645 Sasidharan S, Yajnik V, Khalili H, Garber J, Xavier R, Ananthakrishnan AN. Genetic risk factors for serious infections in inflammatory bowel diseases. Scand J Gastroenterol 2017;52:570-6. [PMID: 28162010 DOI: 10.1080/00365521.2017.1286381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
646 Chandan JS, Thomas T. Inflammatory bowel disease and oral health. BDJ Team 2017;4:17083. [DOI: 10.1038/bdjteam.2017.83] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
647 Gerçeker E, Yüceyar H, Kasap E, Demirci U, Ekti BC, Aydoğdu İ, Miskioğlu M. Treatment of inflammatory bowel disease by leukocytapheresis. Transfus Apher Sci 2017;56:421-6. [PMID: 28454883 DOI: 10.1016/j.transci.2017.03.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
648 Smith CE, Werkowitch M, Yadrich DM, Thompson N, Nelson EL. Identification of Depressive Signs in Patients and Their Family Members During iPad-based Audiovisual Sessions. Comput Inform Nurs 2017;35:352-7. [PMID: 28445171 DOI: 10.1097/CIN.0000000000000353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
649 Patel H, Lissoos T, Rubin DT. Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States. PLoS One 2017;12:e0175099. [PMID: 28426675 DOI: 10.1371/journal.pone.0175099] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
650 Malarcher CA, Wheaton AG, Liu Y, Greenlund SF, Greenlund SJ, Lu H, Croft JB. Hospitalizations for Crohn's Disease - United States, 2003-2013. MMWR Morb Mortal Wkly Rep 2017;66:377-81. [PMID: 28406887 DOI: 10.15585/mmwr.mm6614a1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
651 Issac R, Pengan MC, Anandam AJ. INTESTINAL AND EXTRAINTESTINAL MANIFESTATIONS OF CROHN’S DISEASE- A CROSSSECTIONAL STUDY. jebmh 2017;4:1791-1793. [DOI: 10.18410/jebmh/2017/348] [Reference Citation Analysis]
652 Dimitrov V, White JH. Vitamin D signaling in intestinal innate immunity and homeostasis. Mol Cell Endocrinol 2017;453:68-78. [PMID: 28412519 DOI: 10.1016/j.mce.2017.04.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
653 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 11.5] [Reference Citation Analysis]
654 Lightner AL, Shen B. Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era". Gastroenterol Rep (Oxf) 2017;5:165-77. [PMID: 28852521 DOI: 10.1093/gastro/gow046] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
655 Deol N, Nguyen TM, Parker CE, Khanna R, Feagan BG, Macdonald JK, Jairath V. Infliximab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2017. [DOI: 10.1002/14651858.cd012623] [Reference Citation Analysis]
656 Hillary T, Gutermuth J. Should psoriasis be considered a risk factor for hypogonadism in male patients? A monocentric, prospective, observational pilot study. J Eur Acad Dermatol Venereol 2017;31:e197-8. [PMID: 27556231 DOI: 10.1111/jdv.13944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
657 Hammer T, Lophaven SN, Nielsen KR, von Euler-Chelpin M, Weihe P, Munkholm P, Burisch J, Lynge E. Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development. Aliment Pharmacol Ther 2017;45:1107-14. [PMID: 28176348 DOI: 10.1111/apt.13975] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
658 Gu YB, Zhang MC, Sun J, Lv KZ, Zhong J. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China. J Dig Dis 2017;18:207-11. [PMID: 28251812 DOI: 10.1111/1751-2980.12461] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
659 Strisciuglio C, Giugliano F, Martinelli M, Cenni S, Greco L, Staiano A, Miele E. Impact of Environmental and Familial Factors in a Cohort of Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;64:569-74. [PMID: 27306105 DOI: 10.1097/MPG.0000000000001297] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
660 Mărginean CO, Meliţ LE, Mocanu S, Mărginean MO. Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature. Medicine (Baltimore) 2017;96:e6329. [PMID: 28296755 DOI: 10.1097/MD.0000000000006329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
661 Kostić M, Djakovic L, Šujić R, Godman B, Janković SM. Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications. Appl Health Econ Health Policy 2017;15:85-93. [PMID: 27587010 DOI: 10.1007/s40258-016-0272-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
662 Ritchie LE, Taddeo SS, Weeks BR, Carroll RJ, Dykes L, Rooney LW, Turner ND. Impact of Novel Sorghum Bran Diets on DSS-Induced Colitis. Nutrients 2017;9:E330. [PMID: 28346392 DOI: 10.3390/nu9040330] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
663 Bibi S, Kang Y, Du M, Zhu MJ. Maternal high-fat diet consumption enhances offspring susceptibility to DSS-induced colitis in mice. Obesity (Silver Spring) 2017;25:901-8. [PMID: 28339172 DOI: 10.1002/oby.21816] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
664 Guan Q, Zhang J. Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm 2017;2017:4810258. [PMID: 28420941 DOI: 10.1155/2017/4810258] [Cited by in Crossref: 77] [Cited by in F6Publishing: 92] [Article Influence: 12.8] [Reference Citation Analysis]
665 Manceau H, Chicha-Cattoir V, Puy H, Peoc'h K. Fecal calprotectin in inflammatory bowel diseases: update and perspectives. Clin Chem Lab Med. 2017;55:474-483. [PMID: 27658156 DOI: 10.1515/cclm-2016-0522] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 9.3] [Reference Citation Analysis]
666 Samples J, Evans K, Chaumont N, Strassle P, Sadiq T, Koruda M. Variant Two-Stage Ileal Pouch-Anal Anastomosis: An Innovative and Effective Alternative to Standard Resection in Ulcerative Colitis. J Am Coll Surg. 2017;224:557-563. [PMID: 28315811 DOI: 10.1016/j.jamcollsurg.2016.12.049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
667 Bergeron F, Bouin M, D'Aoust L, Lemoyne M, Presse N. Food avoidance in patients with inflammatory bowel disease: What, when and who? Clin Nutr 2018;37:884-9. [PMID: 28359542 DOI: 10.1016/j.clnu.2017.03.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
668 Bao X, Feng Z, Yao J, Li T, Yin Y. Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm. 2017;2017:6869259. [PMID: 28392631 DOI: 10.1155/2017/6869259] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
669 Khan I, Samson SE, Grover AK. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal. Med Princ Pract 2017;26:201-17. [PMID: 28278495 DOI: 10.1159/000468988] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
670 Figliuolo VR, Savio LEB, Safya H, Nanini H, Bernardazzi C, Abalo A, de Souza HSP, Kanellopoulos J, Bobé P, Coutinho CMLM, Coutinho-Silva R. P2X7 receptor promotes intestinal inflammation in chemically induced colitis and triggers death of mucosal regulatory T cells. Biochim Biophys Acta Mol Basis Dis 2017;1863:1183-94. [PMID: 28286160 DOI: 10.1016/j.bbadis.2017.03.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
671 Dart RJ, Samaan MA, Powell N, Irving PM. Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis. Clin Exp Gastroenterol 2017;10:57-66. [PMID: 28424557 DOI: 10.2147/CEG.S110547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
672 Young Cho J, Yeon Kim H, Me Kim H, Na Song H, Hong E, Hwang J, Sook Chun H. Standardized ethanolic extract of the rhizome of Curcuma xanthorrhiza prevents murine ulcerative colitis by regulation of inflammation. Journal of Functional Foods 2017;30:282-9. [DOI: 10.1016/j.jff.2017.01.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
673 Panizza PSB, Viana PCC, Horvat N, dos Santos VR, de Araújo DAP, Yamanari TR, Leite CDC, Cerri GG. Inflammatory Bowel Disease: Current Role of Imaging in Diagnosis and Detection of Complications: Gastrointestinal Imaging. RadioGraphics 2017;37:701-2. [DOI: 10.1148/rg.2017160050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
674 Cummins EP, Crean D. Hypoxia and inflammatory bowel disease. Microbes and Infection 2017;19:210-21. [DOI: 10.1016/j.micinf.2016.09.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
675 Metzger CE, Narayanan A, Zawieja DC, Bloomfield SA. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover: IBD IN RODENT MODEL ALTERS OSTEOCYTE PROTEIN CONTROLLING BONE TURNOVER. J Bone Miner Res 2017;32:802-13. [DOI: 10.1002/jbmr.3027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
676 Li X, Song P, Li J, Tao Y, Li G, Li X, Yu Z. The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2017;14. [PMID: 28264519 DOI: 10.3390/ijerph14030238] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
677 Kim H, Banerjee N, Sirven MA, Minamoto Y, Markel ME, Suchodolski JS, Talcott ST, Mertens-Talcott SU. Pomegranate polyphenolics reduce inflammation and ulceration in intestinal colitis-involvement of the miR-145/p70S6K1/HIF1α axis in vivo and in vitro. J Nutr Biochem 2017;43:107-15. [PMID: 28282584 DOI: 10.1016/j.jnutbio.2017.02.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
678 Sarkate A, Dhaneshwar SS. Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation. World J Gastroenterol 2017; 23(7): 1147-1162 [PMID: 28275295 DOI: 10.3748/wjg.v23.i7.1147] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
679 Singh S, Chowdhry M, Umar S, Bilal M, Clarke K. Variations in the medical treatment of inflammatory bowel disease among gastroenterologists. Gastroenterol Rep (Oxf) 2018;6:61-4. [PMID: 29479445 DOI: 10.1093/gastro/gox005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
680 Manresa MC, Taylor CT. Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function. Cell Mol Gastroenterol Hepatol 2017;3:303-15. [PMID: 28462372 DOI: 10.1016/j.jcmgh.2017.02.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
681 Nakagome S, Chinen H, Iraha A, Hokama A, Takeyama Y, Sakisaka S, Matsui T, Kidd JR, Kidd KK, Said HS, Suda W, Morita H, Hattori M, Hanihara T, Kimura R, Ishida H, Fujita J, Kinjo F, Mano S, Oota H. Confounding effects of microbiome on the susceptibility of TNFSF15 to Crohn's disease in the Ryukyu Islands. Hum Genet 2017;136:387-97. [PMID: 28197769 DOI: 10.1007/s00439-017-1764-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
682 Sotillo J, Ferreira I, Potriquet J, Laha T, Navarro S, Loukas A, Mulvenna J. Changes in protein expression after treatment with Ancylostoma caninum excretory/secretory products in a mouse model of colitis. Sci Rep 2017;7:41883. [PMID: 28191818 DOI: 10.1038/srep41883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
683 Nemati S, Teimourian S. An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets. Middle East J Dig Dis. 2017;9:69-80. [PMID: 28638582 DOI: 10.15171/mejdd.2017.54] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
684 Kirk PS, Govani S, Borza T, Hollenbeck BK, Davis J, Shumway D, Waljee AK, Skolarus TA. Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel Disease. Urology 2017;104:131-6. [PMID: 28163082 DOI: 10.1016/j.urology.2017.01.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
685 Schreiner P, Biedermann L, Rossel JB, Rogler G, Pittet V, von Känel R; Swiss IBD Cohort Study Group. Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:310-7. [PMID: 28079622 DOI: 10.1097/MIB.0000000000001012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
686 Gao Y, Khan S, Akerman M, Sultan K. Analysis of the clinical indications for opiate use in inflammatory bowel disease. Intest Res 2017;15:83-9. [PMID: 28239317 DOI: 10.5217/ir.2017.15.1.83] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
687 Melinder C, Hiyoshi A, Fall K, Halfvarson J, Montgomery S. Stress resilience and the risk of inflammatory bowel disease: a cohort study of men living in Sweden. BMJ Open 2017;7:e014315. [PMID: 28130207 DOI: 10.1136/bmjopen-2016-014315] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
688 Chen X, Hou J, Yuan Y, Huang C, Liu T, Mo C, Li H, Chen B, Xu Q, Hou Z, He W, Liu F. Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis. BioDrugs 2016;30:207-17. [PMID: 27120055 DOI: 10.1007/s40259-016-0173-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
689 Tanideh N, Jamshidzadeh A, Sepehrimanesh M, Hosseinzadeh M, Koohi-Hosseinabadi O, Najibi A, Raam M, Daneshi S, Asadi-Yousefabad SL. Healing acceleration of acetic acid-induced colitis by marigold (Calendula officinalis) in male rats. Saudi J Gastroenterol 2016;22:50-6. [PMID: 26831607 DOI: 10.4103/1319-3767.173759] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
690 Földes A, Kádár K, Kerémi B, Zsembery Á, Gyires K, S Zádori Z, Varga G. Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage. Curr Neuropharmacol 2016;14:914-34. [PMID: 26791480 DOI: 10.2174/1570159x14666160121115210] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
691 Rayen J, Currie T, Gearry RB, Frizelle F, Eglinton T. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease. Tech Coloproctol 2017;21:119-24. [PMID: 28066859 DOI: 10.1007/s10151-016-1578-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
692 Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18:2. [PMID: 28061847 DOI: 10.1186/s12865-016-0187-3] [Cited by in Crossref: 325] [Cited by in F6Publishing: 339] [Article Influence: 54.2] [Reference Citation Analysis]
693 Ananthakrishnan AN. The New Face of IBD. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
694 Hibi T, Imai Y, Senoo A, Ohta K, Ukyo Y. Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study). J Gastroenterol 2017;52:1101-11. [PMID: 28324167 DOI: 10.1007/s00535-017-1326-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
695 Frigstad SO, Høivik M, Jahnsen J, Dahl SR, Cvancarova M, Grimstad T, Berset IP, Huppertz-Hauss G, Hovde Ø, Torp R, Bernklev T, Moum B, Jelsness-Jørgensen LP. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol 2017;52:100-6. [PMID: 27603182 DOI: 10.1080/00365521.2016.1233577] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 10.3] [Reference Citation Analysis]
696 Saeed SA, Kugathasan S. Epidemiology of Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
697 Rossetto C, Bisognin M, Guimarães A, Zeni L, Giovanella L, Enokawa M, Zardo B, Cunha J, Muller C, Paiva E. VASCULITE LEUCOCITOCLÁSTICA INDUZIDA POR ADALIMUMABE. Revista Brasileira de Reumatologia 2017;57:S303-S304. [DOI: 10.1016/j.rbr.2017.07.404] [Reference Citation Analysis]
698 Patel JD, Gale HI, Chang KJ. Imaging of Large Bowel with Multidetector Row CT. Multislice CT 2017. [DOI: 10.1007/174_2017_7] [Reference Citation Analysis]
699 Coward S, Kaplan GG. IBD in the New World, Old World, and Your World. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
700 Vatn MH. Environmental Factors in the Epidemiology of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_1] [Reference Citation Analysis]
701 Targownik LE, Bernstein CN. The Economics of Inflammatory Bowel Disease. Clinical Gastroenterology 2017. [DOI: 10.1007/978-3-319-53763-4_21] [Reference Citation Analysis]
702 Schoeb TR. Gnotobiotics and Inflammatory Bowel Disease. Gnotobiotics 2017. [DOI: 10.1016/b978-0-12-804561-9.00008-6] [Reference Citation Analysis]
703 Vong LB, Nagasaki Y. Development of Redox Nanomedicine for Gastrointestinal Complications via Oral Administration Route. ACS Symposium Series 2017. [DOI: 10.1021/bk-2017-1253.ch002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
704 Alam P, Dash S, Climent C, Kaur G, Choudhury AR, Casanova D, Alemany P, Chowdhury R, Laskar IR. ‘Aggregation induced emission’ active iridium( iii ) complexes with applications in mitochondrial staining. RSC Adv 2017;7:5642-8. [DOI: 10.1039/c6ra24792j] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
705 Sadraei H, Asghari G, Khanabadi M, Minaiyan M. Anti-inflammatory effect of apigenin and hydroalcoholic extract of Dracocephalum kotschyi on acetic acid-induced colitis in rats. Res Pharm Sci 2017;12:322-9. [PMID: 28855944 DOI: 10.4103/1735-5362.212050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
706 Hendel K, Kjærgaard S, El-hussuna A. A systematic review of pre, peri and postoperative factors and their implications for the lengths of resected bowel segments in patients with Crohn's disease. International Journal of Surgery Open 2017;7:10-6. [DOI: 10.1016/j.ijso.2017.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
707 Conaghan PJ, Mortensen NJMC. Inflammatory Bowel Disease: Ulcerative Colitis. Coloproctology 2017. [DOI: 10.1007/978-3-662-53210-2_14] [Reference Citation Analysis]
708 Sonnenberg A, Turner KO, Genta RM. Differences in the socio-economic distribution of inflammatory bowel disease and microscopic colitis. Colorectal Dis 2017;19:38-44. [PMID: 27166978 DOI: 10.1111/codi.13378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
709 Smythe M. Orally Delivered Peptides for Treatment of Inflammatory Bowel Disease. Comprehensive Medicinal Chemistry III 2017. [DOI: 10.1016/b978-0-12-409547-2.12417-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
710 White JH. Vitamin D deficiency and the pathogenesis of Crohn's disease. J Steroid Biochem Mol Biol 2018;175:23-8. [PMID: 28025175 DOI: 10.1016/j.jsbmb.2016.12.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
711 Algahtani FH, Farag YM, Aljebreen AM, Alazzam NA, Aleem AS, Jabri FF, Rajab MH, Shoukri MM. Thromboembolic events in patients with inflammatory bowel disease. Saudi J Gastroenterol 2016;22:423-7. [PMID: 27976637 DOI: 10.4103/1319-3767.195558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
712 Silva FA, Rodrigues BL, Ayrizono ML, Leal RF. The Immunological Basis of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:2097274. [PMID: 28070181 DOI: 10.1155/2016/2097274] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 10.7] [Reference Citation Analysis]
713 Thomas AS, Lin P. Ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol. 2016;27:552-560. [PMID: 27585211 DOI: 10.1097/icu.0000000000000310] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
714 Al-Maawali AK, Nguyen P, Phang PT. Modern Treatments and Stem Cell Therapies for Perianal Crohn's Fistulas. Can J Gastroenterol Hepatol 2016;2016:1651570. [PMID: 28053967 DOI: 10.1155/2016/1651570] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
715 Tanideh N, Bahrani M, Khoshnood-mansoorkhani MJ, Mehrabani D, Firoozi D, Koohi-hosseinabadi O, Iraji A. Evaluating the Effect of Melillotus officinalis L. Aqueous Extracts on Healing of Acetic Acid-Induced Ulcerative Colitis in Male Rats. Ann Colorectal Res 2016;4. [DOI: 10.17795/acr-42856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
716 Kalla R, Kennedy NA, Ventham NT, Boyapati RK, Adams AT, Nimmo ER, Visconti MR, Drummond H, Ho GT, Pattenden RJ, Wilson DC, Satsangi J. Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases. Am J Gastroenterol 2016;111:1796-805. [PMID: 27596694 DOI: 10.1038/ajg.2016.342] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 8.9] [Reference Citation Analysis]
717 Wang Q, Wang G, Zhou J, Gao L, Cui Y. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis. International Journal of Pharmaceutics 2016;515:176-85. [DOI: 10.1016/j.ijpharm.2016.10.002] [Cited by in Crossref: 93] [Cited by in F6Publishing: 75] [Article Influence: 13.3] [Reference Citation Analysis]
718 Manresa MC, Tambuwala MM, Radhakrishnan P, Harnoss JM, Brown E, Cavadas MA, Keogh CE, Cheong A, Barrett KE, Cummins EP, Schneider M, Taylor CT. Hydroxylase inhibition regulates inflammation-induced intestinal fibrosis through the suppression of ERK-mediated TGF-β1 signaling. [corrected]. Am J Physiol Gastrointest Liver Physiol 2016;311:G1076-90. [PMID: 27789456 DOI: 10.1152/ajpgi.00229.2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
719 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
720 Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756-1770. [PMID: 27914657 DOI: 10.1016/s0140-6736(16)32126-2] [Cited by in Crossref: 1306] [Cited by in F6Publishing: 1116] [Article Influence: 186.6] [Reference Citation Analysis]
721 Semerano L, Julia C, Aitisha O, Boissier MC. Nutrition and chronic inflammatory rheumatic disease. Joint Bone Spine 2017;84:547-52. [PMID: 27914804 DOI: 10.1016/j.jbspin.2016.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
722 Opheim R, Lie Høivik M, Bernklev T, Jelsness-Jørgensen LP, Moum B. The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of Life. Gastroenterol Res Pract 2016;2016:6453657. [PMID: 28003821 DOI: 10.1155/2016/6453657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
723 Gregoire C, Lechanteur C, Briquet A, Baudoux E, Giet O, Delloye O, Baron F, Louis E, Beguin Y. The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn's disease. The Biology and Therapeutic Application of Mesenchymal Cells 2016. [DOI: 10.1002/9781118907474.ch50] [Reference Citation Analysis]
724 Rodrigues AV, Puri CP, Bhanushali PB, Shukla KK, Roychoudhury S, Badgujar SB. Development of an indirect immunofluorescence based assay for diagnosis of ulcerative colitis in Indian population. Immunol Lett 2017;181:20-5. [PMID: 27845152 DOI: 10.1016/j.imlet.2016.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
725 Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M. Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease. Dis Markers 2016;2016:6485343. [PMID: 27965521 DOI: 10.1155/2016/6485343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
726 Weigmann B, Neurath MF. Th9 cells in inflammatory bowel diseases. Semin Immunopathol. 2017;39:89-95. [PMID: 27837255 DOI: 10.1007/s00281-016-0603-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
727 Gkentzis A, Kimuli M, Cartledge J, Traxer O, Biyani CS. Urolithiasis in inflammatory bowel disease and bariatric surgery. World J Nephrol 2016; 5(6): 538-546 [PMID: 27872836 DOI: 10.5527/wjn.v5.i6.538] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
728 Li M, Dick A, Hassold N, Pabst T, Bley T, Köstler H, Neubauer H. CAIPIRINHA-accelerated T1w 3D-FLASH for small-bowel MR imaging in pediatric patients with Crohn's disease: assessment of image quality and diagnostic performance. World J Pediatr 2016;12:455-62. [PMID: 27457791 DOI: 10.1007/s12519-016-0047-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
729 Jelsness-Jørgensen LP, Bernklev T, Hovde Ø, Prytz Berset I, Huppertz-Hauss G, Moum B, Lie Høivik M. Patients' perceptions of quality of care and follow-up in inflammatory bowel disease. Scand J Gastroenterol 2016;51:434-41. [PMID: 26635189 DOI: 10.3109/00365521.2015.1102319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
730 Pereira C, Coelho R, Grácio D, Dias C, Silva M, Peixoto A, Lopes P, Costa C, Teixeira JP, Macedo G, Magro F. DNA Damage and Oxidative DNA Damage in Inflammatory Bowel Disease. J Crohns Colitis 2016;10:1316-23. [PMID: 27095753 DOI: 10.1093/ecco-jcc/jjw088] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
731 Anand S, Garg SK, Campbell JP, Singh S, Wadhwa V, Hussein IM, Kumar A, Ahuja V. Oral janus kinase inhibitors for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2016. [DOI: 10.1002/14651858.cd012420] [Reference Citation Analysis]
732 Wilson JC, Furlano RI, Jick SS, Meier CR. A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease. J Gastroenterol 2016;51:1050-62. [PMID: 27056729 DOI: 10.1007/s00535-016-1199-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
733 Fujii T, Sato M, Hosoi K, Ohbayashi N, Ikuse T, Jimbo K, Aoyagi Y, Kudo T, Ohtsuka Y, Shimizu T. Assessment of the Family History of Patients With Ulcerative Colitis at a Single Center in Japan. J Pediatr Gastroenterol Nutr 2016;63:512-5. [PMID: 27352080 DOI: 10.1097/MPG.0000000000001275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
734 Hsu TY, Shih HM, Wang YC, Lin LC, He GY, Chen CY, Kao CH, Chen CH, Chen WK, Yang TY. Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study. PLoS One 2016;11:e0165411. [PMID: 27802288 DOI: 10.1371/journal.pone.0165411] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
735 Arulanandan A, Dulai PS, Singh S, Sandborn WJ, Kalmaz D. Systematic review: Safety of balloon assisted enteroscopy in Crohn’s disease. World J Gastroenterol 2016; 22(40): 8999-9011 [PMID: 27833391 DOI: 10.3748/wjg.v22.i40.8999] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
736 Ferguson LR, Barnett MP. Why Are Omics Technologies Important to Understanding the Role of Nutrition in Inflammatory Bowel Diseases? Int J Mol Sci 2016;17:E1763. [PMID: 27775675 DOI: 10.3390/ijms17101763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
737 Chen YL, Chen YT, Lo CF, Hsieh CI, Chiu SY, Wu CY, Yeh YS, Hung SH, Cheng PH, Su YH, Jiang ST, Chin HJ, Su YC. Early Detection of T cell Transfer-induced Autoimmune Colitis by In Vivo Imaging System. Sci Rep 2016;6:35635. [PMID: 27762297 DOI: 10.1038/srep35635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
738 Hussein IM, Parker CE, Jairath V, Khanna R. Oral janus kinase inhibitors for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2016. [DOI: 10.1002/14651858.cd012381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
739 Gurvits GE, Lan G, Tan A, Weissman A. Vaccination practices in patients with inflammatory bowel disease among general internal medicine physicians in the USA. Postgrad Med J 2017;93:333-7. [PMID: 27733673 DOI: 10.1136/postgradmedj-2016-134266] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
740 Donia M, Pedersen M, Svane IM. Cancer immunotherapy in patients with preexisting autoimmune disorders. Semin Immunopathol 2017;39:333-7. [DOI: 10.1007/s00281-016-0595-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
741 Cleveland NK, Rodriquez D, Wichman A, Pan I, Melmed GY, Rubin DT. Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis. Dig Dis Sci 2016;61:2972-6. [PMID: 27557706 DOI: 10.1007/s10620-016-4275-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
742 Kaaru E, Bianchi A, Wunder A, Rasche V, Stiller D. Molecular Imaging in Preclinical Models of IBD with Nuclear Imaging Techniques: State-of-the-Art and Perspectives. Inflamm Bowel Dis 2016;22:2491-8. [PMID: 27580387 DOI: 10.1097/MIB.0000000000000904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
743 McLean LP, Cross RK. Integrin antagonists as potential therapeutic options for the treatment of Crohn's disease. Expert Opin Investig Drugs 2016;25:263-73. [PMID: 26822204 DOI: 10.1517/13543784.2016.1148137] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
744 Xu Y, Dong H, Ge C, Gao Y, Liu H, Li W, Zhang C. CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation. Ann Transl Med 2016;4:301. [PMID: 27668221 DOI: 10.21037/atm.2016.08.25] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
745 Xiong J, Zhou MF, Wang YD, Chen LP, Xu WF, Wang YD, Deng F, Liu SD. Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice. Sci Rep 2016;6:34079. [PMID: 27659202 DOI: 10.1038/srep34079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
746 Quezada SM, Langenberg P, Cross RK. Cigarette smoking adversely affects disease activity and disease-specific quality of life in patients with Crohn's disease at a tertiary referral center. Clin Exp Gastroenterol 2016;9:307-10. [PMID: 27703391 DOI: 10.2147/CEG.S104652] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
747 Li Y, Chen P, Sun J, Huang J, Tie H, Li L, Li H, Ren G. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease. Sci Rep 2016;6:33550. [PMID: 27633114 DOI: 10.1038/srep33550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
748 Wang X, Qin L, Cao J, Zhao J. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn's disease: a systematic review and meta-analysis. Curr Med Res Opin 2016;32:2007-12. [PMID: 27533749 DOI: 10.1080/03007995.2016.1226168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
749 Zamani MR, Aslani S, Salmaninejad A, Javan MR, Rezaei N. PD-1/PD-L and autoimmunity: A growing relationship. Cell Immunol 2016;310:27-41. [PMID: 27660198 DOI: 10.1016/j.cellimm.2016.09.009] [Cited by in Crossref: 160] [Cited by in F6Publishing: 172] [Article Influence: 22.9] [Reference Citation Analysis]
750 Peyrin-biroulet L, Chamaillard M. Invited review: NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. Journal of Endotoxin Research 2007;13:135-9. [DOI: 10.1177/0968051907080429] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
751 Semerano L, Julia C, Aitisha O, Boissier M. Alimentation et rhumatismes inflammatoires. Revue du Rhumatisme Monographies 2016;83:238-244. [DOI: 10.1016/j.monrhu.2016.07.001] [Reference Citation Analysis]
752 Schoehl J, Mechie NC, Schwoerer H, Moerer O, Quintel M, Buck C, Ellenrieder V, Neesse A, Amanzada A. Severe Acute Respiratory Distress Syndrome during Infliximab Therapy in a Patient with Crohn Disease. Case Rep Gastroenterol 2016;10:574-80. [PMID: 27920644 DOI: 10.1159/000450676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1]